Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,retinoid binding (GO:0005501),-0.8374368816368012,-2.253117166144583,0.0,0.0,0.0,8/22,6.28%,ALDH1A2;NR2F2;PTGDS;RBP1;CYP26B1;ABCA4;RBP4;CRABP2
prerank,cation channel activity (GO:0005261),-0.5344212705096366,-1.9106035504918863,0.0,0.048615446356907156,0.085,26/94,12.81%,SLC24A3;TRPM3;NALCN;PIEZO2;MCU;ANXA2;PKD1;KCNK5;ANO6;PKD2;TRPC3;ABCC9;TRPM6;ANXA6;KCNQ4;ANO1;CALHM2;CACNA1D;CALHM5;TRPC6;TRPM4;SLC24A5;TMEM175;CACNB2;PSEN1;PANX1
prerank,metalloendopeptidase activity (GO:0004222),-0.5326015053581203,-1.8871856439075254,0.0,0.045638990457504684,0.12,24/76,11.61%,TRABD2B;THSD4;ADAMTS2;ADAMTS12;ADAMTSL3;ADAMTS10;ADAMTS6;ADAMTSL5;MMP14;MMP16;ADAMTS5;ADAM9;ADAMTS17;ADAMTSL4;ADAMTS15;ADAMTSL1;MMP2;ADAMTS16;ADAM19;ADAM33;IDE;ADAMTS1;MMP19;AFG3L2
prerank,sialyltransferase activity (GO:0008373),0.7910486558760013,1.848449955077869,0.001692047377326565,0.3296419902912621,0.247,6/20,2.39%,ST8SIA4;ST6GALNAC3;ST3GAL6;ST8SIA6;ST3GAL1;ST6GALNAC2
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),0.817711272963416,1.8476809078723428,0.0,0.1112206715210356,0.25,3/16,0.40%,PTPRG;PTPRM;PTPRB
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),0.817711272963416,1.8476809078723428,0.0,0.1112206715210356,0.25,3/16,0.40%,PTPRG;PTPRM;PTPRB
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.6932465461227345,1.8127480587463396,0.0016051364365971107,0.15376592839805825,0.41,5/32,2.87%,SLC6A6;SLC7A5;SLC1A1;SLC38A5;SLC43A2
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.7010354576881624,1.7744079115542353,0.003355704697986577,0.2309503944174757,0.616,5/30,4.15%,SLC39A10;SLC40A1;SLC39A8;SLC30A1;SLC31A1
prerank,cAMP binding (GO:0030552),0.8206136844224547,1.7476805725845874,0.0088339222614841,0.2872642344255663,0.748,5/11,8.10%,PDE2A;RAPGEF2;PDE4D;RAPGEF4;PDE4B
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),-0.7348236071511339,-1.7461278026356684,0.004310344827586207,0.29094856416659237,0.637,4/13,1.89%,BMP6;BMP5;BMP7;BMP4
prerank,inorganic cation transmembrane transporter activity (GO:0022890),-0.5535433496260104,-1.7392954780777345,0.0028735632183908046,0.2541893338089717,0.669,13/48,10.60%,TRPM3;NALCN;PIEZO2;SLC41A1;SLC12A2;PKD2;ABCC9;TRPM6;SLC12A7;CALHM2;CALHM5;TRPC6;TRPM4
prerank,protein phosphatase 2A binding (GO:0051721),0.7109032939362596,1.7361025900654259,0.005,0.2870010185506241,0.797,5/23,4.92%,MFHAS1;DAB2IP;CTTNBP2NL;FOXO1;STRN4
prerank,retinoic acid binding (GO:0001972),-0.7719516690537312,-1.729892402406554,0.0021929824561403508,0.23728967864680875,0.705,4/12,17.20%,NR2F2;CYP26B1;RXRA;RARA
prerank,death receptor activity (GO:0005035),0.8331536320712839,1.7277162252828606,0.007751937984496124,0.2810248217536408,0.821,4/11,2.32%,TNFRSF19;FAS;TNFRSF25;TNFRSF11A
prerank,BMP receptor binding (GO:0070700),-0.7348247777462019,-1.7137975494618813,0.00625,0.24421111974621293,0.755,4/12,1.89%,BMP6;BMP5;BMP7;BMP4
prerank,leak channel activity (GO:0022840),-0.6530373225250963,-1.7069503937126682,0.0024691358024691358,0.23216356015339337,0.783,5/18,12.81%,KCNK2;NALCN;KCNK5;TMEM175;PANX1
prerank,cation transmembrane transporter activity (GO:0008324),0.6144462169598139,1.6936197156294066,0.00463678516228748,0.38514065871089537,0.939,5/48,1.98%,SLC6A6;SLC7A5;SLC7A1;SLC1A1;SLC38A5
prerank,monocarboxylic acid binding (GO:0033293),-0.691214307576284,-1.6927006441280819,0.0072992700729927005,0.24241579714022415,0.838,7/18,22.36%,NR2F2;CYP26B1;RXRA;NR1H4;RARA;PSAP;PYGL
prerank,platelet-derived growth factor binding (GO:0048407),-0.7513684939970569,-1.6899011390698924,0.013513513513513514,0.22442477481494694,0.85,7/11,2.17%,COL1A2;COL3A1;COL1A1;PDGFRB;COL5A1;PDGFRA;COL6A1
prerank,anion transmembrane transporter activity (GO:0008509),0.7843293487283608,1.6849427391724687,0.0056179775280898875,0.38431432038834945,0.955,3/12,1.24%,ABCG2;SLCO2B1;SLC39A8
prerank,acylglycerol lipase activity (GO:0047372),0.8106657198984399,1.6760803946099967,0.009633911368015413,0.3909473604368932,0.965,2/11,2.92%,ABHD2;LIPE
prerank,phospholipid transfer activity (GO:0120014),0.6949980494423789,1.6526951128631473,0.014084507042253521,0.46305654581310673,0.986,12/21,17.57%,CERT1;PLTP;PITPNC1;PRELID2;PITPNA;ABCA3;MTTP;GLTP;PLEKHA3;PITPNB;TRIAP1;C2CD2L
prerank,protease binding (GO:0002020),-0.451162167826149,-1.6469150040767624,0.0,0.3078376965048686,0.946,22/99,8.93%,COL1A2;COL3A1;COL1A1;TIMP2;CCBE1;TIMP3;SLC2A13;ANXA2;ATP9A;STIM1;F3;AMFR;ADAMTSL4;FAP;ECM1;LCOR;BCL2;PRKN;SELENOS;BDKRB2;LDLR;DPP4
prerank,organic anion transmembrane transporter activity (GO:0008514),0.5124433156232198,1.6459492375748923,0.001287001287001287,0.45890123226288276,0.993,11/134,1.98%,SLCO1C1;SLC6A6;SLC7A5;ABCC4;SLC7A1;ABCG2;SLC1A1;MFSD2A;SLCO2B1;SLC39A8;SLC38A5
prerank,calcium channel activity (GO:0005262),-0.46099130765605745,-1.6394125712018872,0.0034482758620689655,0.30368118106959185,0.959,24/84,13.29%,SLC24A3;CACNA1C;CACNA2D3;MCU;ANXA2;PKD1;CACNA2D1;PKD2;TRPC3;ANXA6;P2RX4;CACNA1D;TRPC6;CACNB4;ITGAV;TRPM4;SLC24A5;TRPC4;CACNB2;PSEN1;CATSPER3;PANX1;ORAI2;CACNB1
prerank,lipoprotein particle binding (GO:0071813),0.6813069917589002,1.639077717570458,0.025252525252525252,0.4612977851941748,0.994,4/20,2.93%,PLTP;STAB1;SCARF1;SCARB1
prerank,metallopeptidase activity (GO:0008237),-0.4390631441833114,-1.6366419317698584,0.0,0.28757143151150105,0.964,27/113,11.61%,TRABD2B;THSD4;ADAMTS2;ADAMTS12;ADAMTSL3;ADAMTS10;PAPPA;ADAMTS6;ADAMTSL5;MMP14;MMP16;ANPEP;ADAMTS5;ADAM9;ADAMTS17;ADAMTSL4;ADAMTS15;ADAMTSL1;MMP2;ADAMTS16;ACE;ADAM19;ADAM33;IDE;ADAMTS1;MMP19;AFG3L2
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.7406528207566622,-1.6316644885763083,0.017543859649122806,0.28014119453185715,0.968,3/10,5.61%,SLC6A13;SLC6A12;SLC6A1
prerank,secondary active transmembrane transporter activity (GO:0015291),0.5920315560513367,1.6303599506836703,0.0060790273556231,0.4698068365695793,0.996,6/51,3.10%,SLCO1C1;SLC7A5;MFSD2A;SLCO2B1;SLC16A2;SLC22A8
prerank,alanine transmembrane transporter activity (GO:0022858),0.7589856696699222,1.626964758063394,0.020484171322160148,0.4551421230279126,0.996,2/12,1.98%,SLC6A6;SLC38A5
prerank,sulfuric ester hydrolase activity (GO:0008484),-0.6898481715389322,-1.603617394627668,0.03146067415730337,0.3354135081304438,0.986,8/12,24.60%,SULF1;SULF2;ARSI;ARSB;GNS;GALNS;ARSG;SGSH
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.6411454619894982,-1.592369728756018,0.022321428571428572,0.3474392167573352,0.99,4/15,7.90%,ALDH1A1;ALDH1A2;ALDH7A1;ALDH4A1
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",0.7554736787892842,1.5904625503377505,0.034026465028355386,0.5973874303969161,0.999,2/11,1.14%,SGMS1;SGMS2
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.6855511563791981,1.5891966417169856,0.033628318584070796,0.5696151058522114,0.999,3/20,3.02%,SLC39A10;SLC39A8;SLC30A1
prerank,heparan sulfate sulfotransferase activity (GO:0034483),-0.6546437113447435,-1.587731976577704,0.02522935779816514,0.340950105182535,0.992,8/15,14.18%,HS3ST3A1;HS2ST1;HS3ST3B1;HS6ST1;HS6ST2;NDST2;NDST4;NDST1
prerank,low-density lipoprotein particle binding (GO:0030169),0.7031622252455211,1.581106189076007,0.03146853146853147,0.5780371742462954,1.0,4/16,2.93%,PLTP;STAB1;SCARF1;SCARB1
prerank,cadherin binding (GO:0045296),0.456688237112081,1.5807779710871632,0.0022935779816513763,0.5509945767597086,1.0,55/315,9.27%,PROM1;COBLL1;PTPRM;ITGA6;PTPRB;BSG;DOCK9;TJP1;SPTBN1;KDR;DAB2IP;MACF1;ESYT2;WASF2;BMPR2;EPN2;MRTFB;FASN;TJP2;FNBP1L;TRIM25;FLNB;F11R;STK38;PTPRJ;LRRFIP1;CDH2;CD2AP;STXBP6;PPFIBP1;CDH20;TBC1D2;CTNND1;CTNNB1;HSP90AB1;CDH8;EIF4H;EPS8L2;MRE11;BAIAP2;DBNL;STAT1;PKN2;DCHS1;CDH19;PKP4;PKM;CTNNA3;TWF2;SPTAN1;EIF3E;IQGAP1;CLINT1;SLC3A2;CAPG
prerank,solute:anion antiporter activity (GO:0140323),-0.6640722916924277,-1.577319659955528,0.02666666666666667,0.3513871547905705,0.996,4/14,8.95%,SLC7A11;SLC26A7;SLC26A2;SLC4A2
prerank,amyloid-beta binding (GO:0001540),0.5242468230079607,1.574686434417086,0.011428571428571429,0.5536626285829865,1.0,18/79,11.29%,ITM2A;INSR;CACNA1A;APBB2;FZD6;TGFB2;BCHE;FZD4;CLSTN1;RAMP3;EPHA4;ATP1A3;GRIA4;APBA2;PFDN4;PFDN2;AGER;GRIN2B
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.48599491730726796,1.5729754963771954,0.0,0.5371300612312445,1.0,37/147,10.86%,DOCK4;DOCK9;FGD5;PREX2;RAPGEF2;RASGRF2;DENND3;DOCK1;RASGRP4;ARHGEF15;ELMO1;CYTH1;SPATA13;ARHGEF2;KALRN;RAPGEF1;TIAM1;ABR;RIN3;RAPGEF3;DENND5B;CYTH3;EPS8L2;CCDC88A;DENND4C;RAPGEF4;SOS1;RASGRP2;RGL2;ARHGEF5;PREX1;ARHGEF7;FGD6;EIF2B1;EIF2B2;DENND1B;LAMTOR5
prerank,pentosyltransferase activity (GO:0016763),-0.5140540956122004,-1.571715990376455,0.03021978021978022,0.3481931217055392,0.998,15/36,16.87%,LARGE1;PARP8;PARP3;LACC1;SIRT3;TNKS2;PARP4;PARP11;PARP6;PARP1;UPP2;SIRT2;QPRT;TIPARP;UMPS
prerank,AMP binding (GO:0016208),-0.6944451188268845,-1.5690950615129509,0.03146067415730337,0.3389191117452956,0.999,4/11,10.34%,PRKAG2;MPPED2;PFKP;PRKAG3
prerank,cell adhesion mediator activity (GO:0098631),0.642639169874392,1.5679947077249765,0.034071550255536626,0.5341825730793583,1.0,7/24,11.16%,BSG;ESAM;ROBO4;DSCAML1;CNTN2;BCAM;PLXNB3
prerank,semaphorin receptor binding (GO:0030215),0.6470719353427993,1.5631253321571488,0.02512562814070352,0.5336582220873787,1.0,7/23,9.32%,SEMA3C;SEMA7A;SEMA6A;SEMA6B;SEMA4F;SEMA6D;SEMA4C
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.6878847762562321,-1.5552172408980565,0.015945330296127564,0.3610960704624309,1.0,5/11,11.92%,ITPR1;TRPC3;TRPC6;ITPR2;TRPC4
prerank,phospholipase inhibitor activity (GO:0004859),-0.6971258215966698,-1.5425989952710228,0.04421052631578947,0.3808510616735446,1.0,4/10,5.77%,ANXA2;ANXA1;ANXA4;ANXA5
prerank,FAD binding (GO:0071949),-0.5606843833190955,-1.541896200904762,0.0380952380952381,0.3664923090046878,1.0,11/24,20.48%,MICAL3;DDO;MICAL2;PRODH;MTHFR;CRY2;MICAL1;SQOR;SQLE;KMO;AGPS
prerank,glycerophospholipid flippase activity (GO:0140333),0.7539481964909545,1.5397963998407806,0.044036697247706424,0.6169933252427184,1.0,6/11,9.75%,ATP10A;ATP8A1;ATP11A;ABCA3;ATP11C;ATP10B
prerank,enoyl-CoA hydratase activity (GO:0004300),-0.6908054361613518,-1.5347670180968165,0.04925053533190578,0.37098215612830343,1.0,8/10,25.58%,AUH;ECHDC2;ECHDC1;ECHDC3;EHHADH;ECI1;HADHA;ECHS1
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.7334799321039992,1.5311967250222753,0.05525846702317291,0.6350865267923824,1.0,3/11,2.56%,DAB2IP;MAP4K2;STK38
prerank,SH3 domain binding (GO:0017124),0.527889628432065,1.5306544845397172,0.023703703703703703,0.6142075973121179,1.0,12/62,4.44%,SHANK3;DAB2IP;AFAP1L1;WASF2;ARHGAP27;ELMO1;AFAP1L2;ADAM15;PTPN12;CD2AP;EVL;GRB2
prerank,phosphatidylcholine transporter activity (GO:0008525),0.6940172527461663,1.530126390489084,0.047619047619047616,0.5946764476421637,1.0,9/17,11.60%,ATP10A;PLTP;ABCG1;PITPNC1;PITPNA;ABCA3;ABCA7;ATP10B;MTTP
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.6069379393084576,1.5240278667493945,0.04753521126760563,0.600958973259123,1.0,5/24,7.17%,CERT1;DAB2IP;OSBP;SNX3;PLEKHA5
prerank,phosphatidylinositol binding (GO:0035091),0.502315513729932,1.5219571323098093,0.013755158184319119,0.5905415655339806,1.0,18/91,7.28%,MCF2L;HIP1;MYO1E;ESYT2;FES;HIP1R;SCARB1;EPB41;PARD3;SNX13;PITPNC1;PITPNA;PIGU;CCDC88A;ESYT1;PLEKHF2;FCHO2;WDFY3
prerank,metal ion transmembrane transporter activity (GO:0046873),-0.5329052010018269,-1.5185428821507736,0.04308390022675737,0.40281369838580217,1.0,11/27,19.77%,ITPR1;SLC41A1;SLC12A2;CNNM2;SLC9B2;ITPR2;ATP2A3;ZDHHC13;MAGT1;ATP2B3;TUSC3
prerank,glutamate receptor binding (GO:0035254),0.6680787785634321,1.5138905526807174,0.05273069679849341,0.6060186589805825,1.0,4/17,6.43%,HIP1;SHANK3;HOMER2;HOMER1
prerank,protein tyrosine kinase activity (GO:0004713),0.48232252012748555,1.513609354500348,0.012080536912751677,0.5886194914290048,1.0,21/108,6.86%,FLT1;IGF1R;TEK;KDR;INSR;TIE1;FES;FLT4;PTK2;JAK3;ZAP70;MERTK;LYN;CAMKK2;EPHA4;FYN;RET;YES1;AATK;EPHB4;HCK
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.7235162798814566,1.5108649230020728,0.06273062730627306,0.5810153261988821,1.0,6/12,12.15%,PIK3R6;PIK3R3;PIK3C3;PIK3C2A;IPMK;PIK3CB
prerank,GTPase activator activity (GO:0005096),0.4341043755217877,1.5097164140003712,0.001142857142857143,0.5688038754640206,1.0,58/313,8.64%,CHN2;PLCB1;RASGRP3;DOCK4;DOCK9;FGD5;ARHGAP31;PREX2;ARAP3;TBC1D4;SRGAP2;RAPGEF2;RASGRF2;DENND3;RGS3;ARHGAP27;DOCK1;RASGRP4;ARHGEF15;ELMO1;CYTH1;SPATA13;TBC1D14;ARHGEF2;TBC1D22A;KALRN;RAPGEF1;SIPA1L2;SIPA1;TIAM1;ABR;RIN3;RALGAPA1;GNAQ;TBC1D12;STARD13;RAPGEF3;DENND5B;TBC1D2;CYTH3;USP6NL;EPS8L2;OCRL;CCDC88A;DENND4C;TBC1D5;RAPGEF4;RAP1GDS1;SOS1;RASGRP2;ARHGAP25;RGL2;JUN;ARHGEF5;IQGAP1;PREX1;ARHGEF7;OPHN1
prerank,Toll-like receptor binding (GO:0035325),0.7248298829493278,1.509230036687394,0.06066176470588235,0.554332632628294,1.0,4/11,11.08%,DAB2IP;TIRAP;TOLLIP;S100A8
prerank,peptidoglycan binding (GO:0042834),0.748835004444278,1.5062673125897958,0.07352941176470588,0.5512179114414779,1.0,3/10,3.20%,PGLYRP1;NOD1;NOD2
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),0.7402239993788055,1.505997134002802,0.04275092936802974,0.5372979737929677,1.0,1/10,0.11%,MECOM
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.5945273182152235,1.505479723665278,0.05612244897959184,0.5252743556783341,1.0,14/30,22.16%,RPS6KA1;VIL1;XIAP;BIRC3;CST7;SPOCK1;PTTG1;PRDX5;GAS6;CSTB;SERPINB9;UBE2Z;RPS6KA3;SNCA
prerank,pre-mRNA binding (GO:0036002),-0.5262215406251243,-1.4990425790951345,0.043701799485861184,0.4474223771858214,1.0,10/28,22.46%,CELF2;DDX5;RNPC3;SRSF6;RBM41;U2AF2;U2AF1;TRA2B;TARBP2;RBM24
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.634063089521191,-1.4979305062174042,0.04585152838427948,0.43448906857450514,1.0,4/13,7.90%,ALDH1A1;ALDH1A2;ALDH7A1;ALDH4A1
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),-0.6555690422366199,-1.4954522419336136,0.05625,0.42591666560497377,1.0,4/12,4.30%,GAB2;IRS1;SHC1;FRS2
prerank,protein tyrosine kinase binding (GO:1990782),0.5008304667977147,1.4863952455874414,0.028694404591104734,0.5834189071446353,1.0,10/71,5.52%,GRB14;DOCK4;BMPR2;TJP2;NEDD9;DUSP3;ELMO2;HYAL2;CD4;EPHA4
prerank,cell-cell adhesion mediator activity (GO:0098632),0.5486500343779375,1.4839122117469323,0.0436817472698908,0.5789337454490291,1.0,8/42,6.91%,BSG;ESAM;ROBO4;CD200;DSCAML1;STXBP6;BAIAP2;CNTN2
prerank,fibroblast growth factor binding (GO:0017134),-0.5555934421993746,-1.4767375091073434,0.07259953161592506,0.4677825461210356,1.0,5/21,10.36%,FGFR2;THBS1;KL;API5;ITGAV
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.5175260709851646,1.4753842498293417,0.04424778761061947,0.596826530310206,1.0,6/55,1.98%,SLC6A6;SLC7A5;SLC7A1;SLC16A4;SLC16A2;SLC38A5
prerank,poly(U) RNA binding (GO:0008266),-0.5563113696204016,-1.473785612611741,0.06030150753768844,0.4609868753530129,1.0,7/20,16.37%,RBMS3;RBMS1;HNRNPH1;PATL1;FMR1;PABPC4;PABPC4L
prerank,GTPase regulator activity (GO:0030695),0.4359271571500732,1.4732205103718021,0.009791921664626682,0.5913024986997225,1.0,32/212,6.47%,CHN2;PLCB1;RASGRP3;ARHGAP31;RGS12;PREX2;ARAP3;TBC1D4;SRGAP2;RAPGEF2;SH3BP4;RGS3;ARHGAP27;DOCK1;ARL2BP;TBC1D14;TBC1D22A;SIPA1L2;SIPA1;ABR;RALGAPA1;GNAQ;TBC1D12;STARD13;TBC1D2;USP6NL;OCRL;CCDC88A;TBC1D5;RAP1GDS1;SOS1;ARHGAP25
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.511481354383254,1.4688587512003244,0.0381791483113069,0.5950570811695642,1.0,12/60,6.79%,FLT1;IGF1R;TEK;KDR;INSR;TIE1;FLT4;ACVRL1;MERTK;EPHA4;RET;EPHB4
prerank,cyclic nucleotide binding (GO:0030551),0.6207025653031704,1.46818030040595,0.06907894736842106,0.5838628433914387,1.0,6/21,8.10%,PDE2A;RAPGEF2;CNGA2;PDE4D;RAPGEF4;PDE4B
prerank,fibroblast growth factor receptor binding (GO:0005104),-0.5419997228279191,-1.463074362379998,0.055944055944055944,0.47917739490165506,1.0,4/21,4.69%,FGF1;FRS2;KL;FGF2
prerank,solute:sodium symporter activity (GO:0015370),-0.5228124369494375,-1.462291146098343,0.04922279792746114,0.46671448597609916,1.0,7/27,15.90%,SLC4A10;SLC5A6;SLC20A2;SLC4A7;SLC5A3;SLC5A7;SLC20A1
prerank,chemorepellent activity (GO:0045499),0.5889977833994267,1.4589897663293525,0.06578947368421052,0.6049689859762676,1.0,6/25,6.97%,SEMA3C;SEMA7A;SEMA6A;SEMA6B;SEMA4F;SEMA6D
prerank,potassium ion leak channel activity (GO:0022841),-0.5868394565206887,-1.4574596859103621,0.07228915662650602,0.46694279367292835,1.0,2/15,3.08%,KCNK2;KCNK5
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.6672348908447533,1.454727851596604,0.10841121495327102,0.6090118292264669,1.0,5/12,12.00%,CNOT6L;NOCT;PAN3;PAN2;CNOT6
prerank,C2H2 zinc finger domain binding (GO:0070742),0.6856591255107203,1.4530765920876985,0.09347442680776014,0.6021696995713695,1.0,2/11,4.52%,LEF1;GATA2
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),0.5904112944050312,1.450233199198447,0.07296849087893864,0.6001142483313107,1.0,4/26,1.67%,SLC6A6;ABCG2;SLC16A4;SLC16A2
prerank,estrogen receptor binding (GO:0030331),0.566417132415111,1.4474841912158287,0.06829268292682927,0.5983477963394096,1.0,5/32,9.84%,LEF1;NCOA1;CTNNB1;TACC1;SRARP
prerank,hexose transmembrane transporter activity (GO:0015149),0.6849009381823933,1.4470020932981453,0.08960573476702509,0.5881094508495145,1.0,1/12,0.45%,SLC2A1
prerank,phosphatidylglycerol binding (GO:1901611),0.6798006553754152,1.4454773128000296,0.07530647985989491,0.5826473414001523,1.0,3/13,5.13%,PLTP;PITPNC1;PITPNA
prerank,peptidase inhibitor activity (GO:0030414),-0.48822694979521813,-1.440748844390438,0.04533333333333334,0.49992786733885564,1.0,6/33,10.14%,TIMP2;TFPI;GPC3;ITIH2;SERPIND1;RENBP
prerank,phosphate ion binding (GO:0042301),0.700177299556302,1.4370463812805603,0.11259541984732824,0.6013608423963779,1.0,3/10,11.08%,PDE2A;ADSS2;PNP
prerank,diacylglycerol kinase activity (GO:0004143),0.6898987778233954,1.4368984744622102,0.09596928982725528,0.5905643203883495,1.0,4/11,11.93%,DGKH;DGKI;DGKE;DGKZ
prerank,alkali metal ion binding (GO:0031420),-0.6145094146997734,-1.433714952460207,0.10609480812641084,0.5072731268553083,1.0,3/13,8.71%,ATP1A2;HDAC4;TDG
prerank,calcium ion transmembrane transporter activity (GO:0015085),-0.4406058528095295,-1.427680744631586,0.03987730061349693,0.513383523093235,1.0,14/55,12.81%,SLC24A3;ITPR1;MCU;ANXA2;PKD1;PKD2;TRPC3;ANXA6;CACNA1D;ITPR2;SLC24A5;CACNB2;PSEN1;PANX1
prerank,mRNA 3'-UTR binding (GO:0003730),-0.4073309663966116,-1.4267940117572364,0.03546099290780142,0.5015730414263366,1.0,18/79,16.37%,CELF2;RBMS3;CPEB1;CPEB2;DDX5;RBMS1;AUH;CSDC2;YBX3;FXR2;IGF2BP2;RNF20;FMR1;PCBP4;HNRNPA2B1;PABPC4;TUT1;PABPC4L
prerank,potassium ion transmembrane transporter activity (GO:0015079),-0.4768654592088192,-1.4255634179184284,0.046753246753246755,0.49197682905649925,1.0,8/31,12.59%,KCNK5;SLC12A2;PKD2;ABCC9;KCNQ4;SLC12A7;TMEM175;SLC12A4
prerank,glutamate receptor activity (GO:0008066),0.6017833364417802,1.4233827051856036,0.10211267605633803,0.6294501893428623,1.0,12/19,24.75%,GRID2;GRIA4;GRIK5;GRIK2;GRIK1;GRM7;GRM8;GRIA2;GRM2;GRM3;GRIK3;GRID1
prerank,poly-pyrimidine tract binding (GO:0008187),-0.5274037228539408,-1.4200228373660553,0.09836065573770492,0.4959233444696746,1.0,8/23,19.37%,RBMS3;RBMS1;HNRNPH1;PATL1;FMR1;PABPC4;PABPC4L;U2AF2
prerank,Hsp90 protein binding (GO:0051879),0.5529397394671363,1.4191016283158457,0.0734094616639478,0.6333182783539276,1.0,5/33,4.06%,KDR;UNC45B;NOD2;CYP2E1;FKBP6
prerank,insulin-like growth factor I binding (GO:0031994),0.6614816155643127,1.4179334118855147,0.10566037735849057,0.6265494972260749,1.0,3/13,0.95%,IGF1R;ITGA6;INSR
prerank,outward rectifier potassium channel activity (GO:0015271),-0.6190565071477387,-1.4165955705732578,0.09051724137931035,0.49411648309997325,1.0,3/11,4.66%,KCNK2;KCNT2;PKD2
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),-0.5275748965020781,-1.4152447778381512,0.09429280397022333,0.4864448495104768,1.0,3/22,2.18%,RBMS3;CPEB1;CPEB2
prerank,frizzled binding (GO:0005109),-0.4734209648272247,-1.4148447886198199,0.056847545219638244,0.47583135858463604,1.0,14/34,20.27%,WNT4;WNT5B;RNF43;WNT6;WNT9A;FZD7;MYOC;DVL2;WNT11;LRP6;SFRP1;RYK;WNT16;DVL3
prerank,metalloaminopeptidase activity (GO:0070006),-0.5769382786704625,-1.413755248936045,0.0730593607305936,0.4679496286494704,1.0,5/16,8.24%,MMP14;MMP16;ANPEP;ENPEP;NPEPPS
prerank,ATPase binding (GO:0051117),-0.41102624500564017,-1.4119688474058516,0.03194888178913738,0.46252320764048227,1.0,21/71,13.91%,ANK2;EGFR;SLC2A13;PTPN3;SNTA1;ABCA1;PKD2;AR;ATP6V0A4;ATP1B3;TMTC4;ATP1B2;SELENOS;EZR;TOR1AIP1;ESR1;PGR;PSEN1;SYVN1;NKD2;ATP5IF1
prerank,fatty acid synthase activity (GO:0004312),0.7056863297450571,1.4076300955788934,0.1104868913857678,0.653800526422245,1.0,3/10,12.19%,ELOVL7;ELOVL5;ELOVL6
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),0.6825909525395469,1.402672457648982,0.11218568665377177,0.6606701958486776,1.0,3/10,5.22%,SLCO1C1;SLCO2B1;SLC22A7
prerank,voltage-gated calcium channel activity (GO:0005245),-0.4596920499651615,-1.4017211028432732,0.062034739454094295,0.4810393689863948,1.0,11/37,13.29%,CACNA1C;CACNA2D3;CACNA2D1;PKD2;CACNA1G;CACNA1D;CACNB4;ITGAV;CACNB2;CATSPER3;CACNB1
prerank,actin monomer binding (GO:0003785),0.5944989599057681,1.4015358368211432,0.09844559585492228,0.6535264881931875,1.0,6/22,8.14%,NOS3;MRTFA;MTSS1;TMSB4X;TMSB10;TWF2
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),-0.4975692914085601,-1.3949185213295572,0.09254498714652956,0.4903171881240331,1.0,10/25,16.33%,PARP8;PARP3;SIRT3;TNKS2;PARP4;PARP11;PARP6;PARP1;SIRT2;TIPARP
prerank,amino acid transmembrane transporter activity (GO:0015171),0.5007096148852859,1.3948838981418772,0.08233532934131736,0.6681950343851133,1.0,6/47,2.87%,SLC6A6;SLC7A5;SLC7A1;SLC16A2;SLC38A5;SLC43A2
prerank,poly-purine tract binding (GO:0070717),-0.49301530741602195,-1.394840020629243,0.08753315649867374,0.4801382229213431,1.0,9/27,16.93%,RBMS3;RBMS1;DDX1;PATL1;FMR1;DDX3X;PABPC4;PABPC4L;HNRNPDL
prerank,glucose transmembrane transporter activity (GO:0005355),0.614205175124052,1.3869159178558834,0.11545293072824156,0.6858425015915964,1.0,1/17,0.45%,SLC2A1
prerank,alpha-actinin binding (GO:0051393),-0.4985587673439405,-1.3828273863122114,0.07035175879396985,0.5045712844466245,1.0,8/24,7.86%,CACNA1C;PALLD;PDLIM7;DAG1;PKD2;PDLIM2;PDLIM4;CACNA1D
prerank,protein kinase C activity (GO:0004697),0.6288637081183501,1.378801739852297,0.13489208633093525,0.7053197424052615,1.0,4/14,5.38%,PRKCH;PRKD1;PRKD3;PKN1
prerank,clathrin adaptor activity (GO:0035615),0.6273839888068146,1.3777607989494662,0.11879432624113476,0.6979527854831253,1.0,4/15,12.31%,HIP1;HIP1R;AP2M1;AP2B1
prerank,insulin-like growth factor binding (GO:0005520),0.623665337347073,1.3776035051376798,0.12568306010928962,0.687706808442051,1.0,3/15,0.95%,IGF1R;ITGA6;INSR
prerank,actin binding (GO:0003779),0.41723186143315827,1.3724479083258794,0.03969270166453265,0.6948921186519791,1.0,32/170,8.14%,FLII;PARVB;UTRN;ABLIM1;SYNE1;MACF1;MYRIP;NOS3;KLHL2;SLC6A2;MRTFA;FLNB;CORO2B;PTK2;MTSS1;NOD2;VASH1;SSH2;MYO6;TMSB4X;EPS8;EPS8L2;CCDC88A;ACTN4;DBNL;PRICKLE4;PARVG;SORBS1;MSRB2;FHL3;TMSB10;TWF2
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.5853087559958007,1.3690924517384095,0.16817359855334538,0.696210339897764,1.0,9/18,22.16%,RPS6KA1;VIL1;XIAP;BIRC3;PRDX5;GAS6;SERPINB9;RPS6KA3;SNCA
prerank,voltage-gated chloride channel activity (GO:0005247),-0.6119664199560249,-1.3689721768069576,0.12419700214132762,0.535235613910239,1.0,4/10,9.40%,ANO6;CLCN2;ANO1;CLCN6
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.4481195264563036,1.3681752415498554,0.05091937765205092,0.6889241595420954,1.0,19/100,10.91%,CERT1;HIP1;ARAP3;MYO10;DAB2IP;ARAP2;HIP1R;PARD3;OSBP;SNX13;SNX3;CYTH3;TECPR1;PIRT;PLEKHA5;IQGAP1;CLVS2;DENND1B;FERMT2
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.47180065867548876,1.3602649969656107,0.0950965824665676,0.7073321383316676,1.0,11/60,6.79%,FLT1;IGF1R;TEK;KDR;INSR;TIE1;FLT4;MERTK;EPHA4;RET;EPHB4
prerank,motor activity (GO:0003774),0.4751375600763902,1.358837875129188,0.08017492711370262,0.7024555455888561,1.0,12/60,12.40%,MYO1E;STARD9;KIFC3;MYO6;DNAH3;KIF26A;KIF2A;KIF1A;PIN1;KIF3B;KIF23;DNAH8
prerank,MHC class I protein binding (GO:0042288),0.6343408159373952,1.3576164668236506,0.15185185185185185,0.696828135835645,1.0,7/13,20.17%,PILRA;TUBB;TAP2;CD8B;ATP5F1A;TUBB4B;TAP1
prerank,poly(A) binding (GO:0008143),-0.5110586378499447,-1.356525172712084,0.10476190476190476,0.5624509497904219,1.0,7/21,16.93%,RBMS3;RBMS1;DDX1;DDX3X;PABPC4;PABPC4L;HNRNPDL
prerank,endopeptidase activity (GO:0004175),-0.3255926527808325,-1.3545057156575353,0.0,0.557297595752829,1.0,62/257,18.87%,TRABD2B;THSD4;ADAMTS2;ADAMTS12;ADAMTSL3;ADAMTS10;ADAMTS6;ADAMTSL5;PCSK5;MMP14;HTRA3;MMP16;F3;USP11;USP24;ADAMTS5;ADAM9;ADAMTS17;ADAMTSL4;FAP;BACE2;CTSL;ADAMTS15;USP40;ADAMTSL1;MMP2;ADAMTS16;ACE;ADAM19;KLK2;DPP4;USP2;ADAM33;IDE;RHBDL3;ADAMTS1;MMP19;AFG3L2;PSEN1;CTSH;USP42;USP9X;HTRA4;HTRA2;ADAMTS14;CTSZ;CASP3;MASP1;ACE2;ADAMTS9;NRDC;ZMPSTE24;PRSS12;RHBDF1;PARL;SFRP1;CASP6;CASP4;MBTPS1;PCSK6;GZMM;USP16
prerank,carboxylic ester hydrolase activity (GO:0052689),0.4426830997062815,1.3522606178979921,0.06258890469416785,0.7055001046936962,1.0,11/85,10.76%,ABHD2;BCHE;LIPE;PLA2G4B;PNPLA6;NOTUM;GDPD1;ENPP2;LYPLA1;PTRH2;LIPC
prerank,MAP kinase phosphatase activity (GO:0033549),0.635731550568803,1.3489650188700757,0.18063314711359404,0.7068263509641317,1.0,5/12,14.43%,DUSP7;DUSP3;DUSP1;DUSP16;DUSP8
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.615091098266594,1.3465509624180882,0.13611615245009073,0.7054316564702754,1.0,4/15,9.66%,PIK3R6;PIK3R3;SOCS2;SOCS5
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.6266792536858053,1.3436942002051804,0.1690909090909091,0.7058130452965102,1.0,5/12,13.45%,DAB2IP;CCDC88A;GREM1;PGF;CDH5
prerank,active ion transmembrane transporter activity (GO:0022853),0.506743588290152,1.3424073957581768,0.1254071661237785,0.7011726334951457,1.0,4/37,5.22%,SLCO1C1;SLCO2B1;SLC22A8;SLC22A7
prerank,muscle alpha-actinin binding (GO:0051371),-0.5407675446558163,-1.3387178531455244,0.12962962962962962,0.594985902352352,1.0,5/15,7.75%,PALLD;PDLIM7;PKD2;PDLIM2;PDLIM4
prerank,ribosomal large subunit binding (GO:0043023),-0.5864462443488334,-1.337538584857347,0.15319148936170213,0.5876160420266907,1.0,1/11,2.18%,CPEB2
prerank,metalloexopeptidase activity (GO:0008235),-0.413338745043401,-1.3357031285354024,0.06571428571428571,0.5826871752694458,1.0,14/51,15.76%,CPQ;AEBP1;MMP14;MMP16;ANPEP;ACE;ENPEP;NPEPPS;CPXM1;CPXM2;AGBL1;PEPD;ACE2;ZMPSTE24
prerank,cardiolipin binding (GO:1901612),-0.5949083313645481,-1.3321855657715618,0.16,0.5824292825697445,1.0,3/10,18.56%,GSDME;GSDMD;PLEKHN1
prerank,histone demethylase activity (GO:0032452),-0.47348995794865106,-1.3294941776330986,0.11320754716981132,0.579859673402046,1.0,13/27,23.80%,KDM7A;KDM2A;KDM3B;FBXL19;KDM5B;KDM6B;KDM2B;KDM1A;PHF8;RIOX2;PHF2;KDM4D;HR
prerank,transcription coactivator binding (GO:0001223),-0.5084530208713662,-1.3267154663821796,0.11933174224343675,0.5777631618062369,1.0,9/20,12.24%,SMAD3;THRB;CCNT2;RORA;AR;MED25;VGLL4;ESR1;PGR
prerank,double-stranded RNA binding (GO:0003725),0.45001965221943735,1.3191165386157204,0.10238429172510519,0.7759572508143844,1.0,19/70,16.71%,TFRC;LRRFIP1;IFIH1;ADAR;HSP90AB1;EIF4H;TLR3;ACTN1;TLR7;MSN;SLC3A2;OASL;TLR8;ADAD1;RFTN1;ELAVL1;TUBB4B;MRPL44;EIF4A1
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.552116657051462,1.3176919151856223,0.1618705035971223,0.7708788102067835,1.0,9/22,17.33%,DUSP23;DUSP7;DUSP3;DUSP12;DUSP1;DUSP16;DUSP8;MTMR2;PPM1F
prerank,sterol transfer activity (GO:0120015),0.5743279752636339,1.3135053952473812,0.1687170474516696,0.7761223783295992,1.0,3/17,4.02%,PLTP;OSBP;ABCG1
prerank,platelet-derived growth factor receptor binding (GO:0005161),0.602463173347245,1.3088054359136294,0.17406749555950266,0.7838665682223178,1.0,4/13,2.62%,PDGFB;PDGFD;IL1R1;PTPRJ
prerank,death domain binding (GO:0070513),0.6337575316902496,1.3083086193977531,0.2087912087912088,0.7756385581007281,1.0,4/11,8.17%,BCL2L1;CRADD;MCL1;IRGM
prerank,cGMP binding (GO:0030553),0.6306001289272054,1.3053084053332014,0.19160583941605838,0.77758932450857,1.0,3/11,3.81%,PDE2A;RAPGEF2;CNGA2
prerank,calmodulin-dependent protein kinase activity (GO:0004683),-0.4772848360850309,-1.3033347829499897,0.15639810426540285,0.6378852901650485,1.0,10/24,21.05%,CAMK1D;CAMK2D;MAPKAPK3;PHKA2;PTK2B;EEF2K;CAMK1;PHKG2;CAMKK1;PHKA1
prerank,phosphatidic acid binding (GO:0070300),0.559038704777069,1.3026652888524648,0.17905405405405406,0.7773354250532796,1.0,3/19,4.76%,PLTP;RAPGEF2;PITPNC1
prerank,mannosyltransferase activity (GO:0000030),0.5628130061791942,1.3017815382887727,0.1703958691910499,0.7713845369341442,1.0,1/21,0.08%,TMTC2
prerank,MHC protein binding (GO:0042287),0.567408312004999,1.3006633438544615,0.17443868739205526,0.766364984252196,1.0,8/20,14.92%,PILRA;CD4;TUBB;TAP2;CD8B;KIR3DL2;ATP5F1A;TUBB4B
prerank,CARD domain binding (GO:0050700),0.6004525096970987,1.3000329385685487,0.20810313075506445,0.7595008209594517,1.0,6/14,15.35%,NOD1;NOD2;CARD10;IRGM;BCL10;CARD11
prerank,kinase inhibitor activity (GO:0019210),-0.44278538536111955,-1.2994558996715935,0.14609571788413098,0.6391308438903391,1.0,15/33,28.76%,PARVA;GMFB;QARS1;DUS2;LRP6;DNAJC3;CDKN1C;MAPK8IP1;SMCR8;RHOH;SOCS3;TAOK3;TRIB1;AHSG;DUSP19
prerank,store-operated calcium channel activity (GO:0015279),-0.5804453827879565,-1.2991036292644575,0.17256637168141592,0.6294542792591932,1.0,4/10,13.12%,TRPC3;TRPC6;TRPC4;ORAI2
prerank,nucleoside-diphosphatase activity (GO:0017110),0.624149592455002,1.296211536506522,0.18478260869565216,0.7646460120794761,1.0,2/12,6.20%,ENTPD1;ENTPD5
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.48463558921125877,1.2943201072688484,0.15458937198067632,0.7623490856210244,1.0,7/38,7.17%,HIP1;DAB2IP;PARD3;SNX13;SNX3;TECPR1;PLEKHA5
prerank,phospholipase binding (GO:0043274),-0.553558524461717,-1.2939779122643151,0.15932914046121593,0.6344730501627941,1.0,3/13,9.06%,ARHGAP6;PRKN;PDPK1
prerank,symporter activity (GO:0015293),0.6373229894341451,1.2929088394015331,0.20404411764705882,0.7587110581696822,1.0,1/10,0.46%,MFSD2A
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.5659930282206947,1.2912941826339703,0.17421602787456447,0.7556516410766881,1.0,4/18,9.66%,PIK3R6;PIK3R3;SOCS2;SOCS5
prerank,lipase activator activity (GO:0060229),-0.5886268998954103,-1.2894085481419124,0.18843683083511778,0.6385938124814803,1.0,2/10,9.06%,ARHGAP6;PDPK1
prerank,protein phosphatase binding (GO:0019903),0.4105422617954075,1.2857121009937222,0.08811748998664887,0.7660491252022653,1.0,15/117,5.16%,MFHAS1;PPP1R16B;DAB2IP;ITGA1;FLT4;CTTNBP2NL;PTK2;FOXO1;JAK3;PXN;PPP1R9B;SNX3;CTNNB1;STRN4;KCNQ1
prerank,adenylyltransferase activity (GO:0070566),0.5501568964097315,1.2817287924468743,0.18294849023090587,0.7719440563986985,1.0,5/21,10.15%,TENT4A;MTPAP;GPHN;FICD;OASL
prerank,protein phosphorylated amino acid binding (GO:0045309),0.4725454392711191,1.2813428649364338,0.16486902927580893,0.7649188575084424,1.0,14/42,11.86%,SHE;BCAR3;PIK3R3;ZAP70;GRB2;FBXW7;YES1;HCK;PIN1;SHC3;PTPN5;SHB;SHF;SYK
prerank,transcription corepressor binding (GO:0001222),-0.4668131967815909,-1.2809523143166994,0.1184573002754821,0.6547415556489846,1.0,7/27,6.99%,PER3;USP11;NEK6;EHMT2;RORA;PER2;LCOR
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.5221642164062916,1.2800836554863952,0.18076285240464346,0.7610273368175174,1.0,5/23,10.68%,HIP1;HIP1R;SNX3;PLEKHA5;CLVS2
prerank,"DNA binding, bending (GO:0008301)",0.590948236371495,1.2797881246019076,0.19705340699815838,0.7539042327256765,1.0,2/14,4.35%,LEF1;HHEX
prerank,ephrin receptor activity (GO:0005003),-0.5129532152216836,-1.2795960273873583,0.17040358744394618,0.6386253250005145,1.0,4/17,7.23%,EPHA3;EPHA7;EPHA8;EPHB2
prerank,transmembrane-ephrin receptor activity (GO:0005005),-0.5129532152216836,-1.2795960273873583,0.17040358744394618,0.6386253250005145,1.0,4/17,7.23%,EPHA3;EPHA7;EPHA8;EPHB2
prerank,vinculin binding (GO:0017166),0.6129161908559023,1.2780637004258675,0.2060491493383743,0.7513636944302504,1.0,5/11,9.38%,UTRN;CORO2B;PXN;ACTN1;SYNM
prerank,manganese ion binding (GO:0030145),-0.40208004985873647,-1.2758167504222364,0.09809264305177112,0.6399530509770855,1.0,16/48,23.55%,MPPED2;LARGE1;ME1;ADCY2;TDP2;SOD2;B4GALT1;FAM20C;ABL1;DYRK2;PPM1M;PRIMPOL;XPNPEP3;WRN;ATP13A2;GALNT1
prerank,MHC class II protein complex binding (GO:0023026),0.6218807866017586,1.2757830104552896,0.20772058823529413,0.7509698466575646,1.0,4/11,10.71%,HSP90AB1;CD4;PKM;HSPA8
prerank,pseudouridine synthase activity (GO:0009982),-0.5419454660508183,-1.27564613016816,0.18834080717488788,0.6307717188604379,1.0,6/13,28.26%,PUS7;PUS10;RPUSD4;RPUSD1;RPUSD2;RPUSD3
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.5158133687117277,1.2745342278757739,0.18858954041204437,0.7472686355219698,1.0,7/27,13.17%,RNF144B;DCUN1D3;FOXL2;RNF125;TOLLIP;UBE3D;DCUN1D1
prerank,nucleotide diphosphatase activity (GO:0004551),-0.528896893469473,-1.2734573736607548,0.19863013698630136,0.6272734903289773,1.0,3/14,2.07%,FHIT;ENPP1;NUDT4
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),-0.565906161458832,-1.2695747484658917,0.16597510373443983,0.629570749272648,1.0,5/11,12.48%,AMFR;UBR5;UBE4B;PPIL2;PRPF19
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",-0.5856407166068172,-1.268424783176164,0.18543046357615894,0.6241769757042209,1.0,9/10,41.21%,DSE;RENBP;GALE;FUOM;DSEL;GFUS;GLCE;GALM;GNE
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.45014109707918326,1.2673515012041652,0.14630467571644043,0.7639174184540322,1.0,6/53,5.02%,SLC7A5;SLC7A1;SLC1A1;SLC38A5;SLC43A2;SLC1A2
prerank,GTPase binding (GO:0051020),0.37993001360159634,1.2589804004372807,0.09744214372716199,0.7844935244434637,1.0,37/195,13.05%,DOCK4;FGD5;SPTBN1;SRGAP2;RASIP1;SH3BP4;CAV1;FNBP1L;UNC13B;ARHGEF2;RIN3;YBX1;PEX5L;EPS8;USP6NL;PKN1;STK19;OCRL;RAPGEF4;NCKAP1;UNC13D;RAB34;IQGAP1;RAB11FIP4;PAK1;FGD6;BICDL1;CYFIP1;KIF3B;EXOC4;EXOC2;TBC1D30;GNB1;CYRIB;RANBP9;TMEM127;FGD2
prerank,hexosyltransferase activity (GO:0016758),0.40951609192838084,1.2572503494905374,0.13231197771587744,0.7824273740898058,1.0,10/101,7.21%,TMTC2;CSGALNACT1;GBE1;B4GALT5;B4GALT4;MFNG;B3GNT2;FUT9;PIGM;GCNT7
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.6078460623797146,1.2544805318514818,0.24150943396226415,0.7841634474430452,1.0,2/12,5.11%,TENT4A;MTPAP
prerank,sulfotransferase activity (GO:0008146),-0.43205474368950936,-1.2538795097713054,0.13178294573643412,0.6579504674528935,1.0,9/33,15.22%,UST;HS3ST3A1;HS2ST1;CHST15;HS6ST1;CHST8;CHST3;CHST1;GAL3ST2
prerank,ionotropic glutamate receptor binding (GO:0035255),0.5952104465259789,1.2536033970491962,0.23703703703703705,0.7792245576932229,1.0,3/10,13.53%,SHANK3;SHISA6;IGSF11
prerank,phospholipase activator activity (GO:0016004),-0.5600274633839152,-1.2526308736519736,0.20997920997921,0.6531253715924967,1.0,2/10,9.06%,ARHGAP6;PDPK1
prerank,PDZ domain binding (GO:0030165),0.4357527075651661,1.248727702049959,0.1676470588235294,0.7886663151569422,1.0,16/61,10.76%,DOCK4;USHBP1;CADM1;RAPGEF2;F11R;FZD4;ACOX1;GRID2;PLEKHA1;ATP2B1;SLC9A3;TMEM88;TMEM88B;CLCN3;ADAM17;CRIPT
prerank,nuclear receptor coactivator activity (GO:0030374),0.4478517522369687,1.2478918428882277,0.16789396170839468,0.7839337235693614,1.0,14/52,13.23%,ETS1;NCOA1;PKN1;ACTN4;ACTN1;BUD31;NCOA2;TACC1;HMGA1;CNOT9;HELZ2;PRKCB;CNOT6;PSMC3IP
prerank,protein homodimerization activity (GO:0042803),0.3466093454522315,1.2465146750240483,0.03389830508474576,0.7808610003467407,1.0,101/590,12.47%,TFRC;ABCG2;HIP1;PECAM1;PDGFB;SRGAP2;CADM1;BCL2L1;DAB2IP;SYNE1;RASIP1;TGFB2;PDE2A;ZHX3;XDH;TBX1;TPD52;IL6R;FLT4;HIP1R;GCH1;TPD52L1;TRIM14;B2M;F11R;FZD4;NOD1;LRRFIP1;TBC1D22A;KLHL7;DEFA6;GBP4;STK10;DSCAML1;GBP5;VIL1;ZBTB16;ABCG1;IKBKB;HHEX;SARS1;NOS2;HSP90AB1;MTPAP;CD4;CAT;ACOX1;INPP5F;CCDC88A;GSTA4;TPST2;ACTN4;ADAM10;TOX3;MCL1;STAT1;ACTN1;YARS2;FICD;BST2;ACSL6;KCNH2;ST6GAL1;SHMT2;KCNN2;MKLN1;CST7;TERF2;CPOX;FOXP3;PDXK;PRDM9;CAV2;IRAK2;GREM1;RAB11FIP4;BNIP3L;SNRPC;GLB1;CBS;HPGDS;BANF1;COQ9;CNOT9;PDCD10;TIMM10;HSPB1;HOOK1;ABCD1;TPM4;RBPMS;MMAA;SLK;SH3GLB1;MID1;PIP4K2A;CEACAM1;NAA60;GDF15;PANK3;TERF1
prerank,myosin II binding (GO:0045159),0.6284282193315051,1.245029941850242,0.24053030303030304,0.7785573422330098,1.0,2/10,1.44%,SHROOM4;SHROOM1
prerank,epidermal growth factor receptor binding (GO:0005154),0.505879641242098,1.244124842065397,0.2026359143327842,0.7742773384334452,1.0,6/25,12.18%,HIP1;GRB2;CCDC88A;TGFA;CNOT9;TNK2
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.5110393285481419,1.2437934278528917,0.1884297520661157,0.7681596379449839,1.0,4/25,6.22%,HIP1;ARAP3;HIP1R;PLEKHA1
prerank,sodium ion transmembrane transporter activity (GO:0015081),-0.44298082183289444,-1.2393956315055528,0.18453865336658354,0.6836062960189311,1.0,8/27,10.27%,SLC41A1;SLC8A3;SLC9A2;SLC8B1;SLC9B2;SLC8A1;SLC9A9;SLC9A1
prerank,cytokine activity (GO:0005125),-0.3231735744165095,-1.2382824485780937,0.058577405857740586,0.677988387031462,1.0,14/131,4.69%,BMP6;IL34;WNT4;BMP5;BMP7;WNT5B;BMP4;WNT6;IL18;WNT9A;IL16;CXCL16;TNFRSF11B;FGF2
prerank,transmitter-gated ion channel activity (GO:0022824),0.49354931797654483,1.2364524561485233,0.21153846153846154,0.7856750189275852,1.0,17/29,25.86%,GRID2;CHRNB1;GABRB1;GRIA4;GRIK5;GRIK2;GRIK1;GABRG1;GABRG3;GABRA1;GABRB2;GLRA2;GRIA2;GRIK3;GABRA2;GRID1;GABRG2
prerank,lysine N-methyltransferase activity (GO:0016278),-0.46065457611505656,-1.2353381569116464,0.2078239608801956,0.6782350842771783,1.0,11/20,28.73%,EHMT2;SETD7;SETD4;EEF2KMT;SETD2;KMT5A;SETD6;EEF1AKMT2;SMYD2;ANTKMT;METTL21C
prerank,calcium:sodium antiporter activity (GO:0005432),-0.5603220887931896,-1.23460684088063,0.21861471861471862,0.6710602590038819,1.0,5/10,11.17%,SLC24A3;SLC8A3;SLC8B1;SLC8A1;SLC24A5
prerank,phosphotyrosine residue binding (GO:0001784),0.46380113137970064,1.2338746623613401,0.2046875,0.7868832055383936,1.0,12/37,11.86%,SHE;BCAR3;PIK3R3;ZAP70;GRB2;YES1;HCK;SHC3;PTPN5;SHB;SHF;SYK
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.576257501176594,1.2318544966960818,0.23476702508960573,0.7865575868647773,1.0,2/13,1.98%,SLC7A1;SLC38A5
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.4165828270803663,1.2306775554691338,0.15689149560117302,0.7832855774856969,1.0,14/72,10.18%,PLCB1;FLII;HIP1;TIRAP;HIP1R;PARD3;STXBP6;VIL1;KCNQ1;SYT7;FCHO2;TWF2;CAPG;AMER2
prerank,growth factor receptor binding (GO:0070851),0.4021104686758822,1.229769807400289,0.14381720430107528,0.7794222280694217,1.0,17/95,12.20%,HIP1;PDGFB;PDGFD;IL1R1;IL6R;PTPRJ;GRB2;FGF16;CCDC88A;FYN;TGFA;PGF;ADAM17;CNOT9;CNTF;TNK2;IL27RA
prerank,LRR domain binding (GO:0030275),-0.5145061500632259,-1.2284323991304076,0.21945701357466063,0.6801395006491769,1.0,2/14,0.50%,ROBO1;PAWR
prerank,nucleoside-triphosphatase activity (GO:0017111),0.3618246782841027,1.227926364475027,0.11225658648339061,0.7786593066023676,1.0,41/248,13.02%,DNM3;MYO1E;RHOBTB1;GCH1;RAB31;GNAI2;GBP7;GBP4;GBP5;GNAQ;MYO6;MTG1;KIF26A;GNA12;RHOB;EFTUD2;TBC1D24;ABCA3;KIF2A;ATP2B1;KIF1A;RALB;DNM2;RAB11A;RAP1B;PIN1;IRGM;GTPBP1;GPN3;DNA2;GFM1;RAB3B;ABCD1;RAC1;HRAS;MMAA;RAB4A;RND1;GNB1;GPN2;RAB1A
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),-0.4137191661953236,-1.2278164840425214,0.1801566579634465,0.6732259888362181,1.0,13/33,25.66%,AR;CTR9;AGO2;PCF11;RPRD2;WDR43;URI1;PAF1;ELP4;TBP;WAC;UVSSA;SMYD2
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.40192979421134867,1.227215685466887,0.162534435261708,0.7743528057724778,1.0,18/91,10.68%,PLCB1;FLII;HIP1;TIRAP;HIP1R;PARD3;STXBP6;VIL1;SNX3;KCNQ1;SYT7;PIRT;PLEKHA5;FCHO2;TWF2;CAPG;AMER2;CLVS2
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.5083396441077916,1.2261438488296208,0.21368948247078465,0.7710475864161367,1.0,6/23,11.57%,PLCB1;PLCB4;PLCG1;PLCH2;CHRM3;PLCH1
prerank,water transmembrane transporter activity (GO:0005372),0.5869196755698486,1.2248776370583323,0.2722222222222222,0.7686492562857854,1.0,2/11,4.59%,AQP11;AQP7
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.3602497889157717,1.2239762182596936,0.09824561403508772,0.7648011007178707,1.0,31/254,8.56%,LEF1;MECOM;ETS1;ERG;ELK3;ZIC3;SOX17;KLF7;MEF2C;FOXO1;ZBTB16;PRDM2;IRF2;HHEX;FOXF1;RREB1;CREB1;KLF4;NKX2-8;NR1H2;GTF2I;IRF5;SOX18;NFIC;SOX12;HINFP;JUN;ATF6B;TCF12;KLF6;ELK4
prerank,disordered domain specific binding (GO:0097718),0.5112439636362742,1.2212189908118656,0.23887973640856672,0.7671236653035,1.0,4/23,9.03%,CALM1;HSP90AB1;FYN;DFFB
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.5778844089498142,1.21815066654331,0.25754884547069273,0.7705381523058253,1.0,1/11,1.89%,DDAH1
prerank,R-SMAD binding (GO:0070412),-0.4784927591021906,-1.2164183199721768,0.22115384615384615,0.6983870721935547,1.0,4/18,2.35%,LDLRAD4;SMAD3;DDX5;SMAD6
prerank,CoA-ligase activity (GO:0016405),-0.5004878051979871,-1.2153195146327873,0.22466960352422907,0.6930057466779631,1.0,4/14,15.54%,ACSL1;ACSS3;AACS;ACSS1
prerank,protein kinase binding (GO:0019901),0.34310112334862186,1.2147013418627937,0.06731813246471227,0.7747184791984273,1.0,90/480,12.53%,TFRC;FRMD5;UTRN;BCL2L1;DAB2IP;RHOBTB1;BMPR2;MAP4K2;CAV1;TJP2;TIRAP;GCH1;NEDD9;TRIM14;STK38;TBC1D14;PTPRJ;RGCC;PTK2;IFNAR2;DUSP7;ACVRL1;NOD2;MAP3K1;PRKD2;HDAC9;HDAC7;DUSP3;ACTB;PLCG1;IKBKB;CALM1;GRB2;HINT1;CEP68;KCNQ1;CD4;RHOB;PKN1;EPHA4;CCDC88A;TSKS;ADAM10;RFFL;ADCY4;CDKN2B;IRF5;PTPRR;SPAG9;PRKAR2B;LRBA;PIN1;TWF2;IRGM;FAM83G;ACSL3;IQGAP1;RPS7;PTN;CAV2;ARHGEF7;SHC3;CDK5RAP2;MSN;CAVIN2;PPP1CB;CCND3;PRKAR2A;TRIB2;GRB7;DCX;PDCD10;SMAD1;NBEAL2;PRKAB1;HSPB1;FERMT2;DUSP1;EXOC2;RAC1;PRKCB;ADIPOR1;GSK3A;HIF1A;RND1;CEACAM1;CCNK;RPTOR;DUSP16;MAPRE3
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.4678989961599709,1.2138121929012782,0.2048,0.7708973184088016,1.0,6/34,5.11%,ARAP3;MYO10;ARAP2;HIP1R;PARD3;CYTH3
prerank,phosphoric diester hydrolase activity (GO:0008081),0.45418770557645194,1.2132943624120505,0.22749590834697217,0.7660760887796983,1.0,4/35,5.89%,GPCPD1;PLCB4;PLD4;GDPD1
prerank,protein phosphatase 1 binding (GO:0008157),0.5165879725583198,1.2127415369201762,0.24701873935264054,0.761754075076339,1.0,5/21,9.53%,PPP1R16B;PPP1R9B;KCNQ1;PHACTR4;PPP1R11
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.47577001047967105,1.2124163970391375,0.22955974842767296,0.756568567961165,1.0,4/33,3.78%,RNF144B;DCUN1D3;FOXL2;RNF125
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.4477263334479107,-1.2099538517719928,0.215962441314554,0.7011207229703618,1.0,4/21,2.52%,PDE1A;PDE5A;PDE3A;PDE8B
prerank,nuclear export signal receptor activity (GO:0005049),-0.5358692338929095,-1.2086965573597082,0.24078091106290672,0.6965995751882071,1.0,4/11,16.48%,RANBP17;XPO5;XPO6;XPO1
prerank,calcium-release channel activity (GO:0015278),-0.46675851267646895,-1.2070093800729866,0.21603563474387527,0.6929763108440182,1.0,5/17,13.36%,ITPR1;PKD2;RASA3;ITPR2;TPCN1
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.5023961748050394,-1.206085420084736,0.24503311258278146,0.6873014634374217,1.0,2/14,2.84%,SLC26A7;SLC26A2
prerank,cytokine receptor binding (GO:0005126),0.39848537571771275,1.2046496316755109,0.19724137931034483,0.774022173341424,1.0,16/83,13.42%,KITLG;TGFB2;CXCL12;IL6R;PXDN;SOCS2;OSMR;PGF;LIFR;ADAM17;CNTF;TNFSF11;SYK;IL27RA;DDT;SDCBP
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.43996231287358234,-1.2009596983426738,0.22358722358722358,0.6939694472277451,1.0,4/23,2.52%,PDE1A;PDE5A;PDE3A;PDE8B
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.4919603866287098,1.1960579810158778,0.24916943521594684,0.7949835400580995,1.0,6/24,9.79%,ZDHHC14;ZDHHC9;ZDHHC20;ZDHHC19;ZDHHC18;ZDHHC22
prerank,CXCR chemokine receptor binding (GO:0045236),0.5735379889132682,1.1951227145497132,0.2964426877470356,0.7917170848661257,1.0,1/11,1.41%,CXCL12
prerank,acylglycerol O-acyltransferase activity (GO:0016411),-0.45763692059454525,-1.1943254532206191,0.2469733656174334,0.7044048228903743,1.0,6/20,15.28%,MOGAT3;AGPAT4;LPGAT1;LCLAT1;GPAT3;PNPLA3
prerank,FMN binding (GO:0010181),0.5716412549199248,1.1939169077408276,0.2698412698412698,0.7892336023933167,1.0,2/11,4.51%,NOS3;NOS2
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),-0.2675156241289387,-1.193773307094751,0.0,0.6980758427974098,1.0,108/730,10.10%,FOXP2;PBX1;SOX5;MAF;ZIC1;NFIA;ZEB2;NR2F2;ZIC4;GLI3;ZBTB7C;PRRX1;RARB;ZBTB20;GLI2;ZFHX3;CREB5;ZKSCAN2;ZFHX4;GLIS3;FOXD1;HLF;SMAD3;PKNOX2;FOXP4;HOXC4;HOXC6;ARNT2;HOXB3;TEAD1;NR6A1;HOXA3;HOXA5;NFAT5;MEOX2;THRB;HDAC4;MXI1;TOP1;IKZF2;HOXB4;PRRX2;CREB3L2;TEF;SALL1;NR1D2;HOXB6;FOXC2;DNMT3A;FOXC1;TBX15;KCNIP3;HIVEP2;MLXIP;PLAGL1;RBPJ;ZNF423;HOXA7;MKX;ZNF367;RORA;AR;GLIS2;PPARA;PBX4;HIF3A;RUNX2;KLF3;SIX1;TBX18;EBF4;IKZF4;BCL6;TEAD3;CHD2;HEYL;NR3C2;MEIS1;PBX3;GLI1;ZEB1;SMAD9;ZFAT;ZNF568;FOXJ2;NFATC4;EBF2;ELF4;ZSCAN29;KLF15;RFX7;MITF;FOXL1;KDM6B;POU6F1;HSF2;ATOH8;CREB3L1;STAT5A;ZNF23;FOXO3;SOX6;MGA;ZNF483;ZKSCAN7;ARNT;CEBPB;ELK1
prerank,protein tyrosine phosphatase activity (GO:0004725),0.40727075353097225,1.1935252188408392,0.18776671408250356,0.7842758121732636,1.0,8/71,5.14%,PTPRG;PTPRM;PTPRB;PTPRJ;DUSP23;PTPN12;DUSP3;CDC14A
prerank,cholesterol transfer activity (GO:0120020),0.5257340346239636,1.1917008617008562,0.2736842105263158,0.7843727129344845,1.0,2/16,4.02%,PLTP;ABCG1
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.586909528658468,1.1915820620953486,0.27345309381237526,0.7787578837525743,1.0,6/10,22.26%,ATXN3;CYLD;TNFAIP3;OTUD4;DESI2;STAMBP
prerank,kinase binding (GO:0019900),0.3392968686667887,1.1915741434578078,0.08378672470076169,0.772925230628148,1.0,82/435,12.68%,TFRC;FRMD5;UTRN;BCL2L1;DAB2IP;RHOBTB1;CAV1;FAS;PDE8A;BCAR3;TRIM14;TBC1D14;PTPRJ;RGCC;STX1A;PTK2;SP100;IFNAR2;ACVRL1;NOD2;TIAM1;PIK3IP1;MAP3K1;HDAC7;DUSP3;ACTB;PLCG1;IKBKB;CALM1;GRB2;CTNNB1;CEP68;HSP90AB1;CD4;RHOB;TTC28;TSKS;ATP1A4;ADAM10;RFFL;PPP2R5A;CDKN2B;IRF5;PTPRR;CD160;LRBA;IRGM;FAM83G;ACSL3;IQGAP1;RPS7;PTN;CAV2;ARHGEF7;SHC3;CDK5RAP2;MSN;PPP1CB;CCND3;CNOT9;BTG1;GRB7;DCX;PDCD10;SMAD1;NBEAL2;PRKAB1;TOLLIP;CDC6;HSPB1;FERMT2;EXOC2;UBQLN1;RAC1;ADIPOR1;HIF1A;RND1;CEACAM1;CCNK;RPTOR;MAPRE3;WWC1
prerank,acid-thiol ligase activity (GO:0016878),-0.5009115485664801,-1.1889282343970766,0.23318385650224216,0.7050930889876199,1.0,4/13,15.54%,ACSL1;ACSS3;AACS;ACSS1
prerank,hormone receptor binding (GO:0051427),0.5415372192930297,1.1887504300158962,0.28545454545454546,0.7757371836962035,1.0,2/14,4.86%,SOCS2;NPPA
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.5747283010244819,1.1876270862996747,0.3031423290203327,0.7672408456328528,1.0,5/10,20.82%,DUSP7;DUSP1;DUSP16;DUSP8;DUSP6
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.5747283010244819,1.1876270862996747,0.3031423290203327,0.7672408456328528,1.0,5/10,20.82%,DUSP7;DUSP1;DUSP16;DUSP8;DUSP6
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.44908708744793613,1.1873116410873437,0.23717948717948717,0.7625355163967826,1.0,10/35,12.18%,FES;PTK2;ZAP70;LYN;FYN;YES1;HCK;PTK6;SYK;TNK2
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.5520749345660888,1.1842011067633664,0.2706333973128599,0.7661277778510623,1.0,5/12,8.10%,PDE2A;PDE8A;PDE4D;PDE7B;PDE4B
prerank,5'-3' exonuclease activity (GO:0008409),0.5573320384432,1.1830691217899199,0.29927007299270075,0.7638335326884124,1.0,9/14,21.81%,MRE11;DCP2;DXO;FAN1;TRIR;EXOG;XRN1;XRN2;DCLRE1C
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),-0.26502818014129637,-1.1811456420890336,0.0,0.7202688843306876,1.0,106/731,10.10%,FOXP2;PBX1;SOX5;MAF;ZIC1;NFIA;ZEB2;NR2F2;ZIC4;GLI3;ZBTB7C;PRRX1;RARB;ZBTB20;GLI2;ZFHX3;CREB5;ZKSCAN2;ZFHX4;GLIS3;FOXD1;HLF;SMAD3;PKNOX2;FOXP4;HOXC4;HOXC6;ARNT2;HOXB3;TEAD1;NR6A1;HOXA3;HOXA5;NFAT5;MEOX2;THRB;HDAC4;MXI1;TOP1;IKZF2;HOXB4;PRRX2;TEF;SALL1;NR1D2;HOXB6;FOXC2;DNMT3A;FOXC1;TBX15;KCNIP3;HIVEP2;MLXIP;PLAGL1;RBPJ;ZNF423;HOXA7;MKX;ZNF367;RORA;AR;GLIS2;PPARA;PBX4;HIF3A;RUNX2;KLF3;SIX1;TBX18;EBF4;IKZF4;BCL6;TEAD3;CHD2;HEYL;NR3C2;MEIS1;PBX3;GLI1;ZEB1;SMAD9;ZFAT;ZNF568;FOXJ2;NFATC4;EBF2;ELF4;ZSCAN29;KLF15;RFX7;MITF;FOXL1;KDM6B;POU6F1;HSF2;ATOH8;STAT5A;ZNF23;FOXO3;SOX6;MGA;ZNF483;ZKSCAN7;ARNT;CEBPB;ELK1
prerank,amino acid binding (GO:0016597),0.467407541552855,1.1808503364719651,0.24620573355817876,0.7650034403172676,1.0,10/31,20.55%,NOS3;DDAH1;NOS2;GRIN3B;SHMT2;GRIN2B;GRM7;GLRA2;AGXT;ASS1
prerank,alpha-tubulin binding (GO:0043014),0.4661748208085365,1.1774770619648198,0.2588996763754045,0.7698417757608621,1.0,5/31,8.53%,TTLL7;EFHC2;DIP2B;FYN;TRIM36
prerank,adenylate cyclase binding (GO:0008179),-0.5401450349856638,-1.1729718688741597,0.2946058091286307,0.7367169307450677,1.0,3/10,4.15%,ADCY5;AKAP12;ADCY2
prerank,acetylglucosaminyltransferase activity (GO:0008375),-0.3764564960562567,-1.166676308033233,0.24242424242424243,0.7469923058302619,1.0,6/46,4.19%,B3GALT1;LARGE1;EXT1;MGAT3;MGAT4C;OGT
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.5743691171124958,1.163282194231532,0.31346153846153846,0.8067863148246275,1.0,4/10,12.15%,PIK3R3;PIK3C3;PIK3C2A;PIK3CB
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",-0.5320569901488876,-1.162327700036836,0.29568788501026694,0.7517600155487225,1.0,1/10,0.41%,DPYSL3
prerank,aminopeptidase activity (GO:0004177),-0.42329764091655536,-1.1616886702417817,0.25609756097560976,0.7456715467549666,1.0,5/26,8.24%,MMP14;MMP16;ANPEP;ENPEP;NPEPPS
prerank,I-SMAD binding (GO:0070411),-0.47930781956562185,-1.15743758471894,0.30376940133037694,0.7503729760858882,1.0,6/13,9.16%,SMAD3;SMAD6;TGFBR1;SMAD9;TGFB1I1;AXIN1
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.5223468879738893,1.1572277442579701,0.29842931937172773,0.8201271195430782,1.0,1/14,0.03%,SPOCK2
prerank,protein phosphatase inhibitor activity (GO:0004864),0.4636442840119445,1.155086396987868,0.2946859903381642,0.8207619347104235,1.0,13/26,26.12%,PPP1R9B;PPP1R2;PTN;PPP1R11;PPP1R14C;PPP1R8;BOD1;PPME1;SET;ENSA;PABIR1;LMTK2;PPP1R14A
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),-0.2539811997282846,-1.1538194489271287,0.0,0.7528866869751745,1.0,116/830,10.10%,FOXP2;PBX1;SOX5;MAF;ZIC1;NFIA;ZEB2;NR2F2;ZIC4;AEBP1;GLI3;ZBTB7C;PRRX1;RARB;ZBTB20;GLI2;ZFHX3;CREB5;ZKSCAN2;ZFHX4;GLIS3;FOXD1;HLF;SMAD3;PKNOX2;FOXP4;HOXC4;HOXC6;ARNT2;OSR1;HOXB3;TEAD1;NR6A1;HOXA3;HOXA5;NFAT5;MEOX2;THRB;HDAC4;CUX1;MXI1;TOP1;IKZF2;HOXB4;PRRX2;TEF;SALL1;NR1D2;HOXB6;FOXC2;DNMT3A;FOXC1;TBX15;KCNIP3;HIVEP2;MLXIP;PLAGL1;RBPJ;ZNF423;HOXA7;MKX;ZNF367;RORA;AR;GLIS2;PPARA;PBX4;HIF3A;RUNX2;KLF3;PURG;SIX1;TBX18;EBF4;ZNF25;IKZF4;BCL6;TEAD3;NFXL1;CHD2;HEYL;HOXC8;NR3C2;MEIS1;PBX3;GLI1;ZEB1;SMAD9;ZFAT;ZNF568;FOXJ2;NFATC4;ATF5;EBF2;ELF4;ZSCAN29;KLF15;RFX7;MITF;FOXL1;KDM6B;POU6F1;RBAK;HSF2;ATOH8;STAT5A;ZNF23;FOXO3;SOX6;MGA;TWIST2;ZNF483;ZKSCAN7;ARNT;CEBPB;ELK1
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.5227827219481219,-1.1516019597535974,0.29130434782608694,0.7517928176744255,1.0,5/10,16.92%,KDM7A;KDM2A;KDM2B;PHF8;RIOX2
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.5248796542392494,1.1512592249866493,0.2900355871886121,0.8271199939320388,1.0,3/13,9.68%,SH3BP4;CCDC88A;ARHGDIA
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.4973741125623104,-1.1511029986901689,0.31140350877192985,0.7454232063115255,1.0,6/12,6.60%,IGF1;IRS1;SHC1;ARRB1;IGF2;GNAS
prerank,microtubule motor activity (GO:0003777),0.40882173452434767,1.1421267469810936,0.2716417910447761,0.849505471555393,1.0,9/51,12.40%,STARD9;KIFC3;DNAH3;KIF26A;KIF2A;KIF1A;KIF3B;KIF23;DNAH8
prerank,cholesterol binding (GO:0015485),0.4163940513027185,1.1417156274147167,0.27216174183514774,0.8449639792203288,1.0,6/47,8.95%,PROM1;CAV1;OSBPL1A;ABCG1;OSBPL10;NPC1
prerank,mechanosensitive ion channel activity (GO:0008381),0.5445601011131631,1.140853213657336,0.33697632058287796,0.841869137037523,1.0,4/12,5.69%,PIEZO1;TMEM63B;TMC5;TMC7
prerank,TBP-class protein binding (GO:0017025),0.4886875649894985,1.1398910114495735,0.29743589743589743,0.8390721466328924,1.0,6/21,19.85%,HHEX;TAF1B;YEATS2;GTF2B;THRA;BRF2
prerank,lysophospholipase activity (GO:0004622),0.49366245169231615,1.1393294391459876,0.3264957264957265,0.8350528418284789,1.0,5/20,8.87%,PLA2G4B;PNPLA6;GDPD1;ENPP2;LYPLA1
prerank,BMP binding (GO:0036122),0.5499913083155017,1.1384216713689321,0.3333333333333333,0.8323580056902206,1.0,2/11,1.29%,ENG;BMPR2
prerank,protein phosphatase regulator activity (GO:0019888),0.40622209180062546,1.1375032013024182,0.30401234567901236,0.8295928378097854,1.0,14/53,16.89%,PPP1R16B;PPP1R9B;CALM1;PPP4R1;PPP1R2;PPP2R5A;PTN;PHACTR4;PPP1R15B;B3GAT3;PPP2R2C;BOD1;PPME1;SHOC2
prerank,lipid phosphatase activity (GO:0042577),0.5111735274117974,1.1369150587393326,0.32637571157495254,0.8260164578574148,1.0,2/14,3.82%,SGPP2;PLPP6
prerank,phospholipase C activity (GO:0004629),0.4627441359266874,1.1357670589097417,0.2888146911519199,0.8241637098490103,1.0,6/25,11.57%,PLCB1;PLCB4;PLCG1;PLCH2;CHRM3;PLCH1
prerank,galactosyltransferase activity (GO:0008378),0.5398653541529101,1.1352157275498616,0.34774436090225563,0.8203507917710616,1.0,2/11,2.42%,B4GALT5;B4GALT4
prerank,GTPase activity (GO:0003924),0.341014532987037,1.1338280834002632,0.22461170848267623,0.8191959076269604,1.0,31/192,13.02%,DNM3;RHOBTB1;GCH1;RAB31;GNAI2;GBP7;GBP4;GBP5;GNAQ;MTG1;GNA12;RHOB;EFTUD2;TBC1D24;RALB;DNM2;RAB11A;RAP1B;IRGM;GTPBP1;GPN3;GFM1;RAB3B;RAC1;HRAS;MMAA;RAB4A;RND1;GNB1;GPN2;RAB1A
prerank,SUMO transferase activity (GO:0019789),-0.4603253278102989,-1.1312418668041206,0.2956120092378753,0.7954629011151414,1.0,5/16,18.79%,HDAC4;PIAS1;PIAS2;NSMCE2;MUL1
prerank,copper ion binding (GO:0005507),-0.3622787971428598,-1.1290965307803482,0.2695417789757412,0.7938618774924848,1.0,7/42,7.23%,MOXD1;LOXL3;PAM;SOD3;LACC1;ATP7A;P2RX4
prerank,O-acyltransferase activity (GO:0008374),0.45309340680795895,1.1283244363024818,0.30153321976149916,0.8301798213236659,1.0,16/30,25.85%,MBOAT1;AWAT2;LPCAT3;PRDX6;LRAT;MOGAT2;DGAT1;MBOAT7;LPCAT2;MBOAT2;LPCAT4;DGAT2;GPAT4;GPAM;PLAAT1;LPCAT1
prerank,hyaluronic acid binding (GO:0005540),0.5674463514565913,1.1246825726635437,0.3644859813084112,0.8354399175832617,1.0,2/10,5.07%,LAYN;HYAL2
prerank,small GTPase binding (GO:0031267),0.3450977140066126,1.1234978174426506,0.2490613266583229,0.8337505056634305,1.0,32/170,13.05%,DOCK4;FGD5;SRGAP2;SH3BP4;CAV1;UNC13B;ARHGEF2;RIN3;PEX5L;EPS8;USP6NL;PKN1;STK19;OCRL;RAPGEF4;NCKAP1;UNC13D;RAB34;IQGAP1;RAB11FIP4;PAK1;FGD6;BICDL1;CYFIP1;KIF3B;EXOC4;EXOC2;TBC1D30;CYRIB;RANBP9;TMEM127;FGD2
prerank,guanyl ribonucleotide binding (GO:0032561),0.34104348441472393,1.1231964876613767,0.2387332521315469,0.8294063827366503,1.0,31/196,11.99%,MFHAS1;INSR;RHOBTB1;PDE2A;RAPGEF2;GCH1;RAB31;GBP7;GBP4;GBP5;CNGA2;TGM2;ARF5;REM2;RHOB;RALB;DNM2;RAP1B;ADSS2;ARL4A;RAB39A;ARHGEF5;TUBB;RAB3B;EIF2B2;RAC1;HRAS;MMAA;RAB4A;TUBD1;RND1
prerank,microtubule binding (GO:0008017),0.334985322427323,1.1229047456977566,0.24116930572472595,0.8252348272703973,1.0,40/222,12.61%,DNM3;MACF1;MTUS1;REEP1;STARD9;ARHGEF2;MAP4;FGF13;CCDC69;KIF26A;CLIP1;MAPRE2;RP1;CCDC88A;CCDC88B;KIF2A;KIF1A;DNM2;RAB11A;MAP6D1;MARK4;EML5;MAP1LC3B;CDK5RAP2;EML6;DCX;HAUS6;KIF3B;CRIPT;HOOK1;PEX14;S100A8;KIF23;MAP10;MID1;POLB;MAP4K4;TERF1;MAPRE3;EML1
prerank,protein serine/threonine phosphatase activity (GO:0004722),-0.3343294606173911,-1.1131982743850588,0.25076452599388377,0.8349653304200482,1.0,13/60,11.27%,CTDSPL;PPM1E;LRRK1;CDC14B;PHLPP2;PPM1D;MTMR3;PPM1B;CTDSPL2;PPEF2;PPP1R3C;LRRK2;PPP3CB
prerank,lipase activity (GO:0016298),0.40886466476607963,1.112944908095509,0.3173076923076923,0.849341794768069,1.0,5/43,12.55%,ABHD2;LIPE;LYPLA1;LIPC;PNPLA8
prerank,tubulin binding (GO:0015631),0.32467764341792643,1.11256132591165,0.24452133794694347,0.8453025883763179,1.0,54/296,12.61%,DNM3;TTLL7;MTUS1;EFHC2;REEP1;STARD9;ARHGEF2;MAP4;FGF13;DIP2B;CCDC69;STMN1;KIF26A;CLIP1;TTLL5;MAPRE2;RP1;CCDC88A;FYN;CCDC88B;KIF2A;KIF1A;STMN3;DNM2;RAB11A;STMN4;MAP6D1;BRCA2;MARK4;EML5;MAP1LC3B;ARHGEF7;TRIM36;CDK5RAP2;AGBL5;EML6;PAK1;RITA1;DCX;HAUS6;KIF3B;CCT5;CRIPT;HOOK1;PEX14;S100A8;KIF23;MAP10;MID1;POLB;MAP4K4;TERF1;MAPRE3;EML1
prerank,anion channel activity (GO:0005253),0.38710820745549374,1.1109681031964878,0.3058823529411765,0.845167206554878,1.0,21/61,19.47%,LRRC8B;LRRC8C;CLCA2;GABRB1;CLCN3;CLIC4;GPR89A;GPR89B;TTYH3;GABRQ;LRRC8D;CLCN7;GABRG1;CLCC1;CLIC1;GABRG3;GABRA1;ANO3;GABRB2;GLRA2;ANO5
prerank,vitamin D receptor binding (GO:0042809),-0.4625657137432074,-1.1107828100197652,0.35091743119266056,0.8340166956140902,1.0,6/14,25.19%,MED14;RXRA;MED30;MED4;MED24;MED16
prerank,sterol binding (GO:0032934),0.3922350868685828,1.1099068655709468,0.31296572280178836,0.8432061819652839,1.0,5/56,4.02%,PROM1;CAV1;OSBPL1A;OSBP;ABCG1
prerank,ligand-gated channel activity (GO:0022834),0.44343506458348586,1.1093291988070852,0.34894991922455576,0.8400276622265762,1.0,9/29,13.66%,GRID2;CHRNB1;GRIN3B;GABRB1;GRIA4;GRIN2B;GRIK5;GRIK2;GRIK1
prerank,microtubule minus-end binding (GO:0051011),0.5080063809626607,1.107215096844824,0.3784786641929499,0.8411780428826813,1.0,1/13,1.09%,MACF1
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),0.5085036689405029,1.1063129654102706,0.3567467652495379,0.8387852429351594,1.0,2/14,2.77%,MAL;NOD1
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.4735746136308597,1.1060257549538732,0.35125448028673834,0.8346188853622105,1.0,12/19,25.86%,GRID2;CHRNB1;GRIK5;GRIK2;GRIK1;GABRG1;GABRG3;GABRA1;GRIK3;GABRA2;GRID1;GABRG2
prerank,GABA receptor binding (GO:0050811),-0.5003785811287572,-1.1054580757539927,0.3542600896860987,0.8416853118666534,1.0,6/11,26.58%,TRAK1;PLCL2;ARFGEF2;SHISA7;AKAP5;LHFPL4
prerank,RNA stem-loop binding (GO:0035613),-0.4712056825842776,-1.1027343952647577,0.3598326359832636,0.8418939225361686,1.0,4/12,14.89%,EPRS1;FMR1;DDX3X;LARP6
prerank,ligand-gated ion channel activity (GO:0015276),0.4393889917108168,1.1024910068325287,0.35121951219512193,0.8399958952027413,1.0,9/30,13.66%,GRID2;CHRNB1;GRIN3B;GABRB1;GRIA4;GRIN2B;GRIK5;GRIK2;GRIK1
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.4831790819973326,-1.1022333160194804,0.35343035343035345,0.8351820774650303,1.0,2/11,3.35%,EGFR;MAP3K5
prerank,translation elongation factor activity (GO:0003746),0.49866216765343196,1.1021198261584917,0.3641207815275311,0.8362943475699768,1.0,7/14,22.56%,GTPBP1;EIF5AL1;EIF5A;GFM1;EEFSEC;GTPBP2;EEF1B2
prerank,ATP hydrolysis activity (GO:0140603),0.41195797852549176,1.1018808208792086,0.31892697466467956,0.8321683965059832,1.0,6/41,10.97%,MYO1E;KIF26A;ABCA3;ATP2B1;DNA2;ABCD1
prerank,receptor tyrosine kinase binding (GO:0030971),0.38383705898304243,1.1009621168617183,0.3152337858220211,0.8301582492704418,1.0,8/56,10.44%,GRB14;DOCK4;DUSP3;ELMO2;HYAL2;SHC3;SOCS5;ACP4
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),-0.3751130532909292,-1.1002855790875994,0.3238341968911917,0.8330580363778437,1.0,14/32,20.23%,KDM7A;KDM2A;EGLN3;KDM2B;P4HTM;PHF8;TMLHE;PHYH;ALKBH1;BBOX1;RIOX2;JMJD4;HSPBAP1;TYW5
prerank,channel activity (GO:0015267),0.4133357378577324,1.098850421911277,0.3343558282208589,0.8312439843488449,1.0,4/41,7.08%,AQP11;MCUB;AQP7;CHRNB1
prerank,protein kinase inhibitor activity (GO:0004860),-0.35285152772923795,-1.0976197847994225,0.3010204081632653,0.8331268541063354,1.0,10/42,18.21%,PARVA;GMFB;SPRED1;QARS1;IBTK;DUS2;DNAJC3;CDKN1C;MAPK8IP1;SMCR8
prerank,GTP binding (GO:0005525),0.3366745618113082,1.0952779378550994,0.3013698630136986,0.836842709778086,1.0,27/172,11.99%,MFHAS1;INSR;RHOBTB1;GCH1;RAB31;GBP7;GBP4;GBP5;TGM2;ARF5;REM2;RHOB;RALB;DNM2;RAP1B;ADSS2;ARL4A;RAB39A;ARHGEF5;TUBB;EIF2B2;RAC1;HRAS;MMAA;RAB4A;TUBD1;RND1
prerank,G protein-coupled receptor activity (GO:0004930),0.3211594254390447,1.0924911059606595,0.28486293206197855,0.8400651573187885,1.0,38/239,17.02%,ADGRL4;ADGRE5;ADGRL2;ADGRL3;HCRTR1;S1PR1;ADGRG1;LPAR6;APLNR;CALCRL;CCR7;XPR1;OXTR;ADRA2B;GPR17;OPN5;HCRTR2;CXCR2;GPR52;GPR22;NPR1;AGTR2;CYSLTR1;ADCYAP1R1;TPRA1;MTNR1A;GPR171;GPR75;GPR85;OPN3;RXFP3;RXFP2;GPR62;OPRD1;GRM8;SSTR1;GLP1R;S1PR4
prerank,glucuronosyltransferase activity (GO:0015020),0.47686390390215955,1.0891009773740805,0.3416370106761566,0.8449716271392134,1.0,1/19,0.34%,CSGALNACT1
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",-0.43578099555961336,-1.0842850936224142,0.3724137931034483,0.8645908954142847,1.0,5/17,13.10%,DPYD;BDH2;PTGR2;PECR;DECR1
prerank,translation initiation factor activity (GO:0003743),0.41587778818756876,1.082580053938462,0.3515151515151515,0.8589018993059342,1.0,14/36,16.71%,EIF3F;EIF3E;EIF2B1;EIF3D;MTIF3;EIF2B2;EIF4E;EIF3B;EIF3G;EIF3L;EIF3M;EIF1B;COPS5;EIF4A1
prerank,chloride transmembrane transporter activity (GO:0015108),0.48664425598487365,1.0813308517155997,0.37918871252204583,0.8575340602457016,1.0,1/16,0.40%,SLC1A1
prerank,palmitoyltransferase activity (GO:0016409),0.42660780381039304,1.0808064670035142,0.35323383084577115,0.8541602405272384,1.0,6/28,9.79%,ZDHHC14;ZDHHC9;ZDHHC20;ZDHHC19;ZDHHC18;ZDHHC22
prerank,gated channel activity (GO:0022836),0.5039448417367876,1.0797438217592137,0.39388489208633093,0.8523284334267553,1.0,4/14,5.69%,PIEZO1;TMEM63B;TMC5;TMC7
prerank,nucleotidyltransferase activity (GO:0016779),0.47256155805807376,1.076276229204783,0.40703517587939697,0.8577671569934919,1.0,2/19,5.11%,TENT4A;MTPAP
prerank,ubiquitin-specific protease binding (GO:1990381),-0.4171962759314478,-1.0761021234025063,0.3752808988764045,0.8821976434429615,1.0,6/19,13.57%,AMFR;LCOR;PRKN;SELENOS;SYVN1;PTEN
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.5285233704133547,1.0757026269359138,0.39332096474953615,0.8547713903920633,1.0,2/11,12.89%,CNGA2;HCN2
prerank,calcium channel inhibitor activity (GO:0019855),0.5199312325880676,1.0753786245840309,0.41134751773049644,0.8511527477311102,1.0,3/11,4.35%,MCUB;SLC30A1;CALM1
prerank,cytokine receptor activity (GO:0004896),0.3551634427553898,1.0747995855923635,0.3300970873786408,0.8482196888939911,1.0,17/83,12.97%,IL1R1;IL6R;IFNAR1;FZD4;IFNAR2;IL10RB;OSMR;CD4;IL17RD;IL13RA2;IL4R;GPR17;LIFR;EBI3;IL20RB;IL27RA;IL7R
prerank,1-phosphatidylinositol binding (GO:0005545),0.47875685949359087,1.072724860439771,0.3893805309734513,0.8494300479890907,1.0,3/15,7.28%,SCARB1;EPB41;WDFY3
prerank,iron ion binding (GO:0005506),-0.32931883120702754,-1.071178299427674,0.3008595988538682,0.8898783931167705,1.0,18/48,28.86%,AGMO;AOX1;KDM7A;EGLN3;FXN;PHF8;PHYH;ALKBH1;FDX1;PHF2;TYW5;DNAJC24;FTL;TET1;ACO2;FBXL5;ACP5;SCD
prerank,methyl-CpG binding (GO:0008327),-0.39817440469968424,-1.0709926122956057,0.3654708520179372,0.8823387829062047,1.0,15/22,35.87%,CXXC5;ZBTB38;PRMT5;CXXC4;ZBTB4;MBD2;ERH;TET1;ZCWPW1;UHRF1;MBD3;MBD1;LRWD1;PRMT1;LHX4
prerank,transcription coregulator binding (GO:0001221),-0.33926061282479786,-1.067821632583324,0.3426791277258567,0.8843917492807174,1.0,15/50,12.24%,SMAD3;THRB;PER3;CCNT2;USP11;NEK6;EHMT2;RORA;AR;PER2;LCOR;MED25;VGLL4;ESR1;PGR
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),0.45868422734964037,1.067797852772134,0.4017241379310345,0.8584095411388297,1.0,4/18,3.18%,ENG;LTBP4;BMPR2;ACVRL1
prerank,flavin adenine dinucleotide binding (GO:0050660),-0.33656458187664223,-1.066184211477313,0.3192090395480226,0.8814472957090622,1.0,12/53,11.93%,MICAL3;DDO;MICAL2;AOX1;DPYD;POR;NOX4;PRODH;MTHFR;CRY2;KDM1A;AIFM2
prerank,intracellular calcium activated chloride channel activity (GO:0005229),0.47234945692847424,1.0654037450449185,0.3827993254637437,0.8558716754636051,1.0,5/16,19.47%,TTYH2;CLCA2;TTYH3;ANO3;ANO5
prerank,intracellular chloride channel activity (GO:0061778),0.47234945692847424,1.0654037450449185,0.3827993254637437,0.8558716754636051,1.0,5/16,19.47%,TTYH2;CLCA2;TTYH3;ANO3;ANO5
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.46858165480169073,1.0641123477951022,0.3733826247689464,0.8547999768459377,1.0,1/16,0.40%,SLC1A1
prerank,high voltage-gated calcium channel activity (GO:0008331),-0.46911349576892486,-1.0620899694266295,0.37872340425531914,0.8860092662672673,1.0,5/10,13.29%,CACNA1C;CACNA1D;CACNB4;CACNB2;CACNB1
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.47478764681577595,1.0616663980335952,0.4003831417624521,0.8571596779215168,1.0,2/15,5.02%,SLC1A1;SLC1A2
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),-0.4682052353462653,-1.06151241154587,0.4025157232704403,0.8799169510327143,1.0,7/12,23.80%,KDM7A;KDM3B;KDM1A;PHF8;PHF2;KDM4D;HR
prerank,sequence-specific DNA binding (GO:0043565),-0.24214332897753144,-1.0600657135191998,0.20689655172413793,0.8768984175975867,1.0,122/590,17.97%,FOXP2;PBX1;MAF;ZIC1;ZEB2;NR2F2;ZIC4;GLI3;RARB;ZBTB20;GLI2;CREB5;FOXD1;HLF;SMAD3;PKNOX2;HOXC4;ARNT2;OSR1;TEAD1;NR6A1;HOXA5;NFAT5;MEOX2;THRB;HDAC4;CUX1;HOXB4;PRRX2;TEF;NR1D2;HOXB6;FOXC2;FOXC1;TBX15;PPARGC1A;RBPJ;ZNF423;HOXA7;RORA;GLIS2;PPARA;PBX4;RUNX2;KLF3;SIX1;TBX18;BCL6;HOXC8;NR3C2;KDM2A;SIRT3;FOXJ2;NFATC4;ATF5;ELF4;ZSCAN29;BCL2;KLF15;VSX1;RFX7;FBXL19;KDM5B;FOXL1;KDM2B;POU6F1;HSF2;CREB3L1;ZNF23;FOXO3;CXXC5;ARNT;CEBPB;ELK1;GATA6;ZBTB38;NR2F1;ZNF148;PRMT5;CXXC4;ETV1;KDM1A;TFCP2L1;RXRA;ABL1;ESR1;XRCC5;HOXB5;FOXE1;SNAI1;SP3;ZBTB4;MAFB;MTF1;GZF1;HOXA9;ATF2;NR4A1;ZBTB7B;E2F3;RFX5;SREBF1;NFIB;MYBL2;FOXJ3;ZBTB26;SMG1;NR1H4;NFATC2;JDP2;HOXB2;HOXA6;MBD2;RARA;SIX4;HOXA2;HIC1;ZNF177;PAX2;CALCOCO1;FOXD2;BATF
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),0.49577536339845507,1.0599741862833656,0.41952983725135623,0.8571602534321905,1.0,4/12,3.18%,ENG;LTBP4;BMPR2;ACVRL1
prerank,GTPase inhibitor activity (GO:0005095),-0.44543641676011697,-1.0579543662874829,0.40305010893246185,0.8752833072449774,1.0,2/13,2.27%,CPEB2;SLIT2
prerank,kinase activity (GO:0016301),0.34300472312376595,1.056966513230183,0.3620218579234973,0.8612016763921727,1.0,22/109,13.91%,ITPKB;DGKH;PRKD1;LYN;PRKD3;DGKI;EPHA4;DGKE;PKN2;CHKA;CERKL;PGM2L1;PDXK;PIK3C3;PIK3C2A;IPMK;DGKZ;PIK3CB;MAP4K4;PANK3;CERK;PSTK
prerank,neuropeptide receptor binding (GO:0071855),0.47651548825090706,1.0555887069872416,0.42434782608695654,0.8608757647507757,1.0,3/14,18.55%,NPPA;PPY;NTS
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.5113201151645441,1.0546996851960764,0.40425531914893614,0.8588781856796117,1.0,4/11,17.21%,KCNQ1;KCNH2;KCNJ3;KCNJ5
prerank,RNA polymerase core enzyme binding (GO:0043175),-0.3581903162961544,-1.0506116281630682,0.3949367088607595,0.8896211166678482,1.0,13/33,25.66%,CTR9;AGO2;PCF11;RPRD2;WDR43;URI1;PAF1;SPTY2D1;ELP4;WAC;UVSSA;ERBB2;SMYD2
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.4010699806918476,1.0502187225216273,0.3790849673202614,0.8673202366504854,1.0,19/35,30.32%,TAF1B;STAT1;RRN3;GTF2B;POU2F1;ZBTB17;NR3C1;UBTF;TAF4;TBPL1;FOXP1;TAF1C;MYC;SMARCA4;AGO1;SNAPC3;PARK7;TP53;DR1
prerank,protein kinase regulator activity (GO:0019887),-0.28965392894358133,-1.0499765641771008,0.3724137931034483,0.8840494424600985,1.0,23/95,16.02%,PRKAG2;PARVA;CCNT2;GPRC5C;GMFB;CCNL1;CCND2;QARS1;ELP3;STK11;CCNC;PRKAG3;CCNH;ANKRD54;STRADA;WNK1;DUS2;WNT11;CCNE2;ELP4;GPRC5A;DNAJC3;CDKN1C
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.41137853685061126,1.0498333836425664,0.4172077922077922,0.8639685159060667,1.0,11/33,20.62%,CNOT6L;NOCT;PDE12;PAN2;DCP2;CNOT6;DIS3L;EXOSC10;XRN1;EXOSC9;XRN2
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.45269339810929676,1.0489397514954752,0.423728813559322,0.8620972505700205,1.0,1/21,0.28%,POLK
prerank,intracellular ligand-gated ion channel activity (GO:0005217),-0.4572324782960743,-1.0485631100195687,0.42887029288702927,0.8806724375293683,1.0,2/11,7.09%,ITPR1;RASA3
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.4550133794514125,1.0468505417759384,0.4223385689354276,0.863532525339074,1.0,4/20,10.08%,TJP2;MAGI3;AK4;CMPK1
prerank,ionotropic glutamate receptor activity (GO:0004970),0.4648073230371032,1.0443531387170235,0.40034965034965037,0.8660288038531553,1.0,9/17,24.02%,GRIN3B;GRIA4;GRIN2B;GRIK5;GRIK2;GRIK1;GRIA2;GRIK3;GRIN1
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",-0.42992222676458386,-1.0406359557991518,0.43529411764705883,0.8977156351258956,1.0,8/14,34.92%,ALDH4A1;MTHFR;MTHFD1;AASS;PYCR3;PYCR1;ALDH1L1;CRYM
prerank,DNA polymerase activity (GO:0034061),0.4446696893729639,1.0405919065079436,0.4355108877721943,0.8719452645751824,1.0,1/22,0.28%,POLK
prerank,histone deacetylase binding (GO:0042826),0.34405514279441796,1.0392416723249722,0.39609483960948394,0.8711064228768144,1.0,9/88,8.41%,LEF1;MEF2C;HDAC9;HSP90AB1;TAL1;PKN1;PKN2;INSM1;FOXP3
prerank,voltage-gated anion channel activity (GO:0008308),-0.42095217711917626,-1.0366666388312438,0.42795698924731185,0.9028664890884474,1.0,4/15,9.40%,ANO6;CLCN2;ANO1;CLCN6
prerank,syntaxin-1 binding (GO:0017075),0.43281718919165324,1.03638423747666,0.4330434782608696,0.874365180663829,1.0,6/22,14.09%,UNC13B;SYPL1;STXBP1;SYNPR;CPLX1;SYPL2
prerank,WW domain binding (GO:0050699),0.4141597113190631,1.0360542987344543,0.408130081300813,0.8709165818936798,1.0,6/26,18.20%,RAPGEF2;NDFIP2;TNK2;TCEAL6;TCEAL5;DAZAP2
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.4282656615491155,1.0357134301994952,0.429042904290429,0.8676192872365617,1.0,3/24,10.08%,ITPKB;AK4;CMPK1
prerank,ATPase regulator activity (GO:0060590),-0.33542171802704873,-1.0352800402212996,0.3726027397260274,0.8998167744406741,1.0,12/38,21.13%,FNIP1;SIL1;ATP1B3;ATP1B2;BAG1;TOR1AIP1;BAG3;ATP5IF1;DNAJB4;DNAJB2;TSC1;DNAJC24
prerank,carboxy-lyase activity (GO:0016831),0.42841310046513253,1.0351635278759705,0.4388111888111888,0.8648955375447733,1.0,1/23,0.61%,DDC
prerank,transcription regulatory region nucleic acid binding (GO:0001067),-0.2630074964358653,-1.0332845259448196,0.34972677595628415,0.898276644632138,1.0,36/188,11.74%,BNC2;PBX1;SOX5;ZBTB20;SMAD3;SMAD6;HDAC4;GABPB2;PER3;CREB3L2;FOXC2;FOXC1;BCOR;TBL1XR1;AR;PER2;GLIS2;SIX1;TBX18;GLI1;ZNF568;ATF5;KLF15;CHD3;VSX1;YAP1;CREB3L1;FOXO3;SOX6;CEBPB;ELK1;GATA6;RNF10;CRY2;MTERF3;RXRA
prerank,tropomyosin binding (GO:0005523),-0.4135650793483658,-1.0320879057255998,0.4419642857142857,0.8948170578217104,1.0,6/16,17.24%,CALD1;S100A6;LMOD1;TMOD3;TNNT3;TMOD2
prerank,cAMP response element binding (GO:0035497),-0.4716117996858614,-1.0318294145100668,0.4288939051918736,0.8884681173637742,1.0,5/10,14.31%,CREB5;CREB3L2;CREB3L1;E4F1;ATF2
prerank,voltage-gated sodium channel activity (GO:0005248),-0.38168230640067924,-1.0276078589000344,0.41687344913151364,0.893480091135714,1.0,3/22,4.91%,SCN7A;PKD2;CACNA1G
prerank,N-acetyltransferase activity (GO:0008080),-0.3931782662135679,-1.0264763742477998,0.40384615384615385,0.8901009338850926,1.0,12/19,37.83%,SAT1;NAA80;EP300;SAT2;NAT2;NAT8L;NAA50;AANAT;SMARCE1;ESCO1;NAT10;NAT1
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",-0.44436114541955163,-1.0261727111799748,0.44419134396355353,0.8840229044970124,1.0,7/12,37.58%,AIFM2;NQO1;DCXR;CRYZ;DHRS4;CRYZL1;CBR1
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),-0.43401234888297746,-1.0253045646579328,0.44835164835164837,0.8795773282257513,1.0,4/13,15.28%,AGPAT4;LCLAT1;GPAT3;PNPLA3
prerank,nuclear receptor binding (GO:0016922),0.32854769777386755,1.0241419096959663,0.42236842105263156,0.889750806862952,1.0,18/111,12.54%,LEF1;NCOA1;CTNNB1;PKN1;ACTN4;STAT1;BUD31;NCOA2;TACC1;YWHAH;ARID1A;HMGA1;SRARP;OASL;PRKCB;ZBTB7A;HIF1A;GTF2B
prerank,heme binding (GO:0020037),0.3541225269277057,1.0230487139786504,0.4339080459770115,0.8885123357566281,1.0,11/65,10.85%,NOS3;FLVCR2;CYP2E1;PXDN;NOS2;CYP11B1;CYP11A1;CAT;TBXAS1;CBS;CYBB
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.37182073543476013,1.0215128809608602,0.4426229508196721,0.8883436171726204,1.0,2/44,3.46%,MECOM;MEN1
prerank,myosin binding (GO:0017022),-0.30648918367702394,-1.0196146428168424,0.42857142857142855,0.889227647853796,1.0,5/55,3.47%,CALD1;KIRREL1;GSN;TRAK1;DMD
prerank,chemokine binding (GO:0019956),-0.3462575149994056,-1.0193142740774899,0.46808510638297873,0.8833030499631358,1.0,4/30,10.36%,PDPN;CCR9;FGF2;ITGAV
prerank,lipoprotein particle receptor binding (GO:0070325),-0.3571986163527643,-1.01669507032508,0.4457831325301205,0.8844057661696786,1.0,7/27,21.72%,LRP1;APOE;HSP90B1;APBB3;AP2A1;SNX17;LANCL1
prerank,actinin binding (GO:0042805),0.43399615023458477,1.0152607372622358,0.43463497453310695,0.9011841553975959,1.0,2/21,2.01%,PROM1;MAGI1
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),-0.3277005366231414,-1.014874201572549,0.4040114613180516,0.882470685542895,1.0,6/38,6.75%,SERPING1;TFPI;ANXA2;SERPINH1;SERPIND1;SERPINF1
prerank,RNA polymerase II complex binding (GO:0000993),-0.34519767745485935,-1.0138665327806204,0.42597402597402595,0.8786394157367979,1.0,8/32,15.33%,CTR9;AGO2;PCF11;RPRD2;WDR43;URI1;PAF1;ELP4
prerank,phosphatase inhibitor activity (GO:0019212),0.4345539199388065,1.0132570234132054,0.4665551839464883,0.9024144769762574,1.0,8/20,24.85%,PPP1R9B;PPP1R2;PTN;BOD1;PPME1;SET;ENSA;LMTK2
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.4060516108399734,1.0126667741809487,0.4458041958041958,0.8996368704490292,1.0,5/26,13.25%,CSGALNACT1;B3GNT2;B3GALT4;B4GALNT1;B3GALT2
prerank,phosphatidylinositol kinase activity (GO:0052742),0.4539121386545829,1.0101841857707377,0.4573502722323049,0.9020943902696111,1.0,5/15,12.15%,PIK3R3;PIKFYVE;PIK3C3;PIK3C2A;PIK3CB
prerank,potassium ion antiporter activity (GO:0022821),-0.40872351508774607,-1.0072349826675098,0.4361948955916473,0.891062704995194,1.0,5/15,11.17%,SLC24A3;SLC9A2;SLC9A9;SLC9A1;SLC24A5
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.39239210132609104,1.0068114939020334,0.4813008130081301,0.9068442136035749,1.0,10/34,20.62%,CNOT6L;NOCT;PAN3;PDE12;PAN2;CNOT6;DIS3L;EXOSC10;EXOSC9;XRN2
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),-0.43232202151348903,-1.0012827732057257,0.4492753623188406,0.90139194724086,1.0,2/11,18.07%,SLC22A4;SLC25A29
prerank,calcium ion binding (GO:0005509),0.28759172594949267,0.9999467437869988,0.4581901489117984,0.9209828862327839,1.0,47/323,12.62%,SPOCK2;RASGRP3;ESYT2;LTBP4;NOTCH4;RAPGEF2;ADGRL3;TPD52;DYSF;SPARCL1;AGRN;CDH2;PLA2G4B;VIL1;TGM2;CDH20;CALM1;CDH8;CAMKK2;SYT7;ESYT1;RASGRP2;RET;DCHS1;CDH19;SRI;CRNN;CETN2;IQGAP1;ENPP2;NRXN1;SPOCK1;LETM1;DNER;HPGDS;CLGN;LRP2;S100A8;TPM4;PPP3CA;SYT4;CDH10;CDH23;PPP3R1;CALB2;EML1;CPNE6
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.44709479034870137,0.999310384882254,0.4626334519572954,0.9186081157575962,1.0,5/13,13.39%,KCNQ1;PRKAR2B;PRKAR2A;GSK3A;SOX9
prerank,ubiquitin-protein transferase activity (GO:0004842),-0.2376402757292269,-0.9986803698778187,0.47115384615384615,0.9020182192072418,1.0,77/346,17.68%,RNF220;PDZRN3;RNF152;PELI2;UBE2E2;RNF43;SH3RF3;CBLB;AMFR;BCOR;ASB2;TTC3;DTX4;DTX3;TRIM23;FBXO10;RNF145;FBXW8;DTX1;RNF217;UBE2R2;SH3RF2;TRAF3IP2;MGRN1;PRKN;PJA2;UBR5;UBE2E1;RNF214;SMURF2;RNF135;PML;UBE2M;LRSAM1;DDB2;CUL3;RNF31;KCMF1;BTRC;TRIM63;RNF10;KLHL13;HUWE1;NHLRC3;AKTIP;WWP2;MYLIP;RNF20;RNF181;NFX1;UBE2E3;PPIL2;RNF149;PRPF19;PELI3;RNF24;FBXO17;SYVN1;FBXW11;RNF121;TRIM9;KLHL42;NSMCE1;TRIP12;RNF144A;UBE2B;DTX2;UBR2;UBR3;MKRN1;RCHY1;FBXO4;TRAIP;UBR4;FBXO9;UBE2Q1;MEX3C
prerank,metal ion binding (GO:0046872),0.2808397015126452,0.9970121396407768,0.48954895489548955,0.9205531387018477,1.0,79/477,14.18%,SPOCK2;CSGALNACT1;RASGRP3;ESYT2;LTBP4;PDE2A;NOTCH4;RAPGEF2;ADGRL3;TPD52;DYSF;STK38;SPARCL1;AGRN;SNRK;HPRT1;SNN;CDH2;PLA2G4B;VIL1;TGM2;CDH20;CALM1;NT5C3A;CDH8;MTPAP;CAMKK2;PIR;SYT7;PRKACB;ESYT1;RASGRP2;RET;IDH3A;DCHS1;CDH19;SRI;CRNN;CETN2;MAP3K6;IQGAP1;PDXK;ENPP2;NRXN1;SPOCK1;LETM1;DNER;HPGDS;CLGN;NUDT3;LRP2;S100A8;TPM4;PPP3CA;SYT4;CDH10;CDH23;PPP3R1;DXO;CALB2;EML1;CPNE6;MAN1B1;CERK;STK3;CDH5;MT1F;MT1X;MT1M;MT1H;MT1A;MT1E;MT1G;MT1B;FAN1;HACL1;XYLT2;MOV10L1;PDCD6
prerank,histone methyltransferase binding (GO:1990226),0.47491589902135434,0.9967637638807738,0.47574626865671643,0.9170956977320299,1.0,3/11,9.30%,CTNNB1;HSP90AB1;LCORL
prerank,triglyceride lipase activity (GO:0004806),0.4138708939640142,0.9955183257475467,0.47758620689655173,0.9162764226459637,1.0,2/20,10.76%,LIPE;LIPC
prerank,ion channel activity (GO:0005216),-0.2880892689806731,-0.9952853804219791,0.4627450980392157,0.9047059927852893,1.0,10/80,8.56%,TRPM3;NALCN;PIEZO2;PKD2;ABCC9;TRPM6;ANXA6;CALHM2;CALHM5;TRPC6
prerank,ubiquitin-like protein ligase activity (GO:0061659),-0.24824272847673495,-0.9940476601048626,0.4689655172413793,0.9013807682116145,1.0,51/232,16.50%,RNF220;PDZRN3;RNF152;PELI2;RNF43;SH3RF3;CBLB;AMFR;ASB2;PIAS1;DTX4;DTX3;RNF145;DTX1;RNF217;SH3RF2;TRAF3IP2;MGRN1;PRKN;UBR5;SMURF2;RNF135;LRSAM1;CUL3;KCMF1;TRIM63;RNF10;HUWE1;NHLRC3;WWP2;MYLIP;RNF181;NFX1;PPIL2;PIAS2;RNF149;PRPF19;PELI3;RNF24;FBXO17;SYVN1;RNF121;TRIM9;NSMCE1;TRIP12;RNF144A;DTX2;UBR2;UBR3;MKRN1;RCHY1
prerank,protein kinase C binding (GO:0005080),0.3644918906506831,0.9938249940364952,0.453525641025641,0.91663405712158,1.0,14/43,14.97%,TIRAP;PRKD2;HDAC9;HDAC7;HINT1;PKN1;CCDC88A;ADCY4;TWF2;CAVIN2;HSPB1;PRKCB;NELL2;HDAC5
prerank,endopeptidase inhibitor activity (GO:0004866),0.33070069020834214,0.9936983020220223,0.4703448275862069,0.9128183620348812,1.0,10/82,9.50%,SPOCK2;APP;SERPINB5;SERPINA9;SERPINA11;BST2;CST7;PZP;SPOCK1;SERPINI1
prerank,methylation-dependent protein binding (GO:0140034),-0.29999459079669105,-0.9927505459286967,0.48220064724919093,0.8984644736339199,1.0,12/57,15.30%,ZMYND8;KDM7A;PYGO1;SGF29;CHD8;CBX5;TDRD3;MBTD1;PHF8;FMR1;MORC3;ZCWPW2
prerank,ligand-gated calcium channel activity (GO:0099604),-0.37967923062451614,-0.9907493727923657,0.4953051643192488,0.8980030777346204,1.0,4/19,10.60%,ITPR1;RASA3;P2RX4;TRPM4
prerank,titin binding (GO:0031432),-0.4217416136498616,-0.9894910153816415,0.48451327433628316,0.8951935661951733,1.0,3/13,10.39%,ACTN2;CAMK2D;TRIM63
prerank,signal sequence binding (GO:0005048),0.3827013251182522,0.9869626271078995,0.5023041474654378,0.92627153852882,1.0,10/35,19.37%,NFKBIA;PEX5L;CAT;AP2M1;RANBP6;AP2B1;TOMM20L;NUP153;KCNIP2;IPO4
prerank,calcium-dependent phospholipid binding (GO:0005544),0.3598493046066225,0.9860943919819711,0.48303715670436187,0.9244793934215683,1.0,9/49,12.62%,ESYT2;DYSF;PLA2G4B;SYT7;CPNE8;ESYT1;CPNE5;SYT4;CPNE6
prerank,NAD binding (GO:0051287),-0.3487023776256488,-0.9857213271032377,0.45965770171149145,0.8992990310322871,1.0,5/26,8.29%,ALDH1A1;CRYL1;ME1;SIRT3;BDH2
prerank,ion channel inhibitor activity (GO:0008200),0.38145519966422753,0.9834861197069645,0.49835526315789475,0.9268085199321688,1.0,5/35,4.35%,NEDD4L;STX1A;MCUB;SLC30A1;CALM1
prerank,anion:anion antiporter activity (GO:0015301),-0.39523597601390775,-0.9834222243280574,0.4861111111111111,0.8994064274354173,1.0,3/17,8.95%,SLC26A7;SLC26A2;SLC4A2
prerank,ubiquitin protein ligase activity (GO:0061630),-0.242591684385235,-0.9829016294995607,0.5,0.894620006950061,1.0,50/228,16.50%,RNF220;PDZRN3;RNF152;PELI2;RNF43;SH3RF3;CBLB;AMFR;ASB2;DTX4;DTX3;RNF145;DTX1;RNF217;SH3RF2;TRAF3IP2;MGRN1;PRKN;UBR5;SMURF2;RNF135;LRSAM1;CUL3;UBE4B;KCMF1;TRIM63;RNF10;HUWE1;NHLRC3;WWP2;MYLIP;RNF181;NFX1;PPIL2;RNF149;PRPF19;PELI3;RNF24;FBXO17;SYVN1;RNF121;TRIM9;NSMCE1;TRIP12;RNF144A;DTX2;UBR2;UBR3;MKRN1;RCHY1
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),0.46370443867476346,0.980868012396482,0.5053763440860215,0.9292464772114347,1.0,4/11,13.64%,PPP1R2;PPP1R11;PPP1R14C;PPP1R8
prerank,nuclear localization sequence binding (GO:0008139),0.4231570482820677,0.9795730590009556,0.48580968280467446,0.9283676848848698,1.0,4/18,19.37%,NFKBIA;RANBP6;NUP153;IPO4
prerank,transition metal ion binding (GO:0046914),-0.22707218127330236,-0.9782721941203971,0.57,0.9011254213248077,1.0,62/397,11.95%,MPPED2;AGMO;GLI2;TIMP2;MOXD1;SMAD3;LARGE1;PAPPA;ENPP1;AOX1;SEC24D;ZFPM2;HDAC4;MMP16;ACER3;CBLB;SEC24A;ANPEP;LOXL3;PAM;ME1;ADCY2;ZMYND8;BAZ1B;KDM7A;MDM4;ENPP3;IKZF4;SOD3;TDP2;UPB1;LACC1;ZEB1;KDM2A;ATP7A;SIRT3;P2RX4;SOD2;CHD3;PRKN;ACE;ENPEP;FBXL19;KDM5B;NPEPPS;EEA1;KDM2B;RBAK;CHD4;CXXC5;PTGR2;ADAM33;SEC23A;B4GALT1;IDE;CRIP1;FAM20C;EPRS1;CXXC4;RXRA;PHF8;ABL1
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.34539144196108046,-0.9771607180931727,0.48,0.8980527643145013,1.0,6/27,6.46%,SLC26A7;SLC26A2;SLC39A14;SLC22A6;SLC5A5;ANO1
prerank,carboxylic acid binding (GO:0031406),0.37666657834114997,0.9770683134430211,0.49759229534510435,0.9305293627838844,1.0,8/38,14.47%,NOS3;NOS2;SESN3;GRIN3B;SHMT2;GRIN2B;MAG;GRM7
prerank,endopeptidase activator activity (GO:0061133),0.4786168251608839,0.9760801695069254,0.496,0.9292823870773718,1.0,7/10,27.30%,PSME2;APH1A;VSIR;NLRC4;APH1B;PSME1;ADRM1
prerank,transferrin receptor binding (GO:1990459),-0.43549504533308503,-0.9720207921102272,0.5056433408577878,0.9060961908354442,1.0,4/10,15.56%,RGMA;CHUK;CD81;IKBKG
prerank,cation:chloride symporter activity (GO:0015377),-0.4448649725712243,-0.9718938921709266,0.5098039215686274,0.9003812389382649,1.0,4/10,12.59%,SLC12A2;SLC6A1;SLC12A7;SLC12A4
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),-0.3257371513212537,-0.969240904752374,0.5141388174807198,0.901522191503909,1.0,8/34,17.65%,UBE2E2;UBE2R2;UBE2E1;AKTIP;UBE2E3;UFC1;UBE2B;UBE2Q1
prerank,phosphatidate phosphatase activity (GO:0008195),-0.407064860795781,-0.9685064516022656,0.5064102564102564,0.8974967265407996,1.0,1/13,0.81%,PLPP3
prerank,transcription cis-regulatory region binding (GO:0000976),0.2748471470646672,0.9655074241985349,0.5846994535519126,0.9520918401820918,1.0,42/406,9.18%,LEF1;ETS1;FLI1;DACH1;EPAS1;ELK3;ZBTB46;SOX17;MEF2C;SMARCA2;SOX13;MEN1;PRDM2;IRF2;HHEX;FOXF1;RREB1;SOX7;TCF23;BARHL1;KLF1;TAL1;ETV6;TCF7;SNAI2;ACTN4;KLF4;MAX;SOX18;PHOX2A;SOX12;HINFP;JUN;KCNH2;ZFP69;ATF6B;TCF12;PRDM9;CDK5RAP2;ZBTB14;SIM1;HMGA1
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.4665579831489111,0.9630339072146514,0.5234521575984991,0.9543100662199239,1.0,4/12,18.97%,STAT1;GTF2B;POU2F1;TBPL1
prerank,ligand-gated cation channel activity (GO:0099094),0.32497753920385813,0.9620209333103283,0.5157593123209169,0.9526935443197581,1.0,18/75,19.84%,MCOLN1;KCNK6;CHRNB1;GRIN3B;KCNH2;GRIA4;KCNN2;KCNN3;P2RX7;GRIN2B;GRIK5;GRIK2;GRIK1;TRPM8;KCNJ3;KCNJ5;KCNJ6;GRIA2
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),0.37641708701417803,0.9599396064391341,0.5141430948419301,0.9536684519637177,1.0,12/28,25.86%,GRID2;CHRNB1;GRIK5;GRIK2;GRIK1;GABRG1;GABRG3;GABRA1;GRIK3;GABRA2;GRID1;GABRG2
prerank,methylated histone binding (GO:0035064),-0.28490614967805156,-0.9591596046352673,0.5165562913907285,0.9164807970776403,1.0,14/62,18.74%,ZMYND8;KDM7A;PYGO1;SGF29;CHD8;CBX5;TDRD3;MBTD1;PHF8;FMR1;MORC3;ZCWPW2;CHD5;PHF2
prerank,aspartic-type peptidase activity (GO:0070001),-0.4317978808917844,-0.9588282938707,0.4849137931034483,0.9113920933277143,1.0,2/10,12.41%,BACE2;PSEN1
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.46802100633506794,0.958213018048397,0.498134328358209,0.9540828849639569,1.0,5/10,24.77%,CDKN2B;KAT2B;INCA1;CDKN1B;CDKN2C
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),-0.3945257614362433,-0.9564698600944392,0.5161290322580645,0.9120260313573878,1.0,4/15,15.28%,AGPAT4;LCLAT1;GPAT3;PNPLA3
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),-0.32902439970783576,-0.9554582458037026,0.5156626506024097,0.9089264189319426,1.0,4/29,3.53%,SLC13A3;SLC26A7;SLC26A2;SLC1A5
prerank,calcium channel regulator activity (GO:0005246),0.3657068182759399,0.9547813772506647,0.5335413416536662,0.9587671990394986,1.0,7/37,8.93%,MCUB;SLC30A1;PRKG1;CALM1;REM2;SRI;NRXN1
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.4209588789102424,0.9543507033019804,0.5176678445229682,0.9557778771173313,1.0,1/15,3.45%,PLA2G4B
prerank,histone acetyltransferase activity (GO:0004402),-0.32369718453795754,-0.9533610818027349,0.541025641025641,0.9086458426231457,1.0,14/30,27.92%,ARRB1;KAT6B;HAT1;ATF2;EP300;MCM3AP;BAZ1A;NAA40;TAF9;KAT14;NAA50;CREBBP;KAT8;EPC1
prerank,ribosome binding (GO:0043022),-0.2982593571856732,-0.9530502616851924,0.5304878048780488,0.9036355805164729,1.0,15/46,22.70%,CPEB1;CPEB2;MRPS27;EIF3C;FMR1;SRP72;NCLN;IGHMBP2;EIF2A;YTHDF1;SEC61B;C1QBP;SEC61A2;SRP68;CPEB4
prerank,ephrin receptor binding (GO:0046875),0.4110677654768626,0.9525756470900255,0.5354058721934369,0.9562590151647605,1.0,6/21,7.63%,ANKS1A;LYN;GRB2;FYN;ANKS1B;EFNA1
prerank,NAD+ binding (GO:0070403),-0.4183801856770754,-0.9504007503650805,0.5246636771300448,0.9047170045618389,1.0,5/12,23.40%,CRYL1;SIRT3;SIRT2;HADH;SIRT6
prerank,carbohydrate kinase activity (GO:0019200),-0.42502983898842933,-0.9500027311630576,0.5548523206751055,0.9001376715144764,1.0,4/11,16.55%,HK2;GALK1;NAGK;GALK2
prerank,SH2 domain binding (GO:0042169),-0.3237943217090784,-0.9494866724389618,0.5102564102564102,0.8959008238205655,1.0,4/31,3.78%,AFAP1;IRS1;SH3PXD2B;DAG1
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.37061657026688066,-0.9494062217477569,0.5358024691358024,0.8905888822479232,1.0,5/18,11.43%,ALDH1A1;ALDH1A2;AKR1B1;ALDH18A1;AKR1B10
prerank,Hsp70 protein binding (GO:0030544),0.3702289416241775,0.9490616033182303,0.5353697749196141,0.9615448561867601,1.0,4/31,7.85%,NOD2;CYP2E1;FICD;SACS
prerank,N-methyltransferase activity (GO:0008170),-0.36607978230333604,-0.9486703168485879,0.558891454965358,0.8870267287859218,1.0,6/20,25.40%,HNMT;NNMT;TRMT1L;FDXACB1;DIMT1;RNMT
prerank,neurexin family protein binding (GO:0042043),-0.4252291436608121,-0.9472936768468818,0.5349344978165939,0.8850299881984047,1.0,2/10,6.07%,NLGN2;SYTL5
prerank,MAP kinase kinase activity (GO:0004708),-0.3856006092659372,-0.9447872823018336,0.513953488372093,0.8862155452186378,1.0,8/15,22.58%,MAPKAPK3;LRRK2;MAPK14;MAP2K5;MAP2K3;MAP2K1;MAP2K4;MAP3K9
prerank,gap junction channel activity (GO:0005243),0.39351990761456634,0.9439399006183662,0.5468483816013628,0.9701391137462266,1.0,2/22,1.84%,GJD3;GJC1
prerank,delayed rectifier potassium channel activity (GO:0005251),0.37030590128435387,0.9436102924415296,0.5398373983739837,0.967009269508876,1.0,6/32,10.87%,KCNQ1;KCNC2;KCNG2;KCNH2;KCNQ3;KCNA4
prerank,wide pore channel activity (GO:0022829),0.3901796522348522,0.9434972090641351,0.5456081081081081,0.9632648159385112,1.0,2/23,1.84%,GJD3;GJC1
prerank,pyridoxal phosphate binding (GO:0030170),-0.3675180178681534,-0.9426456535112979,0.5550239234449761,0.8862743190398592,1.0,10/20,27.78%,PYGB;PYGM;ABAT;OAT;ACCS;THNSL2;PYGL;PNPO;GLDC;SHMT1
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),-0.42940811790119787,-0.9410263893476705,0.5408805031446541,0.8848740408884267,1.0,6/10,27.39%,NSD2;SETD5;SETD2;NSD1;SMYD2;SETMAR
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.3803249284909792,0.9408820071288239,0.5378151260504201,0.9657441089161262,1.0,5/25,4.51%,NOS3;CYP2E1;FMO2;FMO4;NOS2
prerank,amino acid:sodium symporter activity (GO:0005283),-0.415101920243928,-0.940672864509293,0.5376569037656904,0.8804427842789405,1.0,4/11,5.61%,SLC6A13;SLC1A3;SLC6A12;SLC6A1
prerank,Notch binding (GO:0005112),0.39570709027457096,0.9405070417458351,0.5475040257648953,0.9626380022366203,1.0,7/22,10.24%,NOTCH4;JAG2;DLL4;DNER;KCTD10;ADAM17;DLK2
prerank,peptidase activator activity (GO:0016504),0.3872943672960908,0.9393439131869679,0.5452961672473867,0.9614309900515403,1.0,5/22,11.81%,CAV1;MAL;PSME2;APH1A;VSIR
prerank,potassium:proton antiporter activity (GO:0015386),0.46455076737375933,0.9392884219236974,0.5508021390374331,0.9576101465512097,1.0,4/10,9.42%,SLC9A5;SLC9A3;SLC9A7;SLC9A6
prerank,monovalent cation:proton antiporter activity (GO:0005451),0.4502966267263714,0.9385519982805829,0.5625,0.9554408095155539,1.0,5/12,9.42%,SLC9A5;SLC9A3;LETM1;SLC9A7;SLC9A6
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.4329180516917833,0.9378395887451569,0.5422138836772983,0.9533708171767701,1.0,3/14,10.49%,MINDY1;ATXN3;MINDY2
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.43273086420570334,0.9367925940749809,0.5522935779816514,0.9518628118735506,1.0,4/13,12.15%,PIKFYVE;PIK3C2A;PIP4K2A;PIK3CB
prerank,zinc ion binding (GO:0008270),0.27073780589171936,0.9358177073665058,0.6189376443418014,0.9501886603752349,1.0,51/293,13.52%,SHANK3;MYRIP;PDE2A;SORD;GCH1;TNFSF10;KLF7;ARHGEF2;IFIH1;RNF125;BHMT2;PRDM2;SAMHD1;CRIP2;CLIP1;CD4;RPS29;ZDHHC20;KLF4;MSRB2;MSRB3;KAT6A;SHMT2;TIMM13;PDXK;ENPP2;TRIM24;SNRPC;PGGT1B;KDM4A;HPF1;ZMYND11;TIMM10;ZNF205;DUSP12;S100A8;CTCF;GRIN2B;RPS27;GTF2B;PPARG;CYLD;LTA4H;MT1F;MT1X;MT1M;MT1H;MT1A;MT1E;MT1G;MT1B
prerank,metal ion:proton antiporter activity (GO:0051139),0.4437960779959459,0.9358109645432079,0.5579322638146168,0.9463807139967638,1.0,5/13,9.42%,SLC9A5;SLC9A3;LETM1;SLC9A7;SLC9A6
prerank,MAP kinase activity (GO:0004707),-0.3886981173955859,-0.9354800440803208,0.5337837837837838,0.8886965012973888,1.0,1/14,0.68%,MAPK4
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.44407829643521823,0.9348619353859916,0.5626204238921002,0.9447619842233009,1.0,4/12,17.56%,OPN5;GPR52;OPN3;RRH
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.4227465703182176,0.9345057956777967,0.5285171102661597,0.9418948900997951,1.0,6/14,18.73%,KCNQ1;KCNH2;KCNJ3;KCNJ5;KCNA5;KCNIP2
prerank,dynactin binding (GO:0034452),-0.40435829859404565,-0.9344614445443307,0.5448717948717948,0.8858684208998748,1.0,5/12,23.65%,SNX6;BICD1;SNX5;BBS4;HTT
prerank,chloride channel activity (GO:0005254),0.32664607807782586,0.931791593592764,0.5762463343108505,0.9446458820937356,1.0,18/59,19.47%,TTYH2;CLCA2;GABRB1;CLCN3;CLIC4;TTYH3;GABRQ;CLCN7;GABRG1;CLCC1;CLIC1;GABRG3;PACC1;GABRA1;ANO3;GABRB2;GLRA2;ANO5
prerank,exopeptidase activity (GO:0008238),-0.2927573856872715,-0.9310326949420517,0.5769230769230769,0.8891724285362054,1.0,15/50,21.18%,ANPEP;FAP;NAALAD2;ACE;ENPEP;NPEPPS;DPP4;CTSH;CTSZ;ACE2;ZMPSTE24;CTSA;DPP7;XPNPEP3;GGH
prerank,protein heterodimerization activity (GO:0046982),0.278892783533413,0.9212754453813731,0.6514778325123153,0.9657393289026824,1.0,21/178,11.82%,HIP1;EPAS1;PDGFB;BCL2L1;ZHX3;FZD4;MEF2C;RALGAPA1;ABCG1;IKBKB;ATP1A1;MCL1;SRI;YWHAH;IRAK2;SIM1;CYBB;TPM4;MTTP;UBA3;HIF1A
prerank,UDP-glycosyltransferase activity (GO:0008194),-0.26986751656610297,-0.9198746928738305,0.6235294117647059,0.9114685439780372,1.0,6/70,4.19%,GXYLT2;B3GALT1;LARGE1;EXT1;MGAT4C;OGT
prerank,mitogen-activated protein kinase binding (GO:0051019),0.3716200354941609,0.9187495008437054,0.5774410774410774,0.9678406270306169,1.0,9/29,20.82%,GCH1;PTPRJ;DUSP7;DUSP1;DUSP16;DUSP8;TNIP1;ATF7;DUSP6
prerank,ubiquitin protein ligase binding (GO:0031625),0.2700425713250696,0.9184108972629024,0.6473372781065089,0.9648807080477823,1.0,60/254,19.23%,MFHAS1;FZD6;PRR5L;NFKBIA;FZD4;FOXO1;CD40;SMAD7;HSP90AB1;SLC25A5;PRKACB;ATXN3;FBXW7;RFFL;RALB;UBE2G1;PRKAR2B;JUN;KCNH2;MAP1LC3B;TUBB;KDM4A;CBS;ACTG1;UBXN1;PRKAR2A;TRIB2;AXIN2;SMAD5;CASP8;UBOX5;HSPA8;HIF1A;MID1;TNK2;GGN;ARRDC1;UQCRC1;RPL11;BCL10;TPI1;RBX1;DNAJA1;PRDX6;ELOB;RNF8;APC;HERC2;SUMO1;YWHAZ;RALA;BAG6;MAP1LC3A;HSPA9;SLF1;HLTF;UBE2D1;RPL23;TRAF3;USP25
prerank,receptor ligand activity (GO:0048018),0.2708667691660523,0.91605462296832,0.6432748538011696,0.9668433180133116,1.0,27/245,12.67%,KITLG;SEMA3C;SEMA7A;SEMA6A;PDGFB;TGFB2;JAG2;SEMA6B;WNT7A;NPPA;FGF16;SEMA4F;SEMA6D;TGFB1;TGFA;PTN;GREM1;FAM3D;PGF;SEMA4C;METRN;CNTF;PPY;TNFSF11;GDF15;TNFSF12;IL15
prerank,NAD-retinol dehydrogenase activity (GO:0004745),-0.38931052012109707,-0.915976729898175,0.5766590389016019,0.9158485582556791,1.0,2/14,17.38%,DHRS3;RDH10
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.26714159614281424,0.9131394893551923,0.6498237367802585,0.9696783449340787,1.0,62/269,19.23%,MFHAS1;FZD6;PRR5L;NFKBIA;FZD4;FOXO1;CD40;SMAD7;HSP90AB1;SLC25A5;PRKACB;ATXN3;FBXW7;RFFL;STAT1;RALB;UBE2G1;PRKAR2B;JUN;KCNH2;MAP1LC3B;TUBB;KDM4A;CBS;ACTG1;UBXN1;PRKAR2A;TRIB2;AXIN2;SMAD5;CASP8;UBOX5;HSPA8;HIF1A;MID1;TNK2;HGS;GGN;ARRDC1;UQCRC1;RPL11;BCL10;TPI1;RBX1;DNAJA1;PRDX6;ELOB;RNF8;APC;HERC2;SUMO1;YWHAZ;RALA;BAG6;MAP1LC3A;HSPA9;SLF1;HLTF;UBE2D1;RPL23;TRAF3;USP25
prerank,organic cation transmembrane transporter activity (GO:0015101),-0.37263848092081836,-0.9115739955878005,0.5443645083932853,0.9209464241804387,1.0,3/16,13.98%,SLC22A4;SLC5A7;SLC22A2
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.4036140149735382,-0.9113857257897415,0.55,0.9161097904628351,1.0,1/10,0.35%,PRKAG2
prerank,adenyl nucleotide binding (GO:0030554),-0.3997433672514986,-0.9105617041400463,0.5574837310195228,0.9076555697323725,1.0,3/11,13.66%,SIL1;BAG1;BAG3
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),-0.3997433672514986,-0.9105617041400463,0.5574837310195228,0.9076555697323725,1.0,3/11,13.66%,SIL1;BAG1;BAG3
prerank,mRNA methyltransferase activity (GO:0008174),0.4247886322003881,0.9095346347974413,0.5500910746812386,0.9743027430477158,1.0,6/12,23.95%,TRMT10C;CMTR2;TRMT61B;CMTR1;METTL3;PCIF1
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.2587560866321735,0.909273464908968,0.7044711014176663,0.9711462882351839,1.0,73/431,15.19%,MFHAS1;ABCC6;INSR;RHOBTB1;MAP4K2;MAP4K3;GCH1;RAB31;STK38;SNRK;ACVRL1;GBP7;GBP4;PRAG1;GBP5;ZAP70;ABCG1;TGM2;SARS2;ABCD4;ARF5;REM2;HSP90AB1;MTPAP;RHOB;PRKACB;RPS6KA5;ATP1A1;ATP1A3;RALB;DNM2;YARS2;RAP1B;FICD;ADSS2;PXK;MARK4;ARL4A;RAB39A;ARHGEF5;TWF2;MAP3K6;PDXK;TUBB;P2RX7;TAP2;MYO1F;HSPA8;EIF2B2;ABCD1;RAC1;HRAS;MMAA;RAB4A;TUBD1;ATP5F1A;RND1;MAP4K4;PANK3;PNPLA8;NOL9;STK3;MINK1;HACL1;MOV10L1;RHOV;PFKL;TBCK;STK26;DYNC1LI1;TUBB4B;TUBA1A;ARL4D
prerank,ribonuclease activity (GO:0004540),0.315353648815397,0.9077134957090208,0.5794117647058824,0.9711412288788276,1.0,18/56,22.45%,SAMHD1;PIWIL1;N4BP1;INTS11;RNASEK;RNASE1;CNOT6;RNASE12;TSNAX;PPP1R8;SND1;EXOG;ENDOG;EXOSC10;DICER1;EXOSC9;RNASE6;EXOSC8
prerank,steroid hydroxylase activity (GO:0008395),-0.3741346966177435,-0.9076865744423094,0.6069767441860465,0.90931568533497,1.0,3/16,5.39%,CYP7B1;CYP27A1;CYP1B1
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.40206963429490805,0.90744810768014,0.5865051903114187,0.9680749829120634,1.0,9/17,32.77%,AK4;CMPK1;NOL9;DTYMK;NME2;CMPK2;AK1;AK8;AK7
prerank,NF-kappaB binding (GO:0051059),0.37826310510280875,0.9060038012475228,0.5902777777777778,0.9678016639414881,1.0,6/24,20.35%,NFKBIA;FOXP3;BCL10;TAF4B;CPNE1;COMMD7
prerank,ubiquitin conjugating enzyme activity (GO:0061631),-0.31304001976994916,-0.9059741550001208,0.6128205128205129,0.9084043075002229,1.0,7/31,17.65%,UBE2E2;UBE2R2;UBE2E1;AKTIP;UBE2E3;UBE2B;UBE2Q1
prerank,phosphatase binding (GO:0019902),-0.2434829654639389,-0.9055822515496165,0.7094339622641509,0.9042328910925916,1.0,26/105,16.51%,EGFR;SMAD3;MAGI2;MAP3K5;IKBKE;ANAPC5;MAST2;DLG1;SH3RF2;DLG4;PDLIM4;AP3B1;MET;SPRED1;MTMR3;PPP1R3C;CRY2;RCAN3;TRPC4AP;HSP90B1;WNK1;PIK3R1;MAPK14;GTF2F1;MVP;NFATC2
prerank,semaphorin receptor activity (GO:0017154),-0.39750981329414253,-0.9035986361225956,0.5897435897435898,0.9042638381045811,1.0,2/11,6.78%,PLXNA2;PLXNB2
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.27392264435437574,0.903173584049824,0.6662484316185696,0.9706562598056407,1.0,19/173,8.69%,DACH1;ELK3;KLF12;PPARD;TBX3;BCL6B;LRRFIP1;SOX13;ZBTB16;PRDM2;HHEX;ETV6;SNAI2;MAX;INSM1;JUN;ZFP69;FOXP3;ZBTB14
prerank,DNA binding (GO:0003677),0.25008006440695013,0.9022339044152538,0.7916666666666666,0.9690809078727199,1.0,91/694,13.76%,LEF1;MECOM;ETS1;FLI1;ERG;EPAS1;KLF12;TRIM16;APP;ZIC3;TBX1;PPARD;TBX3;IMPDH1;LRRFIP1;RYBP;SMARCA2;ARID3B;FOXO1;FOXL2;SOX13;MEN1;YBX1;HMBOX1;KLF2;ZBTB16;PRDM2;IRF2;SAMHD1;HHEX;FOXF1;NTHL1;POGK;MRE11;SNAI2;ZCCHC3;AIM2;NKX2-8;STAT1;MAX;NR1H2;PALB2;IRF5;BRCA2;SOX12;HINFP;KAT6A;JUN;TSHZ2;FOXP3;PRDM9;ELK4;ZBTB14;ARID1A;SIM1;FANCG;DEDD2;HMGA1;ZMYND11;BANF1;MCM10;DNA2;LIN9;OASL;NR5A2;CBFB;TLR8;CTCF;RPS27;GTF2H4;ZBTB7A;HIF1A;MPG;JRK;SOX10;POLG2;TERF1;SLPI;PPARG;GTF3C5;WDR48;ZBTB33;POU2F1;CSRNP3;ORC1;TSNAX;SOX9;FAN1;RPS15;SNAPC1;HMGB2
prerank,mRNA binding (GO:0003729),-0.21838665850308203,-0.9014035936192072,0.8380281690140845,0.9044040732121802,1.0,49/249,17.23%,CELF2;RBMS3;SAMD4A;CPEB1;CPEB2;DDX5;SRRM2;RBMS1;HDLBP;RBPMS2;SRSF5;DCP1A;AUH;CSDC2;SNRNP70;AGO2;RBM47;YBX3;LUC7L3;ZC3H12B;PCF11;XPO5;FUBP1;FXR2;SRRM4;NOVA1;SRSF6;IGF2BP2;SRSF4;ACO1;RNF20;RBM5;LUC7L2;FMR1;HNRNPR;NSRP1;RBFOX1;DDX3X;PCBP4;LARP6;HNRNPA2B1;PABPC4;EIF2A;YTHDF1;TUT1;PABPC4L;FYTTD1;PCBP2;G3BP2
prerank,3'-5' exonuclease activity (GO:0008408),0.33382798415044973,0.8992486214873318,0.6152671755725191,0.9724817961165048,1.0,14/45,21.64%,CNOT6L;NOCT;MRE11;PDE12;PAN2;CNOT6;TRIR;DIS3L;REV3L;EXOSC10;EXOSC9;POLD1;XRN2;RAD1
prerank,histone acetyltransferase binding (GO:0035035),0.37984589447491784,0.8953291730304939,0.6043771043771043,0.9774477436765456,1.0,5/21,11.82%,EPAS1;STAT1;FOXP3;ZBTB7A;HIF1A
prerank,MAP-kinase scaffold activity (GO:0005078),0.42501688284538197,0.8949234006679604,0.5837837837837838,0.9747994249072759,1.0,3/11,8.39%,SH3RF1;SPAG9;IQGAP1
prerank,serine-type peptidase activity (GO:0008236),-0.24751579421445247,-0.894178777722526,0.726643598615917,0.9165576185608736,1.0,19/96,18.65%,PCSK5;HTRA3;F3;FAP;MMP2;NAALAD2;KLK2;DPP4;RHBDL3;HTRA1;CTSH;HTRA2;MASP1;PRSS12;RHBDF1;PARL;MBTPS1;PCSK6;GZMM
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.40137124104474803,0.8916531475673436,0.6019230769230769,0.9785421581790682,1.0,2/14,5.02%,SLC1A1;SLC1A2
prerank,SUMO binding (GO:0032183),-0.3828916907487034,-0.8910767353481355,0.6096491228070176,0.9184562195811945,1.0,6/13,21.97%,TDG;PML;HABP4;USPL1;UBA2;CASP8AP2
prerank,protein phosphatase activator activity (GO:0072542),0.4070685145483198,0.8894332606116717,0.6068840579710145,0.9801274976765799,1.0,4/13,14.64%,CALM1;PPP2R5A;PHACTR4;B3GAT3
prerank,calcium activated cation channel activity (GO:0005227),-0.3488112993538457,-0.8893429786970495,0.6405867970660146,0.9174062569067736,1.0,4/17,10.60%,ANO6;KCNMB2;ANO1;TRPM4
prerank,adenyl ribonucleotide binding (GO:0032559),0.25930343550872686,0.8890938980498575,0.71875,0.9772195113043869,1.0,50/291,14.59%,ABCC6;INSR;MAP4K2;PDE2A;RAPGEF2;MAP4K3;STK38;SNRK;ACVRL1;PRAG1;ZAP70;MYO6;ABCG1;SARS2;PDE4D;ABCD4;HSP90AB1;MTPAP;PRKACB;RAPGEF4;RPS6KA5;ATP1A1;ATP1A3;YARS2;FICD;PXK;MARK4;PDE4B;TWF2;MAP3K6;PDXK;P2RX7;TAP2;MYO1F;HSPA8;EIF2B2;ABCD1;ATP5F1A;HMGCR;MAP4K4;PANK3;PNPLA8;NOL9;STK3;MINK1;HACL1;MOV10L1;PFKL;TBCK;STK26
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.41552299325741515,0.8864051304094306,0.6256323777403036,0.979502648295597,1.0,3/13,16.55%,DCT;DDT;IDI1
prerank,ATPase activator activity (GO:0001671),-0.34466247774392716,-0.8855346170579562,0.6286407766990292,0.9208028326194739,1.0,7/20,24.52%,ATP1B3;ATP1B2;TOR1AIP1;DNAJB4;DNAJB2;DNAJC24;AHSA1
prerank,phospholipase activity (GO:0004620),0.29977291213153623,0.8853159893084404,0.6681818181818182,0.9782958147799472,1.0,9/67,12.55%,PLCB4;PLA2G4B;PNPLA6;PLD4;GDPD1;ENPP2;LYPLA1;LIPC;PNPLA8
prerank,telomerase RNA binding (GO:0070034),0.36614935919238556,0.8814243926780513,0.6033333333333334,0.9828996158069276,1.0,8/22,21.66%,HNRNPC;DCP2;SNRPB;NHP2;NAF1;EXOSC10;XRN1;PINX1
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.3022653651384928,0.8801662134155496,0.6525547445255474,0.9820853273820069,1.0,16/74,12.82%,DGKH;NT5C3A;DGKI;DGKE;CHKA;PKM;PGM2L1;PDXK;PIK3C3;PIK3C2A;HK1;IPMK;DGKZ;PIK3CB;PANK3;NOL9
prerank,neuropeptide hormone activity (GO:0005184),0.3687440086653628,0.8801209529010754,0.6141304347826086,0.9786164359002648,1.0,3/22,11.07%,NPPA;CALCB;PPY
prerank,ion gated channel activity (GO:0022839),0.3581884037409571,0.8789225118189841,0.6060126582278481,0.977725251072886,1.0,3/24,4.96%,TTYH2;TMEM63B;CLCA2
prerank,transforming growth factor beta binding (GO:0050431),0.36791463035155425,0.8776067950573062,0.6156462585034014,0.9772758824830886,1.0,5/23,5.46%,ENG;LTBP4;ACVRL1;HYAL2;NRROS
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.2987930236381105,0.8774813308850579,0.6761768901569187,0.9739918699142628,1.0,3/75,2.22%,ABCC4;SORD;IMPDH1
prerank,serine-type endopeptidase activity (GO:0004252),-0.24668756277071555,-0.8726878585237019,0.7677419354838709,0.9438885740341711,1.0,16/80,18.65%,PCSK5;F3;FAP;MMP2;KLK2;DPP4;RHBDL3;CTSH;HTRA2;MASP1;PRSS12;RHBDF1;PARL;MBTPS1;PCSK6;GZMM
prerank,CoA hydrolase activity (GO:0016289),-0.3491094815150977,-0.8720682261543602,0.6255813953488372,0.9400772522916725,1.0,3/16,12.03%,ACOT8;ACOT11;HIBCH
prerank,voltage-gated ion channel activity (GO:0005244),-0.35564650788269125,-0.869213139830372,0.6380090497737556,0.9411564108718793,1.0,2/14,4.66%,ANO6;PKD2
prerank,miRNA binding (GO:0035198),-0.2992992824438194,-0.8688151662945499,0.6666666666666666,0.9369956664057262,1.0,9/30,23.02%,TUT4;ZC3H7B;AGO2;FMR1;HNRNPA2B1;MATR3;ZC3H10;SPOUT1;RBM10
prerank,double-stranded DNA binding (GO:0003690),0.24369820020186006,0.8685848955240236,0.8132337246531484,0.989387048926471,1.0,70/531,12.94%,LEF1;FLI1;ERG;ELK3;KLF12;ZIC3;TBX1;PPARD;TBX3;BCL6B;MEF2C;FOXL2;BACH2;MEN1;YBX1;HMBOX1;KLF2;IRF2;GATA2;SOX7;CREB1;NTHL1;BARHL1;MRE11;TCF7;IRF9;SNAI2;ZCCHC3;KLF4;AIM2;NKX2-8;STAT1;MAX;POU3F4;IRF5;SOX18;PHOX2A;NFIC;SOX12;JUN;ATF6B;TERF2;TCF12;KLF6;FOXP3;ELK4;ZBTB14;KLF13;FOXQ1;ZMYND11;ZNF32;CEBPD;ATOH7;ELF2;PKNOX1;SMAD5;NR5A2;LHX5;GTF2H4;ZBTB7A;LHX9;ONECUT1;SOX10;POLG2;TFEB;LHX6;TERF1;ZNF250;PPARG;WDR48
prerank,ankyrin binding (GO:0030506),0.37720749292349803,0.8685317168020978,0.6240875912408759,0.9859683815880721,1.0,1/19,0.80%,SPTBN1
prerank,single-stranded DNA binding (GO:0003697),-0.23637233531321367,-0.8666001734020302,0.8246268656716418,0.9366488967223197,1.0,35/93,32.96%,SSBP2;TOP1;RBMS1;FBH1;TDP2;RAD51B;FUBP1;RBBP8;REXO4;SMC6;CRY2;NUCKS1;IGHMBP2;ERCC1;PCBP2;DMC1;CDC45;TDP1;MCM3;MCM4;MCM5;MCM9;HMGB1;NUP35;HMCES;RAD51AP1;SETMAR;DHX36;SPRTN;NEIL3;MEIOB;PCBP1;RAD52;POU4F1;MCM8
prerank,Wnt-activated receptor activity (GO:0042813),0.3930945249599012,0.8646612270815955,0.6198198198198198,0.9905246815939951,1.0,4/15,8.59%,FZD6;FZD4;TSPAN12;LRP5
prerank,general transcription initiation factor binding (GO:0140296),0.35377547041644747,0.8619913106505603,0.6443719412724307,0.9924114174499069,1.0,6/25,19.85%,HHEX;TAF1B;YEATS2;GTF2B;THRA;BRF2
prerank,N-acyltransferase activity (GO:0016410),0.34180824640649976,0.8618012859289407,0.6510500807754442,0.9892775454346633,1.0,4/32,5.58%,CERS4;TGM2;TLCD3B;GLYAT
prerank,gamma-tubulin binding (GO:0043015),0.360543702189447,0.8606193471839755,0.641914191419142,0.9881439062927321,1.0,8/22,17.65%,BRCA2;MARK4;ARHGEF7;CDK5RAP2;PAK1;GIT1;DIXDC1;NDRG1
prerank,acetylation-dependent protein binding (GO:0140033),-0.3368758177737697,-0.8593692639271174,0.669833729216152,0.9422963301525016,1.0,4/20,9.70%,ZMYND8;PSME4;MLLT3;BRD9
prerank,lysine-acetylated histone binding (GO:0070577),-0.3368758177737697,-0.8593692639271174,0.669833729216152,0.9422963301525016,1.0,4/20,9.70%,ZMYND8;PSME4;MLLT3;BRD9
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),-0.30125147145809417,-0.8588952412476973,0.685785536159601,0.9383598515601571,1.0,12/28,22.58%,PRKAA2;PRKACA;MAPKAPK3;LRRK2;MAPK14;MAP2K5;RPS6KB1;MAP2K3;TTK;MAP2K1;MAP2K4;MAP3K9
prerank,antiporter activity (GO:0015297),0.36264153048254566,0.8587387744696046,0.65,0.9885662844915687,1.0,4/20,12.39%,ATP1A3;CLCN3;SLC35E4;SLC35C1
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.3095512193473224,0.858183728850564,0.6640866873065016,0.986216671298968,1.0,14/49,19.25%,MINDY1;RNF169;UBXN1;OTUD7A;SHARPIN;MINDY2;UBQLN1;EPS15;TNFAIP3;RAD23A;BAG6;TNIP1;BRCC3;OTUD7B
prerank,growth factor activity (GO:0008083),0.2889252692815681,0.8556213206239871,0.7156726768377254,0.9882326217397922,1.0,7/74,10.58%,PDGFB;JAG2;FGF16;TGFA;PTN;PGF;CNTF
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.3971134710267136,0.8534377855139604,0.6194852941176471,0.9894354531165724,1.0,6/12,21.32%,CDK19;BRD4;CCNK;MAPK1;CDK6;CDK4
prerank,adrenergic receptor binding (GO:0031690),0.3756685217146345,0.8496243723252114,0.6519337016574586,0.9936310684860752,1.0,2/16,4.54%,RAPGEF2;PDE4D
prerank,peptide hormone receptor binding (GO:0051428),-0.36880143271729776,-0.848179918993726,0.6341991341991342,0.955161063511517,1.0,7/11,49.78%,PTHLH;VIP;GNRH1;UCN2;GPHB5;PSMC5;GHRH
prerank,phosphoric ester hydrolase activity (GO:0042578),-0.2717561777822909,-0.847973892215367,0.7272727272727273,0.9507156299807686,1.0,10/49,15.04%,ATP1A2;MPPED2;PXYLP1;PTPN22;LHPP;DUSP10;ACP6;ARMT1;PHOSPHO2;ACP2
prerank,protein-lysine N-methyltransferase activity (GO:0016279),-0.27627504458942187,-0.8467425652004322,0.712707182320442,0.9484264119453185,1.0,15/34,28.73%,EHMT2;SMYD3;SETD7;SETD4;EEF2KMT;KMT5B;EZH2;SETD2;KMT5A;SETD6;EEF1AKMT2;SMYD2;TTLL12;ANTKMT;METTL21C
prerank,retinoic acid receptor binding (GO:0042974),0.3656112857692868,0.8441041435716066,0.656084656084656,1.0,1.0,4/17,12.84%,ACTN4;TACC1;HMGA1;PPARG
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),-0.3295473102769977,-0.8425570527667751,0.687192118226601,0.9523500528076322,1.0,4/18,10.25%,ANXA2;ANXA1;CNN3;TMOD3
prerank,filamin binding (GO:0031005),0.39844564494506013,0.8421605358020349,0.6514285714285715,1.0,1.0,2/11,4.13%,NEBL;RFLNB
prerank,hexosaminidase activity (GO:0015929),-0.36895777556375364,-0.8418817405084965,0.6764044943820224,0.9487929211854566,1.0,4/12,13.88%,CEMIP;CEMIP2;HEXA;NAGA
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.3391182475329758,0.8405915544562121,0.6937394247038917,1.0,1.0,5/29,10.98%,ACER2;HYAL2;ACER1;PARG;MGAM
prerank,leucine zipper domain binding (GO:0043522),-0.3794318570079928,-0.8402470590630242,0.6359743040685225,0.9472359008096757,1.0,1/10,0.50%,PAWR
prerank,transforming growth factor beta receptor binding (GO:0005160),0.3622800309504251,0.8399810147167842,0.6518650088809946,0.9992984567083072,1.0,6/18,12.34%,ENG;TGFB2;SMAD7;TGFB1;FERMT2;TGFBR2
prerank,tau protein binding (GO:0048156),0.32020663422270124,0.8398461311844779,0.6892307692307692,0.9961866269566078,1.0,15/40,22.48%,ACTB;HSP90AB1;FYN;MARK4;PIN1;MARK3;GSK3A;BAG2;BIN1;DYRK1A;DCTN1;BRSK2;SNCA;PRKAA1;LGMN
prerank,acetyltransferase activity (GO:0016407),-0.28854516819235404,-0.8365895175002944,0.7135678391959799,0.9499557433336305,1.0,13/31,26.40%,KAT6B;SAT1;ELP3;NAA80;SPHK1;PAFAH2;EP300;SAT2;NAT8L;DBT;NAA50;CREBBP;KAT8
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.2332650025076169,0.8364120849762414,0.8976545842217484,0.9999231220174427,1.0,77/597,13.39%,LEF1;ETS1;FLI1;ERG;ELK3;KLF12;ZIC3;TBX1;PPARD;SOX17;TBX3;BCL6B;MEF2C;SMARCA2;FOXL2;SOX13;BACH2;MEN1;YBX1;HMBOX1;KLF2;IRF2;HHEX;GATA2;SOX7;CREB1;BARHL1;KLF1;TAL1;TCF7;IRF9;SNAI2;KLF4;NKX2-8;MAX;POU3F4;IRF5;SOX18;PHOX2A;NFIC;SOX12;HINFP;JUN;KCNH2;ATF6B;TCF12;KLF6;FOXP3;PRDM9;ELK4;CDK5RAP2;ZBTB14;KLF13;FOXQ1;ZNF32;CEBPD;MCM10;ATOH7;ELF2;PKNOX1;SMAD5;CDC6;NR5A2;LHX5;CTCF;ZBTB7A;LHX9;ONECUT1;SOX10;TFEB;LHX6;SOX11;ZNF250;PPARG;ZBTB33;ORC1;SOX9
prerank,chemokine receptor activity (GO:0004950),0.33802821378142156,0.8342459610307177,0.6722689075630253,1.0,1.0,5/24,17.12%,CCR7;GPR17;CXCR2;GPR75;CCR2
prerank,DNA secondary structure binding (GO:0000217),0.3332223195271581,0.8341565783730568,0.7008403361344537,0.9975852655805628,1.0,7/31,16.58%,MEF2C;MEN1;HMGA1;RECQL4;HMGB2;MSH2;HMGA2
prerank,potassium channel regulator activity (GO:0015459),-0.2565695220756028,-0.8299126986049347,0.7679083094555874,0.9578906391080361,1.0,6/49,6.15%,WNK4;KCNIP3;KCNMB2;ABCC9;DLG1;FLNA
prerank,chloride channel regulator activity (GO:0017081),0.37931394817203257,0.8285069564348012,0.6516464471403813,1.0,1.0,6/14,23.39%,STX1A;SGK1;SGK3;WNK2;VAMP8;STX8
prerank,bHLH transcription factor binding (GO:0043425),-0.31647349698909344,-0.828310393043826,0.6903669724770642,0.9563804675972815,1.0,2/19,1.40%,FHL2;SMAD3
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.37518431045140527,0.8280767570440548,0.6360485268630849,1.0,1.0,8/14,32.77%,AK4;CMPK1;DTYMK;NME2;CMPK2;AK1;AK8;AK7
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.25217208775117034,0.8270721208910528,0.8,1.0,1.0,21/181,8.90%,LMO2;PPARD;NFKBIA;TBX3;NCOA1;ZFPM1;ACTB;CTNNB1;TCF23;CREB1;TAL1;ACTN4;KLF4;STAT1;GTF2I;BUD31;NCOA2;TACC1;JUN;FOXP3;ARID1A
prerank,G protein-coupled receptor binding (GO:0001664),0.25890320711385356,0.8264366452141643,0.7779273216689099,0.9993132595031126,1.0,18/132,11.07%,CXCL12;REEP1;S1PR1;GNAI2;GNAQ;WNT7A;ZNRF3;HOMER2;GNA12;NPPA;INSL3;HOMER1;ARHGEF12;RTP4;UTS2B;CALCB;HSPA8;PPY
prerank,transaminase activity (GO:0008483),-0.3680177891882793,-0.8256984553820235,0.6760869565217391,0.9565078073963236,1.0,3/11,11.70%,ABAT;OAT;GOT1
prerank,hydro-lyase activity (GO:0016836),-0.26749113801803237,-0.822889975810108,0.7586206896551724,0.9571397017292604,1.0,20/41,26.70%,GMDS;HACD4;AUH;ECHDC2;HACD1;ACO1;ECHDC1;PCBD2;ECHDC3;EHHADH;CYP2S1;ENO2;ECI1;ENO3;HADHA;ALAD;L3HYPDH;ECHS1;UROS;ACO2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",-0.36361425440105044,-0.8209768156617756,0.6919642857142857,0.9559747179341052,1.0,1/10,6.61%,LACC1
prerank,protein serine/threonine kinase activity (GO:0004674),0.23669385755810726,0.8209737883734509,0.8830146231721034,1.0,1.0,72/335,18.24%,PRKCH;BMPR2;MAP4K2;MAP4K3;STK38;PKN3;KALRN;SNRK;RPS6KA1;ACVRL1;MAP3K1;PRKD1;STK10;PRKD2;CDK19;MAP3K8;PRKD3;IKBKB;PIKFYVE;MAST4;PKN1;STK19;LIMK2;PAK5;MAPK3;RPS6KA5;PKN2;MARK4;MARK3;MAP3K6;IRAK2;PAK1;EIF2AK4;STK33;BRD4;STK32C;SLK;PRKCB;GSK3A;SYK;CCNK;PDIK1L;MAP4K4;TGFBR2;RIOK1;HIPK2;CSNK2B;STK24;STK3;MINK1;PIM2;VRK1;SGK1;CAMK2B;GRK6;NEK3;HIPK3;PLK2;SGK3;SGK2;MAPK1;CPNE3;ACVR1;SIK2;TTN;MAP3K11;PRKCG;PRKCE;TBK1;PAK2;WNK2;CDK11B
prerank,sodium:proton antiporter activity (GO:0015385),0.4007979287737289,0.8204025390613996,0.6912028725314183,1.0,1.0,4/11,9.42%,SLC9A5;SLC9A3;SLC9A7;SLC9A6
prerank,GABA-A receptor activity (GO:0004890),0.3529313467034375,0.8185673700184498,0.6827094474153298,1.0,1.0,8/18,25.86%,GABRB1;GABRQ;GABRG1;GABRG3;GABRA1;GABRB2;GABRA2;GABRG2
prerank,solute:proton symporter activity (GO:0015295),0.36143115030640005,0.8161355896994854,0.6964285714285714,1.0,1.0,1/16,1.24%,SLC39A8
prerank,deubiquitinase activity (GO:0101005),0.2661381374446319,0.815919686837802,0.7763888888888889,1.0,1.0,23/88,20.14%,USP53;MINDY1;ATXN3;EIF3F;OTUD7A;MYSM1;MINDY2;PAN2;USP18;CYLD;TNFAIP3;COPS5;USP49;JOSD2;USP32;USP29;BRCC3;OTUD4;USP25;USP21;OTUD7B;DESI2;JOSD1
prerank,RNA 7-methylguanosine cap binding (GO:0000340),-0.34912547028247576,-0.8109294486044487,0.7048458149779736,0.9696696102564725,1.0,2/12,7.30%,CYFIP2;AGO2
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.33091511213646885,0.810340077986917,0.6937086092715232,1.0,1.0,4/28,11.45%,DAB2IP;STAT1;PIDD1;TNFSF11
prerank,retinoid X receptor binding (GO:0046965),0.38682605519093205,0.8095388987165555,0.6775431861804223,1.0,1.0,3/11,12.84%,TACC1;HMGA1;PPARG
prerank,signaling receptor complex adaptor activity (GO:0030159),0.30645280823635884,0.8057451434343743,0.7216,1.0,1.0,5/38,9.08%,SHANK3;CARD10;SORBS1;SPAG9;DEDD2
prerank,protein tyrosine kinase activator activity (GO:0030296),0.34244658769708014,0.8053173787686595,0.735494880546075,1.0,1.0,8/19,29.09%,AFAP1L2;GREM1;GAS6;PAK2;NRG3;EGF;GRM5;DGKQ
prerank,phosphatase activity (GO:0016791),0.27025271960112557,0.8031160450066195,0.7902511078286558,1.0,1.0,17/73,17.46%,PTPRJ;PTPMT1;DUSP23;DUSP3;PLPP6;NOCT;OCRL;PPP1CB;ACP4;DUSP12;DUSP16;ENOPH1;LPIN3;DUSP8;PLPPR4;PLPP2;MINPP1
prerank,voltage-gated potassium channel activity (GO:0005249),0.2694392564288801,0.8030732754157708,0.7926657263751763,1.0,1.0,20/80,19.44%,KCNH8;KCNQ1;KCNC2;KCNK6;KCNG2;KCNH2;KCNN2;KCNN3;KCNQ3;KCNV1;KCNA4;KCNH7;HCN2;KCNF1;KCNJ3;KCNJ5;KCNJ6;KCNA5;KCNIP2;KCNC1
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),-0.3256592064956363,-0.8027435781202718,0.7528604118993135,0.9797908074263353,1.0,2/15,13.00%,CCR9;CMKLR1
prerank,chemoattractant activity (GO:0042056),0.32158716918329533,0.8013892468543524,0.7220447284345048,1.0,1.0,1/26,0.84%,PDGFB
prerank,exoribonuclease activity (GO:0004532),0.3840402576149074,0.8013415750354019,0.6945996275605214,1.0,1.0,7/12,32.98%,CNOT6;EXOSC10;EXOSC9;EXOSC8;ZC3H12A;CNOT7;EXOSC3
prerank,peptide N-acetyltransferase activity (GO:0034212),0.39505025790116544,0.8008098319809984,0.7034883720930233,1.0,1.0,3/10,13.41%,NAA60;NAA16;NAA11
prerank,sodium channel activity (GO:0005272),-0.26632798799933627,-0.7998936494048584,0.7851239669421488,0.9800458044920387,1.0,3/37,4.91%,SCN7A;PKD2;CACNA1G
prerank,metallocarboxypeptidase activity (GO:0004181),-0.2856330406183798,-0.7980699424572489,0.7630922693266833,0.9784184945106009,1.0,6/26,15.39%,AEBP1;CPXM1;CPXM2;AGBL1;PEPD;ACE2
prerank,histone deacetylase activity (GO:0004407),-0.31099442622461565,-0.7945614334569325,0.7589285714285714,0.9798870783486853,1.0,3/19,6.86%,HDAC4;MIER3;SIRT3
prerank,H4 histone acetyltransferase activity (GO:0010485),-0.3579580558437691,-0.7911967106270047,0.75054704595186,0.9809326556049744,1.0,7/10,29.25%,HAT1;ATF2;EP300;NAA40;NAA50;KAT8;MSL3
prerank,kinase activator activity (GO:0019209),-0.277449212285244,-0.7863516899605174,0.801980198019802,0.9841492312662694,1.0,7/30,15.71%,PRKAG2;GPRC5C;STK11;STRADA;WNK1;WNT11;GPRC5A
prerank,ATP binding (GO:0005524),0.23154336897737005,0.7862662292200248,0.9191090269636577,1.0,1.0,43/266,14.59%,ABCC6;INSR;MAP4K2;MAP4K3;STK38;SNRK;ACVRL1;PRAG1;ZAP70;ABCG1;SARS2;ABCD4;HSP90AB1;MTPAP;PRKACB;RPS6KA5;ATP1A1;ATP1A3;YARS2;FICD;PXK;MARK4;TWF2;MAP3K6;PDXK;P2RX7;TAP2;MYO1F;HSPA8;EIF2B2;ABCD1;ATP5F1A;MAP4K4;PANK3;PNPLA8;NOL9;STK3;MINK1;HACL1;MOV10L1;PFKL;TBCK;STK26
prerank,Tat protein binding (GO:0030957),-0.35135108656715514,-0.7862226481004638,0.7443298969072165,0.9797663698532346,1.0,2/10,8.30%,MDFIC;SMARCB1
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.3829819250507773,0.7860966419630073,0.7355679702048417,1.0,1.0,1/10,2.13%,CD200
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.26784538133132196,0.7832518838556448,0.8052708638360175,1.0,1.0,14/69,16.94%,CERS4;ZDHHC14;ZDHHC9;GLYAT;ZDHHC20;KAT6A;AWAT2;ZDHHC18;LPCAT3;GTF2B;NAA16;MOGAT2;ZDHHC21;DGAT1
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),-0.2567490818381624,-0.7799609016128116,0.8285714285714286,0.9849472741502479,1.0,8/40,13.79%,DNMT3A;PCMT1;HNMT;NNMT;THUMPD3;ARMT1;COMT;PRMT8
prerank,DNA-binding transcription factor binding (GO:0140297),0.23659260459083625,0.7784800425348584,0.8858218318695107,1.0,1.0,38/189,17.74%,LMO2;PPARD;TBX3;MEF2C;ZFPM1;HDAC9;HDAC7;PTMA;HHEX;CTNNB1;TCF23;CREB1;TAL1;CRTC1;KLF4;STAT1;GTF2I;TLE4;JUN;TCF12;HSPB1;ZBTB7A;TLE1;EIF4E;PPARG;HIPK2;ZBTB17;BBS10;SP1;CTBP1;HDAC5;RBL1;HCFC1;MEF2D;YWHAZ;LYAR;SIN3A;USF1
prerank,bicarbonate transmembrane transporter activity (GO:0015106),0.35427040968966445,0.7783241056836219,0.726148409893993,1.0,1.0,1/15,1.24%,SLC39A8
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),-0.34222496809870706,-0.7773871934432177,0.770042194092827,0.9842793559800813,1.0,6/11,23.23%,CASP12;CASP3;CASP6;CASP4;PYCARD;CASP9
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.260356850017072,0.7753749915329802,0.8151862464183381,1.0,1.0,14/73,16.82%,HCRTR1;APLNR;CALCRL;OXTR;SORCS1;NLRP6;HCRTR2;NPR1;CYSLTR1;ADCYAP1R1;RXFP3;RXFP2;OPRD1;GLP1R
prerank,C-C chemokine receptor activity (GO:0016493),0.323218390741254,0.7752403492953157,0.7635726795096323,1.0,1.0,4/21,17.12%,CCR7;CXCR2;GPR75;CCR2
prerank,phosphatase activator activity (GO:0019211),0.3487781999708252,0.7745997594734484,0.7216117216117216,1.0,1.0,4/14,14.64%,CALM1;PPP2R5A;PHACTR4;B3GAT3
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.3423923141144239,0.7693770030910846,0.7580645161290323,1.0,1.0,3/16,10.50%,NTHL1;CD38;SMUG1
prerank,death receptor binding (GO:0005123),0.35246143299353977,0.7678743450889995,0.7319223985890653,1.0,1.0,2/15,8.31%,DAB2IP;PIDD1
prerank,GABA-gated chloride ion channel activity (GO:0022851),0.35524950236281033,0.7658635863685596,0.7236842105263158,1.0,1.0,7/12,25.86%,GABRB1;GABRG1;GABRG3;GABRA1;GABRB2;GABRA2;GABRG2
prerank,aspartic-type endopeptidase activity (GO:0004190),-0.3328876653194657,-0.7651291709380641,0.759825327510917,0.9985733944726854,1.0,3/12,15.68%,BACE2;PSEN1;HM13
prerank,RNA binding (GO:0003723),0.20886585833880858,0.7635167031921832,0.9969849246231156,1.0,1.0,313/1321,22.07%,TFRC;SORBS2;RBM20;SPTBN1;SYNE1;MACF1;NANOS3;NOVA2;QKI;FASN;PRPF38B;AGFG1;TRIM25;FLNB;LRRFIP1;MAP4;IFIH1;YBX1;NPM3;MSI2;TMSB4X;ADAR;SAMHD1;SARS2;SARS1;GRB2;SELENOH;NANOS2;NOCT;MRPL12;PIWIL1;HSP90AB1;RPL38;SLC25A5;MTPAP;EFTUD2;EIF4H;TLR3;NOL4;MRPL13;RPL13;NANOS1;PPIA;ACTN4;GPATCH1;PIN4;ZCCHC3;MRPL10;EDC3;RPL36A;PTBP3;MAK16;RPL3;ABT1;PKN2;STXBP1;ZNFX1;RNPS1;ACTN1;N4BP1;YARS2;BST2;RPL27;NPM2;RPSA;TLR7;MRPL14;JUN;SRP14;SNU13;TIAL1;PKM;NOP16;TDRD7;TWF2;EIF3E;RPS7;CSTF2;DHX37;RPL9;PDAP1;MSN;SNRPF;RPL18;SLC3A2;HNRNPC;SNRPC;GTPBP1;CCT3;PDCD11;RBM19;SCG3;EIF2AK4;LRRC47;MAGOHB;DNA2;RPL13A;EIF3D;OASL;EIF5A;ZCRB1;GFM1;HSPA8;HELZ2;HSPB1;TASOR;TLR8;RPS11;LARP1B;WDR36;RPL8;DCP2;MPHOSPH10;RBPMS;NCBP2;RPS27;PWP2;RPL19;GPKOW;NOL10;TRMT10C;RBM45;R3HDM1;UTP3;MRPL54;ATP5F1A;NELFCD;DXO;RPS9;MRPL28;ZFP36L1;MRPL20;RPP38;ASCC3;EIF4E;SLPI;ADAD1;RO60;EDF1;SNRPB;DCP1B;ZC3H11A;DHX32;PUM3;KMT2C;CCDC137;RBM42;TSNAX;RPL11;LTA4H;FSCN1;EIF3B;EIF3G;PPP1R8;ZC3H7A;RPL22L1;RPS15;HMGB2;PSTK;SRBD1;RPL37;METAP2;FAM98A;RPS28;STIP1;MOV10L1;SERBP1;RFTN1;ESF1;EIF3L;G3BP1;DYNC1LI1;RPS10;ELAVL1;UTP11;LBR;COA6;PNO1;TNS1;YTHDC2;ZBED4;TUBB4B;RTRAF;DDX55;FBRSL1;RALYL;IREB2;RCC2;NOC4L;FRG1;SND1;TSN;UBTF;EIF1B;NOL7;MRPL40;RPS25;AQR;MCRS1;MRPL44;ZC3HAV1;RPL37A;CS;YLPM1;MRPS9;MRPL9;PRPF40A;ZC3H13;ISG20L2;CPNE3;FAU;UBAP2;RPP21;DDX18;NHP2;RBFOX3;UNC50;SUMO1;EIF4A1;ALKBH8;YWHAZ;CSTB;NTPCR;NOL8;MYH10;ISY1;LYAR;SAMSN1;NUDT1;HSPA9;RPL15;RANGAP1;NAF1;HLTF;DEK;SF3A2;HSPE1;MSI1;CDK11B;DDX11;LSM4;RBM38;RRP12;SNRPD2;EXOSC10;S100A16;MRPL16;MRPL23;RPL17;RPL23;XRN1;RPL34;CMSS1;OTUD4;DICER1;PUF60;SUCLG1;MRPL39;HNRNPLL;CDC5L;CCDC9B;RBM8A;RBMS2;RPS18;RTCB;GTF2E2;NUDT16;WDR75;DAZL;ZFP36L2;MECP2;TRMT2A;EXOSC9;NOC2L;CAPRIN1;APEH;THUMPD1;JMJD6;HNRNPM;ASS1;ELAVL2;XRN2;MRPL21;GCN1;NSUN6;GRWD1;NVL;XPOT;RBM15;RPL21;RDX;RADX;LRPPRC;HSD17B10;RPS4X;DDX54;ARL6IP4;EIF3H;RPP30;METTL3;RPL18A;NCBP1;HMGN5;PINX1;TXN;RPS21;NUP42;ZNF638;SUB1;RACK1;PEF1;DUSP11;RBM27
prerank,chemokine activity (GO:0008009),0.2933079244968646,0.7631619800471694,0.7898193760262726,1.0,1.0,1/31,1.41%,CXCL12
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),-0.28646969677216316,-0.7598389293836469,0.8013856812933026,0.996871515041928,1.0,9/21,25.48%,CDK8;CDK14;CDK7;CDKL1;CDKL3;CDK5;CDK12;CDK10;CDK9
prerank,cyclin-dependent protein kinase activity (GO:0097472),-0.28646969677216316,-0.7598389293836469,0.8013856812933026,0.996871515041928,1.0,9/21,25.48%,CDK8;CDK14;CDK7;CDKL1;CDKL3;CDK5;CDK12;CDK10;CDK9
prerank,syntaxin binding (GO:0019905),0.26319364625170905,0.7581708380246626,0.8548621190130624,1.0,1.0,10/61,15.70%,CACNA1A;UNC13B;SYPL1;STXBP1;RAB11A;SYNPR;SNAP29;CPLX1;SYPL2;SCFD2
prerank,potassium channel activity (GO:0005267),0.2501711229830381,0.7579318796303699,0.8732782369146006,1.0,1.0,16/89,14.51%,KCNH8;KCNQ1;KCNC2;KCNK6;KCNG2;KCNH2;KCNN2;KCNQ3;KCNV1;KCNA4;KCNH7;GRIK5;GRIK2;HCN2;GRIK1;KCNF1
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),-0.3402043650187191,-0.757503194849288,0.775,0.9958578126253488,1.0,2/11,11.43%,AKR1B1;AKR1B10
prerank,protein serine/threonine kinase activator activity (GO:0043539),-0.25439558632080095,-0.756493027822918,0.8408488063660478,0.9927698065557023,1.0,6/34,14.30%,FAM20A;CCNT2;IGF2;CAB39L;STRADA;DDX3X
prerank,ADP binding (GO:0043531),-0.27525407930673096,-0.7558343755693105,0.8161764705882353,0.9892428511992988,1.0,2/25,4.11%,PRKAG2;ME1
prerank,voltage-gated cation channel activity (GO:0022843),0.24474544008345062,0.7546453747765203,0.8638239339752407,1.0,1.0,14/97,12.89%,KCNH8;CACNA1A;KCNQ1;KCNC2;CACHD1;KCNG2;GRIN3B;KCNH2;KCNQ3;KCNV1;KCNA4;GRIN2B;KCNH7;HCN2
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.35433554575148485,0.7528484487749697,0.7693726937269373,1.0,1.0,1/12,2.77%,NOD1
prerank,histone methyltransferase activity (GO:0042054),-0.2531323020791733,-0.751108870245266,0.8424068767908309,0.9916603596372614,1.0,10/32,20.68%,EHMT2;SMYD3;SETD7;PRMT5;PRMT8;KMT5B;EED;EZH2;SETD2;KMT5A
prerank,CCR chemokine receptor binding (GO:0048020),0.30186565903216606,0.749043475960863,0.8117443868739206,1.0,1.0,6/28,24.65%,NES;CCL1;CCR2;CCL25;CNIH4;NARS1
prerank,chemokine receptor binding (GO:0042379),0.279577261407827,0.7463383568419929,0.827140549273021,1.0,1.0,1/35,1.41%,CXCL12
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.32943723092293853,0.7455744494239883,0.7945454545454546,1.0,1.0,6/16,19.21%,INPP5F;MTMR6;MTMR12;MTMR2;SYNJ1;MTMR1
prerank,sequence-specific mRNA binding (GO:1990825),-0.33770253948947304,-0.7434424717568855,0.7734204793028322,0.9978290333249483,1.0,3/10,22.46%,FMR1;LARP6;RBM24
prerank,glycine binding (GO:0016594),0.3613303904163691,0.7406973992961506,0.7495327102803738,1.0,1.0,6/11,28.95%,GRIN3B;GRIN2B;GLRA2;GRIN1;GLRA1;GRIN3A
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.34060819405388465,-0.740550364719379,0.7870182555780934,0.9973209010427946,1.0,3/10,8.93%,FAP;NAALAD2;DPP4
prerank,nucleosomal DNA binding (GO:0031492),-0.2750996108618017,-0.7402654787778672,0.8348623853211009,0.9932631766699368,1.0,6/21,18.14%,SMARCC2;SMARCB1;CHD4;MBD2;SMARCC1;RBBP4
prerank,inward rectifier potassium channel activity (GO:0005242),0.3052015966207586,0.7401416155013817,0.807495741056218,1.0,1.0,7/24,18.39%,KCNK6;KCNH2;KCNN2;KCNN3;KCNJ3;KCNJ5;KCNJ6
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",-0.31630467146668817,-0.7382278085401119,0.8080357142857143,0.9916690606431063,1.0,5/12,16.81%,AOX1;SDHB;FXN;CISD2;FDX1
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.27243154159113775,0.7367087705694769,0.8607594936708861,1.0,1.0,13/42,24.77%,CCNY;CDKN2B;CCNI;CCND3;CCNK;CCNL2;CCNT1;KAT2B;CCNQ;CCNJL;INCA1;CDKN1B;CDKN2C
prerank,endopeptidase regulator activity (GO:0061135),-0.24331158662740407,-0.735870866158675,0.8994565217391305,0.9901632918210495,1.0,5/40,11.00%,TFPI;ITIH2;SERPIND1;RENBP;PSME3
prerank,3'-5' DNA helicase activity (GO:0043138),0.33051538972941147,0.7321645350115283,0.7985739750445633,1.0,1.0,3/16,12.65%,NAV2;RECQL4;ASCC3
prerank,single-stranded telomeric DNA binding (GO:0043047),0.3533902487794893,0.730442007550117,0.7734082397003745,1.0,1.0,5/11,29.30%,TERF2;TERF1;RPA1;NABP2;HNRNPA1
prerank,tau-protein kinase activity (GO:0050321),-0.2676968557476864,-0.7286633042420224,0.8364928909952607,0.9953242418339615,1.0,2/20,5.88%,ROCK2;MARK1
prerank,5'-nucleotidase activity (GO:0008253),0.3403988790851084,0.7279594713334624,0.7548845470692718,1.0,1.0,2/13,5.23%,NT5C3A;NT5C2
prerank,carbohydrate:cation symporter activity (GO:0005402),-0.3238926969104128,-0.7270220785782875,0.8134171907756813,0.9930228072764885,1.0,2/11,14.36%,SLC5A3;SLC2A10
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),-0.3049607672578294,-0.7231848058414514,0.8163716814159292,0.9935625477415577,1.0,3/13,11.20%,THUMPD3;TRMT10B;TRMT1L
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.30219294016131065,-0.7227507944431656,0.8231441048034934,0.989746749579087,1.0,3/13,15.25%,GABRA3;GLRB;GABRE
prerank,tumor necrosis factor receptor binding (GO:0005164),0.3403908919780257,0.7224385378393011,0.7838765008576329,1.0,1.0,5/12,24.92%,STAT1;TNFSF11;TRAF3;TRAF6;TRAF1
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.3049528092164485,0.7196820966549882,0.8249027237354085,1.0,1.0,4/21,13.66%,WASF2;KCNQ1;AKAP9;AKAP6
prerank,nuclease activity (GO:0004518),0.25886269658014344,0.7196720854684706,0.8820826952526799,1.0,1.0,13/52,18.00%,SAMHD1;NTHL1;MRE11;N4BP1;DFFB;DNA2;PDE12;RNASE1;RNASE12;SND1;ISG20L2;EXOG;ENDOG
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",-0.31911028815505293,-0.7184533273721996,0.7873303167420814,0.9905653786245645,1.0,1/12,1.07%,B3GALT1
prerank,GABA receptor activity (GO:0016917),0.2992108021930295,0.7182487963783996,0.8177083333333334,1.0,1.0,9/21,25.86%,GABRB1;GABRQ;GABRG1;GABRG3;GABRA1;GABRB2;GABBR2;GABRA2;GABRG2
prerank,receptor antagonist activity (GO:0048019),-0.2785458489431883,-0.7169081911119186,0.8401826484018264,0.9882557473717086,1.0,1/17,1.64%,DKK3
prerank,ligand-gated anion channel activity (GO:0099095),0.3145986527140457,0.7155838579625096,0.8082437275985663,1.0,1.0,9/17,25.86%,GABRB1;GABRG1;GABRG3;GABRA1;GABRB2;GLRA2;GABRA2;GLRA1;GABRG2
prerank,cysteine-type peptidase activity (GO:0008234),-0.20700185330874604,-0.7137639971092619,0.9569230769230769,0.9878017616914433,1.0,30/73,29.20%,USP11;USP24;CTSL;USP40;USP2;ATG4A;OTULINL;CTSH;USP42;USP9X;CTSZ;CASP3;USP50;SFRP1;CASP6;CASP4;USP16;USP13;OTULIN;GGH;USP15;CASP9;USP10;USP37;USP36;USP20;USP47;USP9Y;USP1;USP33
prerank,nucleotidase activity (GO:0008252),0.3245550616092212,0.7108561395080026,0.7996515679442509,1.0,1.0,2/15,5.23%,NT5C3A;NT5C2
prerank,ubiquitin binding (GO:0043130),-0.20852498425413693,-0.7098997261647623,0.9595959595959596,0.9877822758917745,1.0,23/73,24.37%,SMAD3;TSG101;PRKN;RNF31;OTULINL;AUP1;SIRT2;IKBKG;DNAJB2;USPL1;MVB12A;TOP2A;NBR1;USP16;USP13;ASCC2;RAE1;OTUB1;NEDD4;TOM1L1;UBAP1L;UBXN2A;UCHL3
prerank,thioesterase binding (GO:0031996),0.34048490413951044,0.7082337388164253,0.8014184397163121,1.0,1.0,6/11,29.35%,RAC1;TRAF3;TRAF6;TRAF1;CDC42;TRAF2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.2494943305379636,0.7076730581880853,0.9032258064516129,1.0,1.0,5/54,5.12%,ACER2;HDAC9;TGM2;HINT1;ACER1
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.3118601271408514,0.706977210025023,0.7993311036789298,1.0,1.0,1/16,5.35%,PIR
prerank,acyl-CoA hydrolase activity (GO:0047617),-0.27592208671660956,-0.7030304933271457,0.8514150943396226,0.9910883459271699,1.0,12/17,46.73%,ACOT8;ACOT11;PLA2G6;THEM4;ACOT1;ACOT13;ACOT12;ACOT2;ACAA2;BAAT;ACOT4;ACOT7
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.34137128748505535,0.7023258864089358,0.8096153846153846,1.0,1.0,3/11,13.41%,NAA60;NAA16;NAA11
prerank,cysteine-type endopeptidase activity (GO:0004197),-0.19936457441721467,-0.7007896869362369,0.9837662337662337,0.9893680801480801,1.0,30/78,29.20%,USP11;USP24;CTSL;USP40;CASP12;USP2;CTSH;USP42;USP9X;CTSZ;CAPN1;CASP3;SFRP1;CASP6;CASP4;USP16;USP13;PYCARD;USP15;CASP9;CAPN15;USP10;USP37;USP36;USP20;USP47;USP9Y;USP1;GPAA1;USP33
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.33053496238601676,0.700621615757507,0.8096947935368043,1.0,1.0,1/11,7.08%,CHRNB1
prerank,DNA replication origin binding (GO:0003688),0.2871534420575514,0.6973326376248395,0.8678929765886287,1.0,1.0,6/23,21.01%,MCM10;CDC6;ORC1;DDX11;GRWD1;POLA1
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.2923908187115576,0.6969644520001951,0.833922261484099,1.0,1.0,2/22,3.63%,ATP2C1;ATP6V0A1
prerank,ribosomal small subunit binding (GO:0043024),0.3139136462562515,0.6966034172640198,0.8321917808219178,1.0,1.0,10/17,28.37%,EIF4H;MTIF3;EIF1B;EIF4B;ABCE1;PIM1;ERAL1;PTCD3;EIF1;DHX29
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.3355019890450544,0.6958747407805432,0.7916666666666666,1.0,1.0,3/10,12.57%,CYBB;NCF4;NOX3
prerank,UDP-galactosyltransferase activity (GO:0035250),0.336083581753734,0.6937303197521165,0.8317214700193424,1.0,1.0,3/10,13.25%,B4GALT5;B3GALT4;B3GALT2
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),-0.2465575745471599,-0.6924265989564814,0.8740359897172236,0.9940112092281843,1.0,8/27,26.27%,POLR2A;POLR3K;POLR1C;PRIMPOL;POLR2L;POLR1D;POLR3A;POLR2I
prerank,ubiquitin-dependent protein binding (GO:0140036),0.3414591716210831,0.6920186968700253,0.8143939393939394,1.0,1.0,2/10,13.58%,ANKRD13A;FAN1
prerank,regulatory RNA binding (GO:0061980),-0.2245039576389402,-0.6909668350158331,0.9335180055401662,0.9913756802008429,1.0,11/38,23.02%,TUT4;ZC3H7B;AGO2;FMR1;HNRNPA2B1;MATR3;ZC3H10;TARBP2;PIWIL2;SPOUT1;RBM10
prerank,5'-3' RNA polymerase activity (GO:0034062),-0.24604484281136804,-0.690125762030012,0.8972972972972973,0.9881792246350961,1.0,8/27,26.27%,POLR2A;TENT2;POLR3K;POLR1C;POLR2L;POLR1D;POLR3A;POLR2I
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.27338782059774075,0.6893321375458032,0.8723051409618574,1.0,1.0,13/29,25.85%,PKIG;CDKN2B;PRKAR2B;PRKAR2A;HSPB1;RPTOR;KAT2B;INCA1;CDKN1B;SFN;CDKN2C;PRKAR1A;INKA2
prerank,DNA polymerase binding (GO:0070182),0.3001147742388213,0.6870806187359378,0.8397976391231029,1.0,1.0,7/18,25.09%,HSP90AB1;ACD;POLG2;LONP1;PTGES3;NABP2;SMARCA4
prerank,chloride channel inhibitor activity (GO:0019869),0.34266018078083227,0.6816229078750771,0.8485401459854015,1.0,1.0,1/10,2.69%,STX1A
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.3195601489825236,0.6791247174033765,0.8314606741573034,1.0,1.0,6/11,22.19%,NUDT3;DCP2;NUDT1;NUDT10;NUDT16;DCPS
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),-0.3072640603720027,-0.6786528234586462,0.8682008368200836,0.9953301462107002,1.0,5/10,23.23%,CASP12;CASP3;CASP6;CASP4;CASP9
prerank,RNA cap binding (GO:0000339),0.30652887240907045,0.676786493939235,0.830122591943958,1.0,1.0,7/16,22.19%,EIF3D;CYFIP1;NCBP2;EIF4E;EIF4A1;NCBP1;DCPS
prerank,sodium channel regulator activity (GO:0017080),-0.22213537525175536,-0.6764365580600178,0.9346733668341709,0.9931933160521325,1.0,3/37,3.85%,PTPN3;SNTA1;CAMK2D
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",-0.27752461876147316,-0.6745782425186769,0.8669527896995708,0.9908168483891602,1.0,4/14,17.41%,SDHB;ACO1;RSAD1;NDUFS1
prerank,P-type ion transporter activity (GO:0015662),0.31889543156813505,0.6727044712743524,0.8622641509433963,1.0,1.0,2/12,6.35%,ATP2C1;ATP2B1
prerank,glutathione transferase activity (GO:0004364),0.2826445837604308,0.6720636346210053,0.868421052631579,1.0,1.0,4/23,10.19%,MGST2;GSTA4;HPGDS;GSTK1
prerank,carboxypeptidase activity (GO:0004180),0.25396912549977607,0.6663093870383885,0.9035947712418301,1.0,1.0,5/35,10.49%,MINDY1;VASH1;CPD;AGBL5;MINDY2
prerank,damaged DNA binding (GO:0003684),-0.21519852850233862,-0.6654319128491996,0.9545454545454546,0.9945632210417359,1.0,22/44,36.18%,RBBP8;TDG;DDB2;SMC6;CRY2;XRCC1;EP300;SDE2;ERCC1;CUL4B;NBN;HMGB1;CREBBP;ERCC2;NEIL3;APEX1;FEN1;RAD18;AUNIP;UNG;DCLRE1A;ERCC5
prerank,C-C chemokine binding (GO:0019957),0.2757686364143851,0.6646610370679623,0.8852173913043478,1.0,1.0,2/22,8.20%,CCR7;CXCR2
prerank,thyroid hormone receptor binding (GO:0046966),-0.23525380604865748,-0.6617972321173573,0.9396135265700483,0.9935328800208213,1.0,11/28,27.31%,HMGN3;BRD8;TRIP12;MED30;NCOR1;NSD1;MED4;GTF2H1;MED24;MED16;PRMT2
prerank,hormone activity (GO:0005179),-0.20065412807173794,-0.6564658848393896,0.9696969696969697,0.9938378181828729,1.0,1/54,0.34%,IGF1
prerank,snoRNA binding (GO:0030515),-0.2200529333631553,-0.6529951817086225,0.9525065963060686,0.9925978323309662,1.0,5/30,16.68%,NUDT4;NOP14;XRCC5;GAR1;NOP56
prerank,calcium-activated potassium channel activity (GO:0015269),0.3084423168501348,0.6525503880535284,0.8590476190476191,1.0,1.0,2/11,8.26%,KCNN2;KCNN3
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.30481551789010836,0.6499883054508204,0.8387681159420289,1.0,1.0,3/12,20.49%,SLC25A5;SLC35B3;SLC25A23
prerank,kinesin binding (GO:0019894),0.26312629453570824,0.6426575521585526,0.9182282793867121,1.0,1.0,6/27,17.73%,ACTB;CLSTN1;SPAG9;AP1G1;AP1AR;ARHGEF10
prerank,magnesium ion binding (GO:0000287),0.20032407354816714,0.6420501925052438,0.9870466321243523,1.0,1.0,36/135,22.51%,PDE2A;STK38;SNRK;HPRT1;NT5C3A;MTPAP;PRKACB;IDH3A;MAP3K6;PDXK;HPGDS;NUDT3;DXO;CERK;STK3;FAN1;HACL1;XYLT2;MOV10L1;PDCD6;STK26;MSH2;NLRC4;SIK2;CIB2;TPPP;ADPRS;PGP;NUDT16;MAP2K7;BRSK2;MAST1;SNCA;SIK3;PAPOLA;CDC42BPA
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.2858496117448201,-0.6405689533084785,0.8976545842217484,0.9984209266749712,1.0,2/10,15.25%,GABRA3;GABRE
prerank,GDP binding (GO:0019003),-0.18797417712749184,-0.6398659887079543,0.9938837920489296,0.9948933341499414,1.0,18/63,24.91%,ARL3;TRIM23;RAB21;MRAS;RASL12;MIEF1;RHEB;RIT1;RAB29;GNAI3;RAB11B;RAB22A;RAB14;RERG;RAP2A;RAB9A;RAP2C;RASEF
prerank,beta-tubulin binding (GO:0048487),0.2521410848589286,0.6392255110093584,0.9203821656050956,1.0,1.0,4/31,10.99%,TTLL7;FGF13;CCT5;PEX14
prerank,protein kinase activator activity (GO:0030295),0.22338445810852675,0.6366589828570774,0.9569093610698366,1.0,1.0,6/60,8.39%,AFAP1L2;RGCC;FGF13;CALM1;IRGM;IQGAP1
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),-0.230595576615297,-0.6360143815767284,0.9451073985680191,0.9937949701239632,1.0,8/22,22.15%,IKBKE;ZRANB3;ZBTB1;IKBKG;OPTN;ATRIP;WDR81;TAB3
prerank,E-box binding (GO:0070888),0.2449719062769462,0.6354410802083631,0.9149922720247295,1.0,1.0,5/34,12.84%,TAL1;SNAI2;MAX;CIART;PPARG
prerank,mannose binding (GO:0005537),-0.27145880582485177,-0.6326473398413884,0.9225512528473804,0.9921835888409264,1.0,9/12,52.26%,LMAN1;LMAN2L;COLEC11;LMAN2;CLEC4D;ACR;CLEC6A;CD207;LMAN1L
prerank,NADP binding (GO:0050661),0.25102137984659467,0.6322835278795877,0.9461279461279462,1.0,1.0,6/32,14.82%,NOS3;NOS2;CAT;HMGCR;LBR;QDPR
prerank,rRNA binding (GO:0019843),-0.19939015376099684,-0.6296968023316347,0.9807162534435262,0.9903920778603068,1.0,13/42,27.07%,MRPS27;MTERF4;PPAN;EMG1;RCC1L;UTP23;CIRBP;MRPS6;MRPL18;FASTKD2;ERI1;RPS5;NOP53
prerank,deoxyribonuclease activity (GO:0004536),0.2862373702472807,0.6278080914400944,0.894927536231884,1.0,1.0,2/14,9.03%,MRE11;DFFB
prerank,tRNA binding (GO:0000049),-0.19826023346120866,-0.627036563982991,0.9914772727272727,0.9881402215596028,1.0,20/43,30.76%,TRMT9B;DALRD3;MRPS27;TRMT10B;NSUN2;ALKBH1;ELP5;IGHMBP2;EIF2A;RPUSD4;DARS2;TYW5;FARS2;TRNAU1AP;AIMP1;SEPSECS;PTCD1;KARS1;TERT;CTU1
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.24444885340956077,0.6223964351053073,0.9365079365079365,1.0,1.0,7/34,21.84%,NDUFA2;NDUFA8;NDUFA4;NDUFA12;NDUFB3;NDUFC1;NDUFA10
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.24444885340956077,0.6223964351053073,0.9365079365079365,1.0,1.0,7/34,21.84%,NDUFA2;NDUFA8;NDUFA4;NDUFA12;NDUFB3;NDUFC1;NDUFA10
prerank,four-way junction DNA binding (GO:0000400),0.2750637936718837,0.6212942270471109,0.8971631205673759,1.0,1.0,3/17,15.56%,MEN1;HMGB2;MSH2
prerank,neuropeptide binding (GO:0042923),0.26789967924951885,0.6172980635521121,0.9125874125874126,1.0,1.0,4/18,25.80%,OPRD1;SSTR1;OPRM1;GPR149
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.25797490713595383,0.6150762085074171,0.9207419898819561,1.0,1.0,3/21,12.88%,CHRNB1;P2RX7;GRIK2
prerank,ferrous iron binding (GO:0008198),-0.22743630931152897,-0.6114191881017111,0.9364303178484108,0.993749565500112,1.0,4/21,12.53%,EGLN3;FXN;PHYH;ALKBH1
prerank,phospholipase A2 activity (GO:0004623),0.24559381925063622,0.6109584904992317,0.9422750424448217,1.0,1.0,3/26,14.91%,PLA2G4B;PNPLA8;PRDX6
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.2997868312776583,0.6105568023584869,0.8712121212121212,1.0,1.0,2/10,13.58%,ANKRD13A;FAN1
prerank,protein-arginine N-methyltransferase activity (GO:0016274),-0.26905726600636687,-0.6104207762428445,0.8984198645598194,0.9905372877769676,1.0,3/11,14.99%,PRMT5;PRMT8;PRMT9
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),-0.267782784234903,-0.6084961242363309,0.9193899782135077,0.9878074260205788,1.0,3/11,26.27%,SLC25A24;SLC35B2;SLC25A42
prerank,ribonuclease P RNA binding (GO:0033204),0.2923000804129405,0.6045035178681448,0.8901098901098901,1.0,1.0,3/10,21.47%,RPP38;RPP21;RPP30
prerank,pyrophosphatase activity (GO:0016462),0.21669002290999764,0.604048670521881,0.9698795180722891,1.0,1.0,12/50,22.31%,ENTPD1;ENTPD5;NUDT3;DCP2;DXO;NUDT9;DOLPP1;NUDT1;NUDT10;NUDT16;DCPS;BNIP2
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.21469565092829826,0.6034306067219669,0.984375,1.0,1.0,18/57,27.64%,NDUFA2;NDUFA8;NDUFA4;CYB561A3;UQCRC1;NDUFA12;NDUFB3;NDUFC1;UQCRQ;COX10;UQCR11;NDUFA10;COX15;NDUFA7;COX7A2L;UQCR10;NDUFS5;COX5B
prerank,thiol-dependent deubiquitinase (GO:0004843),0.1982739424791567,0.6029949109517859,0.9858757062146892,1.0,1.0,20/83,20.14%,USP53;ATXN3;OTUD7A;MYSM1;PAN2;USP18;CYLD;TNFAIP3;COPS5;USP49;JOSD2;USP32;USP29;BRCC3;OTUD4;USP25;USP21;OTUD7B;DESI2;JOSD1
prerank,RNA polymerase binding (GO:0070063),-0.23478835199378512,-0.6004914458649795,0.9347826086956522,0.9882953134927809,1.0,5/18,22.11%,CCNT2;PABPN1;BRCA1;TCERG1;NEDD4
prerank,omega peptidase activity (GO:0008242),0.1963624048244323,0.5990059318696901,0.9929873772791024,1.0,1.0,22/89,20.20%,USP53;ATXN3;OTUD7A;MYSM1;PAN2;USP18;ASRGL1;CYLD;TNFAIP3;COPS5;USP49;JOSD2;USP32;USP29;BRCC3;OTUD4;USP25;USP21;OTUD7B;DESI2;JOSD1;APEH
prerank,U6 snRNA binding (GO:0017070),0.2732796764927582,0.5939516756268237,0.8946428571428572,1.0,1.0,5/14,25.82%,EIF5A;PRPF4;LSM4;PRPF8;SART3
prerank,exonuclease activity (GO:0004527),0.2194714545912078,0.5900341730025529,0.9751166407465007,1.0,1.0,16/46,22.45%,MRE11;ENPP2;PDE12;CNOT6;DXO;FAN1;TRIR;ISG20L2;EXOG;REV3L;EXOSC10;EXOSC9;XRN2;RAD1;DCLRE1C;EXOSC8
prerank,mRNA 5'-UTR binding (GO:0048027),-0.217255688901901,-0.5890773624486313,0.9703703703703703,0.9903291756453784,1.0,10/24,28.91%,IGF2BP2;FMR1;DDX3X;LARP6;UTP23;NCL;SHMT1;SYNCRIP;IGF2BP1;DHX36
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.26545258842399844,0.5877033222591271,0.9040852575488455,1.0,1.0,4/13,24.16%,DNA2;FAN1;DICER1;GEN1
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),-0.2276498032543158,-0.5858080096971157,0.9497607655502392,0.9881144059553049,1.0,10/20,31.45%,SENP3;OTULINL;USP9X;USP50;OTUB1;SENP5;OTUD5;USP47;YOD1;UFSP2
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",-0.24299065297079703,-0.5841591022351841,0.9260969976905312,0.9849970244016216,1.0,5/14,22.48%,NOX4;CYBA;MICAL1;KMO;NOX1
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.2585115906516175,0.5798565899812174,0.9338103756708408,1.0,1.0,2/15,7.17%,SNX3;PLEKHA5
prerank,endodeoxyribonuclease activity (GO:0004520),-0.2193004992081407,-0.5779621094147278,0.981042654028436,0.9842147507357532,1.0,5/20,15.95%,RBBP8;ENDOV;ZRANB3;ERCC1;RAD50
prerank,snRNA binding (GO:0017069),0.2075217718885391,0.5712538414028364,0.9786585365853658,1.0,1.0,13/42,25.82%,EFTUD2;SNU13;SNRPC;EIF5A;NCBP2;PRPF4;SNRPB2;LSM4;CCNT1;SF3B3;PRPF8;SNRPA;SART3
prerank,endonuclease activity (GO:0004519),0.2059387064815647,0.5711768885649047,0.9790660225442834,1.0,1.0,16/49,27.16%,NTHL1;PIWIL1;MRE11;INTS11;RNASEK;TSNAX;SND1;EXOG;ENDOG;DICER1;ERCC4;KHNYN;ZC3H12A;PNKP;AGO1;ENDOU
prerank,endoribonuclease activity (GO:0004521),0.2158626131969815,0.5692851602443704,0.964110929853181,1.0,1.0,13/32,27.16%,PIWIL1;INTS11;RNASEK;TSNAX;SND1;EXOG;ENDOG;DICER1;RIDA;KHNYN;ZC3H12A;AGO1;ENDOU
prerank,single-stranded RNA binding (GO:0003727),0.21618071177856593,0.5686825453499811,0.9770642201834863,1.0,1.0,15/43,27.14%,IFIH1;EIF4H;TLR7;SNRPC;TLR8;AQR;DDX11;EXOSC10;JMJD6;EIF4B;ADARB2;LONP1;DDX60;HNRNPF;AGO1
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.2680634664887289,0.5643388972770944,0.9326047358834244,1.0,1.0,2/11,16.58%,NTHL1;HMGA2
prerank,purinergic nucleotide receptor activity (GO:0001614),-0.22688175033491004,-0.562766581523488,0.9478458049886621,0.9868731121115555,1.0,2/15,9.43%,P2RX4;P2RY14
prerank,neuropeptide receptor activity (GO:0008188),0.22167724760658003,0.560121780360907,0.9581320450885669,1.0,1.0,7/29,25.66%,SORCS1;HCRTR2;NPY5R;SSTR1;GRPR;OPRM1;SORCS3
prerank,microtubule plus-end binding (GO:0051010),0.23843114695058576,0.5583508922840249,0.9316987740805605,1.0,1.0,7/20,21.14%,CLIP1;MAPRE2;MAPRE3;APC;CLIP2;DCTN1;CLASP1
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.2350024579822844,0.5562325885436663,0.9464285714285714,1.0,1.0,4/22,19.35%,MESD;AP2M1;DNAJA1;LRPAP1
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.2199782863772849,0.5515780187402675,0.964406779661017,1.0,1.0,8/28,21.47%,EDC3;ELAC1;RPP38;MRPL44;RPP21;DICER1;NUDT16;RPP30
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.2520178211461689,0.5509114333035006,0.9509433962264151,1.0,1.0,5/14,19.21%,MTMR6;MTMR12;MTMR2;SYNJ1;MTMR1
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.23728190464699506,0.5401839082694143,0.9615384615384616,1.0,1.0,3/18,21.07%,HSD17B7;HSD17B8;HSD17B10
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.20592672753460417,0.53558930359093,0.9934102141680395,1.0,1.0,9/35,21.25%,NT5C3A;PTRH2;ELAC1;DTWD2;GATC;TRMT12;MRPL58;TRMT5;QTRT2
prerank,acetylcholine receptor activity (GO:0015464),0.22189409684929187,0.5332332881991615,0.9703832752613241,1.0,1.0,2/22,10.93%,CHRNB1;CHRM3
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.19948555058548897,0.5227160437032121,0.990228013029316,1.0,1.0,14/37,28.48%,SARS2;SARS1;YARS2;GARS1;TARS3;FARSB;PARS2;CARS1;NARS1;IARS2;HARS1;VARS1;MARS2;LARS2
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.2595568388676169,0.5185751348431126,0.9533582089552238,1.0,1.0,10/10,74.06%,POLD1;DCLRE1C;EXD2;DCLRE1B;MGME1;DCLRE1A;FEN1;APEX1;TATDN1;EXO1
prerank,nuclear import signal receptor activity (GO:0061608),-0.2079002215393287,-0.5177768804270505,0.9706546275395034,0.9974635633069845,1.0,5/15,26.84%,KPNA3;KPNB1;HIKESHI;KPNA6;KPNA1
prerank,telomeric DNA binding (GO:0042162),0.2017505342437482,0.5140982732084536,0.9814814814814815,1.0,1.0,4/32,12.47%,HMBOX1;TERF2;ACD;TERF1
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.21381909547738687,0.5017504095806196,0.9780405405405406,1.0,1.0,21/21,78.65%,CHRNB1;GRM5;GRIA1;GRM1;CHRNA2;CHRNA6;DRD4;DRD1;CHRNA1;DRD5;CHRNB3;CHRNB4;CHRNE;CHRNA3;CHRNG;CHRNA5;CHRNA7;CHRFAM7A;CHRNB2;CHRNA4;ANXA9
prerank,myosin V binding (GO:0031489),0.2263608748369848,0.5005335230691734,0.9741379310344828,1.0,1.0,2/15,10.48%,RAB11A;RAB3B
prerank,androgen receptor binding (GO:0050681),0.20046185525637852,0.4951039618638638,0.9783333333333334,1.0,1.0,13/25,29.83%,PKN1;PRKCB;ZBTB7A;TRIM68;FOXP1;KDM3A;DAXX;CALR;SMARCA4;SNW1;KDM4C;PARK7;PRPF6
prerank,NADPH binding (GO:0070402),0.2254263489879867,0.49149572533939967,0.9713774597495528,1.0,1.0,3/13,14.82%,HMGCR;LBR;QDPR
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.21978125489297862,0.49136678423187974,0.9663551401869159,1.0,1.0,1/16,3.63%,ATP6V0A1
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.21978125489297862,0.49136678423187974,0.9663551401869159,1.0,1.0,1/16,3.63%,ATP6V0A1
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.2110610020622329,0.47000442670016507,0.9836065573770492,1.0,1.0,4/15,24.41%,PRDM9;KMT2C;RBBP5;WDR82
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.19450717786039573,0.46988006282447126,0.9866666666666667,1.0,1.0,3/22,14.39%,HTR2A;CHRM3;HTR4
prerank,G protein-coupled amine receptor activity (GO:0008227),0.19450717786039573,0.46988006282447126,0.9866666666666667,1.0,1.0,3/22,14.39%,HTR2A;CHRM3;HTR4
prerank,serotonin receptor activity (GO:0099589),0.19450717786039573,0.46988006282447126,0.9866666666666667,1.0,1.0,3/22,14.39%,HTR2A;CHRM3;HTR4
prerank,tRNA methyltransferase activity (GO:0008175),0.20808182785812737,0.4669453030947965,0.9739583333333334,1.0,1.0,7/16,26.67%,TRMT12;METTL2B;METTL2A;ALKBH8;TRMT5;TARBP1;TYW3
prerank,O-methyltransferase activity (GO:0008171),0.22793316839532915,0.458110575376295,0.9794776119402985,0.9999834304929496,1.0,3/10,21.17%,CMTR2;CMTR1;COQ3
prerank,methyltransferase activity (GO:0008168),0.1655926239233341,0.44751844696576487,0.9985141158989599,0.9993030762833521,1.0,15/46,28.31%,LCMT1;EEF1AKMT3;NDUFAF7;MGMT;MRM2;COMTD1;PRMT7;COQ3;METTL3;GCSH;TRMT11;EEF1AKMT4;SUV39H1;DNMT1;DNMT3B
prerank,RNA methyltransferase activity (GO:0008173),-0.17173730981541832,-0.4458229238717802,0.9954128440366973,1.0,1.0,2/19,9.03%,TRMT9B;TGS1
prerank,tRNA-specific ribonuclease activity (GO:0004549),-0.1767065976249612,-0.4244169955998934,1.0,1.0,1.0,3/14,19.15%,PRORP;POP4;TSEN2
prerank,cytochrome-c oxidase activity (GO:0004129),0.1838112408613849,0.41689882436693537,0.9961832061068703,1.0,1.0,7/15,31.47%,NDUFA4;COX10;COX15;COX7A2L;COX5B;COX4I1;COX8A
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),-0.17354178439128526,-0.4149881481101546,0.9976798143851509,1.0,1.0,14/14,82.67%,CAPN1;CAPN15;CAPN11;CAPN5;CAPN8;CAPN3;CAPNS2;CAPN9;CAPN13;CAPN6;CAPNS1;CAPN10;CAPN12;CAPN2
prerank,ribonuclease P activity (GO:0004526),0.18709731491166046,0.3926639324953218,0.9963833634719711,1.0,1.0,3/11,21.47%,RPP38;RPP21;RPP30
prerank,proton transmembrane transporter activity (GO:0015078),-0.12554616364320814,-0.3792598172118292,1.0,0.9992010761318707,1.0,9/39,24.57%,SLC9A1;COX6A1;UQCRFS1;SLC33A1;NNT;ATP6V1F;COX6B1;CLCN4;SLC11A2
prerank,single-stranded DNA helicase activity (GO:0017116),0.14024620022610218,0.3210232859038846,0.9983164983164983,0.999829338592233,1.0,19/19,85.99%,DNA2;CHTF18;RFC2;RFC4;WRNIP1;MCM6;HELQ;DHX9;RAD51;MCM7;MCM2;CHTF8;POLQ;PIF1;DSCC1;RFC5;MCM5;RFC3;HELB
